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2. Abstract  
Congenital limb malformations occur in 1 in 500 to 1 in 1000 human live births and are 
diverse in their epidemiology, aetiology and anatomy. The molecular analysis of disturbed 
gene function in inherited limb malformations provides essential information for the 
understanding of physiological and pathophysiological limb development in humans as well 
as in other vertebrates. The following Ph.D thesis focussed on the identification and molecular 
characterisation of disease causing genes and their pathophysiological mechanism for selected 
human limb defects such as Cenani-Lenz syndrome (CLS), Werner mesomelic syndrome 
(WMS), Bardet-Biedl syndrome (BBS), Split hand/ foot malformation (SHFM) and Temtamy 
preaxial brachydactyly syndrome (TPBS). 
In this context, we were able to identify novel limb specific genes and causative mutations in 
different components of evolutionary highly conserved pathways and, furthermore, to 
elucidate their role in physiological as well as in pathophysiological limb development. In 
detail, we found (i) alterations in the low-density-lipoprotein-related protein 4 (LRP4), an 
antagonistic receptor of Wnt signalling, causing the rare autosomal recessive CLS, (ii) 
specific mutations in the cis-acting limb-specific enhancer of the sonic hedgehog (SHH) gene 
being causative for WMS, and (iii) mutations in CHSY1 to be responsible for TPBS. 
Furthermore, we could show that mutations in the ciliary protein BBS12 can cause a very 
mild BBS phenotype. 
Moreover, we used in vitro studies to obtain insights into the molecular pathogenesis of these 
limb malformations. We studied the effect of five LRP4 mutants on the transduction and 
activation of canonical Wnt signalling by using a Dual-Luciferase Reporter Assay and 
showed that co-expression of each of the five missense mutations with LRP6 and WNT1 
abolish the known antagonistic effect of LRP4 on LRP6-mediated activation of Wnt/ß-catenin 
signalling and thus conclude that homozygous LRP4 mutations in CLS cause a loss of protein 
function.  
Additionally, we functionally characterized the first autosomal recessive p.R332W mutation 
in the WNT10b gene causing SHFM6 and rise evidence that p.R332W causes loss of function 
of Lrp6-mediated Wnt signalling. In this regard we examined the role of the SHFM3 
candidate gene Fgf8 in altering Wnt signalling and demonstrated that Fgf8 is a novel putative 
Wnt signalling antagonist which functions by direct interaction with Wnt10b. Hence, we 
present the first direct cross-talk between Fgf and Wnt signalling pathways and, therefore, 
physically link two important signalling pathways involved in limb initiation and outgrowth. 
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2. Zusammenfassung 
Congenitale Extremitätenfehlbildungen treten mit einer Inzidenz von 1 in 500 bis zu 1 in 1000 
Lebendgeburten auf und sind in ihrer Epidemiologie, Ätiologie und Anatomie sehr 
mannigfaltig. Die molekulare Analyse von krankheitsverursachenden Genen liefert wichtige 
Erkentnisse über physiologische und pathophysiologische Mechanismen der 
Extremitätenentwicklung. Die nachfolgende Dissertation konzentriert sich auf die 
Identifikation und funktionelle Charakterisierung von krankheitsverursachenden Genen und 
ihren pathophysiologischen Mechanismen für ausgewählte humane 
Extremitätenfehlbildungen wie das Cenani-Lenz-Syndrom (CLS), das Werner mesomele 
Syndrom (WMS), das Bardet-Biedl-Syndrom, die  Spalthand/Spaltfuß-Malformation sowie 
das Tentamy preaxiale Brachydaktylie-Syndrom (TPBS). 
In diesem Zusammenhang ist es uns gelungen, neue extremitätenspezifische Gene und 
kausale Mutationen in verschiedenen Komponenten von evolutionär hoch konservierten 
Signalwegen zu identifizieren. Darüber hinaus konnten wir die physiologische und 
pathophysiologische Rolle jener Gene aufklären. Im Einzelnen fanden wir heraus, dass (i) 
Veränderungen im low-densitiy-lipoprotein-related Protein 4 (LRP4), einem antagonistischen 
Rezeptor des Wnt Signalweges, ursächlich sind für das seltene, autosomal rezessive CLS, 
dass (ii) spezifische Mutationen im extremitätenspezifischen, cis-agierenden, regulatorischen 
Element des sonic hedgehog (SHH) Genes das WMS verursachen und dass (iii) Mutationen 
im CHSY1-Gen kausal sind für das TPBS. Des Weiteren konnten wir nachweisen, dass 
Mutationen im ziliären BBS12-Protein einen sehr mild ausgeprägten Phänotyp im BBS 
bewirken. 
Im weiteren Verlauf des Projekts nutzten wir verschiedene in vitro Studien, um die 
molekulare Pathogenese der genannten Extremitätenfehlbildungen aufzuklären. Wir 
untersuchten den Effekt von fünf verschiedenen LRP4-Mutanten auf die Transduktion und 
Aktivierung des kanonischen Wnt Signalweges mittels eines Dual-Luciferase-Assays und 
konnten zeigen, dass die Ko-Expression jeder Mutante mit LRP6 und WNT1 den 
wildtypischen antagonistischen Effekt von LRP4 auf den kanonischen Wnt Signalweg 
aufhebt. Daher schlussfolgern wir, dass homozygote Mutationen im LRP4-Gen CLS 
verursachen und zu einem Funktionsverlust des LRP4-Proteins führen. Zusätzlich haben wir 
die erste rezessive p.R332W Wnt10b-Mutation, die ursächlich für SHFM ist, mittels eines 
Dual-Luciferase-Assays funktionell charakterisiert und nachgewiesen, dass die p.R332W 
Mutation zu einem Proteinfunktionsverlust des Lrp6-vermittelten Wnt Signalweges führt. In 
diesem Zusammenhang untersuchten wir ebenfalls die Rolle des Kandidatengens Fgf8 für 
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SHFM3 im Wnt Signalweg. Mit Hilfe des Dual-Luciferase-Assays ist es uns gelungen, Fgf8 
als neuen Wnt Signalweg Antagonisten, der direkt an Wnt10b binden kann, zu identifizieren. 
Somit zeigen wir die erste direkte Interaktion zwischen dem Fgf und Wnt Signalweg und 
verbinden hierdurch zwei wichtige Signalwege miteinander, die an der 
Extremitätenentwicklung maßgeblich beteiligt sind. 
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3. Introduction 
3.1 Vertebrate limb development 
The genetic processes that control limb development in vertebrates are complex and still not 
fully understood. The current understanding of the molecular genetics of limb development 
was mainly achieved from (i) experiments manipulating genetic interactions of temporal and 
spatial expression of individual genes in vertebrates and invertebrates and (ii) identification of 
genes involved in congenital limb malformations in mouse and human and the subsequent 
functional analysis of the underlying pathogenesis. 
The human limb buds are built on day 26 for the upper limb and day 28 for the lower limb by 
the activation of mesenchymal cells of the lateral mesodermal plate. During the onset of 
outgrowth, the distal border of the ectoderm thickens to form the apical ectodermal ridge 
(AER). The developing limb is characterized by three different compartments; the proximal 
stylopod, the middle zeugopod and the distal autopod and it is patterned into three axes; the 
proximal-distal (PD), the anterior-posterior (AP) and the dorsal-ventral (DV) axis. During 
human development the AP limb axis corresponds to the primary body axis and manifests 
itself in the skeletal morphology of the zeugopod with the radius/ulna in the upper limb and 
the tibia/fibula in the lower limb and in the distinct identities of the autopod developing into 
digits. The thumb has the most anterior and the little finger has the most posterior identity in 
the autopod. 
The AER is an important organizing center for limb bud development and controls the 
outgrowth and the patterning of the PD limb bud axis (Saunders 1948). Initially, T-box family 
transcription factors TBX4 and TBX5 activate FGF10 and WNT3 (Barrow et al. 2003) to 
initiate the outgrowth of the limb bud (Rallis et al. 2003). T-box genes may modify the 
morphology of limbs by selectively inducing or repressing genes that are specific either for 
the forelimb or the hindlimb. For instance, TBX5 can induce expression of the forelimb 
marker HOX9 and repress the hindlimb marker HOXC9 (Rodriguez-Esteban et al. 1999; 
Takeuchi et al. 1999). The HOX gene family is instrumental in proximal-distal patterning. 
HOX genes become up-regulated e.g. by retinoic acid (RA) in the limb bud and especially 
genes from the HOX-A and HOX-D clusters are involved in limb patterning (Yashiro et al. 
2004). For instance, HOXD9 is expressed across the whole limb during zeugopod 
development, but HOXD13 is restricted to the posterior part of the limb. HOXD10, -11 and -
12 are expressed in an overlapping pattern between HOXD9 and HOXD13. This differential 
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expression creates the morphological differences between the radius and the ulna in the 
forelimb and the tibia and fibula in the hindlimb (Zakany and Duboule 2007). 
 
The AP axis is patterned and controlled by the zone of polarising activity (ZPA), which 
consists of a collection of cells at the posterior border of the developing limb. The formation 
of the ZPA depends on the expression of HOXB-8 and RA in the posterior mesoderm (Charite 
et al. 1994). The development of the AP axis is mainly mediated through the expression of 
sonic hedgehog  (SHH), which is up-regulated in the ZPA through RA (Riddle et al. 1993). A 
complicated set of positive  and negative feedback loops exists, in which e.g. SHH stimulates 
FGFs in the AER and FGFs in the AER activate SHH in the ZPA (Zuniga et al. 1999).  
 
 
ZPA
AER
SHH
FGFsGREM
proximal distal
anterior
posterior
HOXs
HAND2
GLI3R
WNT3
BMPs
Retinoic acid
TBX5
WNT7a
LMX1
EN1
 
 
 
Figure 1: The developing limb bud with the relative position of the zone of polarizing    
Activity and the apical ectodermal ridge (AER). TBX5 induces WNT3 expression which itself 
triggers the expression of FGFs and thereby forms the AER. FGFs from the AER together 
with retinoic acic and different HOX genes induce the expression of SHH in the ZPA. The 
SHH signal is maintained by WNT7a, which itself is repressed by engrailed 1 (EN1). 
 
WNT7a, which is one of the factors responsible for the preservation of the SHH signal in the 
ZPA, was shown to be mainly involved in the development of the DV axis by inducing the 
transcription factor LMX1, which specifies cells to the dorsal site. WNT7a itself is repressed 
by the transcription factor engrailed 1, which is induced by bone morphogenic proteins 
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(BMPs) from the ventral ectoderm (Dealy et al. 1993). BMPs, which are expressed in 
response to the SHH signal from the ZPA, act via cell surface bone morphogenic protein 
receptors (BMPRs) and are essential for the formation of bone and cartilage. For instance 
BMP2 plays a key role in osteoblast differentiation and induction of bone formation while 
BMP4 controls the formation of limbs from the mesoderm. Under the influence of SHH, 
BMP2 and BMP7 play a major role in digit identity and formation (Zou and Niswander 1996; 
Jena et al. 1997). Finally the temporal and spatial control of progressive skeletal development 
is monitored by SOX9 and RUNX2, which initiate the condensation and differentiation of 
chondroblasts in the developing limb (Weston et al. 2003). 
 
3.2 Signalling pathways important in limb development 
Vertebrate limb development results from a temporally and spatially co-ordinated expression 
of many different genes and pathways including the Shh-Gli, Fgf and Wnt signalling-
pathway. Because defects in these pathways have dramatic and devastating effects on limb 
development the understanding and investigation of each of them is of high relevance. In the 
following, some of the most important signalling pathways for vertebrate limb development 
are described separately, although it has to be mentioned that in the limb bud a complex 
interaction between these pathways might exist, which forms different positive and negative 
feedback loops and thereby maintains the expression of a specific signal. 
 
3.2.1 The Shh signalling pathway 
In human development, the SHH gene is expressed in the gut, the neural tube and in the zone 
of polarizing activity in the posterior part of the limb bud (Odent et al. 1999). The elements of 
the Shh-Patched-Gli-pathway are highly conserved among species, indicating the essential 
role of this pathway during development. 
In order to function in development patterning, the SHH protein first needs to be processed to 
an active N-terminal form, which is modified by the addition of cholesterol (Pepinsky et al. 
1998; Williams et al. 1999). The SHH protein functions by binding to its 12-span 
transmembrane receptor proteins PATCHED-1 (PTCH-1) and PATCHED-2 (PTCH-2) (Stone 
et al. 1996). Without the SHH signal, PTCH-1 and PTCH-2 block downstream signal 
transduction through a physical interaction with the 7-span transmembrane protein 
SMOOTHENED (SMO). Binding of SHH to PTCHs results in the activation of GLI zinc 
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finger transcription factors which are normally inhibited by the suppressor-of-fused (SUFU). 
The activation of the intracellular signal transduction by SHH releases Gli1 which finally 
activates gene expression (Huangfu and Anderson 2006). 
Genetic analysis in the transgenic mouse mutant Sasquatch (Ssq), which resembles a pre-axial 
polydactyly phenotype, showed initial evidence for the regulation of the SHH gene (Lettice et 
al. 2003). In the Ssq mouse, a random transgenic insertion of a HOXB1 human placental 
alkaline phosphatase construct on chromosome 5 displays extopic SHH expression at the 
anterior margin of the developing limb bud. The transgene insertion was physically linked to 
SHH, but is placed in intron 5 of the neighbouring gene LMBR1 (limb-region homolog 1) 
located about 1 Mb away (Lettice et al. 2003). A cis-trans test showed that this 800 bp long 
highly conserved region, which was named zone of polarizing activity regulatory sequence 
(ZRS), acts as a cis enhancer to directly affect the expression of the SHH gene (Lettice et al. 
2003). The authors concluded that the ZRS is responsible for initiation of SHH expression in 
limb bud development and that it also drives the posteriorly restricted spatial expression 
pattern (Lettice et al. 2003). 
 
3.2.2 Fgf signalling 
Fibroblast growth factors (FGFs) belong to a large family of highly conserved polypeptide 
growth factors which mediate a variety of cellular responses during embryonic development 
and in the adult organism. FGFs function by binding and activating their specific cell surface 
tyrosine kinase Fgf receptors (FGFRs) (Ornitz and Itoh 2001) and the Fgf signalling pathway 
itself is one of the most ubiquitous in biology. Ligand binding results in receptor dimerization 
and activation of intrinsic tyrosine kinases, leading to trans-phosphorylation of multiple 
tyrosine residues on the receptor. These residues then serve as docking sites for the 
recruitment of SH2 (src-homology-2) or PTB (phosphotyrosine binding) domains of adaptors, 
docking proteins or signalling enzymes (Dailey et al. 2005). Activated FGFRs then act as 
transducers for several downstream intracellular signalling pathways, including extracellular 
signal-regulated kinase (ERK), p38 mitogen-activated kinases, phospholipase C gamma, 
protein kinase C (PKC) and phospatidylinositol 3-kinase (PI3K)(Klint and Claesson-Welsh 
1999). 
Fgf signalling is crucial for the PD outgrowth in human limb development. In the developing 
limb bud, the AER is positioned and induced by the expression of Fgf8 and Fgf10, followed 
by expression of Fgf4 (Niswander et al. 1993). A positive feedback loop, regulated by the 
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Wnt signalling pathway, is then established between Fgf8 and Fgf10, such that Fgf10 
promotes Fgf8 expression and Fgf8 promotes Fgf10 expression (Agarwal et al. 2003). Further 
evidence for the importance of the pathway in limb development comes from a conditional 
knockout of Fgf4 and Fgf8. Mouse lacking these two gene products fails to form limbs (Sun 
et al. 2002). 
 
3.2.3 The canonical Wnt signalling pathway  
The Wnt signalling pathway is an evolutionary highly conserved pathway in metazoan 
animals that regulates fundamental aspects of cell fate determination, cell migration, cell 
polarity, neural patterning and organogenesis during embryonic development. The extra-
cellular Wnt signal induces several intra-cellular signal transduction cascades such as the 
canonical or Wnt/ß-catenin-dependent pathway and the non-canonical or ß-catenin-
independent pathway which can be further split into the Planar Cell Polarity pathway and the 
Wnt/Ca2+ pathway (Wodarz and Nusse 1998). Wnt proteins are secreted glycoproteins that 
bind to the N-terminal extra-cellular domain of the frizzled (Fz) receptor family and their 
expression during development is restricted both temporally and spatially (Yamaguchi 2001; 
He et al. 2004). Low-density-lipoprotein receptor-related protein 5/6 (LRP5/6) are required 
for mediating the Wnt signalling (He et al. 2004). Also Norrin and R-Spondin, which can bind 
to the LRP5/6 receptor, are capable of activating Wnt signalling independent of a Wnt signal 
(Kazanskaya et al. 2004; Xu et al. 2004). A key mechanism in regulating Wnt signalling is the 
presence of diverse numbers of secreted Wnt antagonists like dickkopf (DKK) proteins, wise, 
cerebrus, Wnt-inhibitor protein (WIF) or the Sost protein (Bouwmeester et al. 1996; Glinka et 
al. 1998; Itasaki et al. 2003; Semenov et al. 2005; Cadigan and Liu 2006).  
The hallmark of the canonical Wnt pathway is the accumulation and translocation of 
cytoplasmatic ß-catenin into the nucleus. Without Wnt signalling, ß-catenin is degraded by 
axin, adenomatosis polyposis coli (APC), protein phosphatase 2A (PP2A), glycogen synthase 
kinase 3 (GSK3) and casein kinase 1α (CK1α) (He et al. 2004; Gordon and Nusse 2006). 
Phosphorylation of ß-catenin within this complex targets it for ubiquitilation and proteolytic 
destruction by the proteosomal machinery (He et al. 2004). After binding to the receptor 
complex, the Wnt signal is first transduced to cytoplasmatic dishevelled (DSH) which is able 
to directy interact with Fz (Wallingford and Habas 2005). This induces the phosphorylation of 
LRP5/6 by CK1 and GSK3-ß and allows the translocation of axin from the cytosol to the 
membrane. Axin now binds to the phosphorylated LRP5/6 and this triggers the stabilisation of 
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ß-catenin via either sequestration and/or degradation of axin and allows the translocation of ß-
catenin to the nucleus where it complexes with LEF/TCT family members to mediate 
transcriptional activation of target genes (Mao et al. 2001b; He et al. 2004; Zeng et al. 2008). 
These target genes then control posterior patterning, heart, lung, kidney, skin and bone 
formation (Yamaguchi 2001; Logan and Nusse 2004; Clevers 2006). 
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Figure 2: The canonical Wnt-signalling pathway. Without a ligand, ß-catenin gets 
ubiquitilated and degraded. Binding of e.g. Wnts, NORRIN or R-SPONDIN2 results in the 
translocation of ß-catenin to the nucleus where it binds to TCF/LEF and induces the 
expression of target genes. WISE, DKK and SOST are known inhibitors of canonical Wnt-
signalling. 
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3.2.3.1 Wnt signalling in limb development 
Wnt signalling plays a fundamental role in the developing limb bud and controls multiple 
processes such as limb patterning and limb morphogenesis. Several Wnt genes such as Wnt3, 
Wnt4, Wnt6, Wnt7a, Wnt7b, Wnt9b, Wnt10a, Wnt10b and Wnt16 are highly expressed in the 
ectoderm and AER during early limb development (Witte et al. 2009) and especially Wnt3 
has been shown to be essential for limb initiation and AER induction (Barrow et al. 2003). 
Wnt3 in the developing limb bud triggers the expression of Fgf10 and Fgf8 and leads to a 
positive feedback loop between these three components which is required for AER 
maintenance and the proximal-distal limb outgrowth (Barrow et al. 2003). Furthermore, Wnt 
signalling is important for determining the dorsal-ventral limb identity (Galceran et al. 1999). 
Wnt7a is highly expressed in the dorsal limb ectoderm and is responsible for dorsal-ventral 
patterning by regulating the expression of Lmx1b, a factor which determines the dorsal 
mesodermal cell fate in the limb (Parr et al. 1993; Parr and McMahon 1995). In addition, 
Wnt7a signalling also regulates the expression of Shh in the ZPA and, since there is a positive 
feedback loop between Shh and Fgf4 in the AER (Laufer et al. 1994; Niswander et al. 1994), 
Wnt7a signalling also indirectly affects AP and DP patterning in the limb bud. 
During late limb morphogenesis, Wnt signalling is determining the position and morphology 
of limb structures such as muscles, tendons and skeletal elements (Yang 2003). Wnt11 for 
instance is expressed in the periphery of the limb mesoderm and is involved in muscle fibre 
differentiation whereas Wnt5a triggers muscle fibre specification (Anakwe et al. 2003). 
Finally, Wnt signalling is also involved in bone formation by regulating chondrogenic 
differentiation from mesenchymal progenitors as well as osteoblast proliferation (Rudnicki 
and Brown 1997; Hartmann and Tabin 2001). While Wnt5a was found to promote 
chondrocyte differentiation in the distal limb bud (Yang et al. 2003), Wnt1, Wnt7a and Wnt14 
are known inhibitors of chondrocyte differentiation (Hartmann and Tabin 2001). 
 
3.2.3.2 Low-density lipoprotein receptor-related proteins 4 and 6 (Lrp4 & Lrp6) 
The low-density lipoprotein receptor (Ldlr) superfamily consists of 10 structurally related 
proteins. Lrp1, Lrp1b, Lrp2, Ldlr, Vldlr, Lrp4, Lrp5, Lrp6, Lrp8 and Lrp12 are cell surface 
receptors with diverse biological functions such as lipid metabolism, protection against 
atherosclerosis, neurodevelopment, the transport of nutrients and vitamins and limb 
development (May et al. 2007).  
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Lrp4 or multiple EGF-like domain LDL receptor related protein 4 (Megf7) is associated with 
limb development and the formation of digits (May et al. 2007). Like all family members, 
Lrp4 exhibits a ligand binding type repeat, EGF-precursor homology domains, an O-
glycosylation domain, a transmembrane domain, a cytoplasmatic tail and, similar to Lrp1, an 
NPxY sequence which mediates it to the endocytic machinery (Chen et al. 1990). LRP4 is 
expressed in migratory primordial germ cells in the hindgut, in spermatogonia of the neonatal, 
adult testis and in the immature oocytes and follicular cells in females (Yamaguchi et al. 
2006). The Lrp4 knockout mouse is characterized by polysyndactyly of the fore and hind 
limbs, craniofacial and tooth abnormalities (Johnson et al. 2005). Johnson et al. could show 
that the loss of Lrp4 results in an abnormal expression of important signalling molecules like 
Fgf8, Shh, Bmp2, Bmp4 and Wnt7a, which are crucial for normal digit formation. Moreover, 
the authors demonstrate that Lrp4 is able to inhibit the Wnt-induced activation of the 
Luciferase Reporter in an activity assay, assuming that Lrp4 antagonizes the Lrp5/6 mediated 
activation of the pathway. LRP4 mutations causing syndactyly have so far been found in 
Holstein cattle (Duchesne et al. 2006). 
Recently, Choi et al. showed that Lrp4 is also expressed in osteoblasts and that it regulates 
bone growth and turnover in vivo by binding sclerostin, an osteocyte secreted inhibitor of 
bone formation (Choi et al. 2009). The authors could also demonstrate that Lrp4 is a receptor 
for Dkk1, another inhibitor of Wnt/ß-catenin signalling. Finally, another group reported that 
Lrp4 is expressed in epithelial cells during tooth development and that it binds the Bmp 
antagonist Wise through its highly conserved EGF-like domain and thus acting as a modulator 
and integrator of Bmp and Wnt signalling during tooth morphogenesis (Ohazama et al. 2008). 
 
Another prominent member of the Ldlr family is the LRP6 gene located on human 
chromosome 12p13.3-p11.2 encoding the low-density lipoprotein receptor-related protein 6 
(LRP6) (Brown et al. 1998). Lrp6 functions as a coreceptor for Wnt signal transduction by 
activating Wnt-frizzled signalling as well as Wnt-responsive genes. It could be shown that the 
extracellular domain of Lrp6 binds Wnt1 and thereby induces dorsal axis duplication and 
neural crest formation (Tamai et al. 2000). Furthermore, it could be elevated that Lrp6 is a 
specific, high-affinity receptor for Dkk1 and Dkk2 and that Dkk1 and Lrp6 interact 
antagonistically during embryonic head formation in Xenopus laevis (Mao et al. 2001a). 
Moreover, Semenov et al. found that human SOST protein antagonizes Wnt signalling by 
binding the extracellular domain of the LRP6 receptor and thereby disrupts the Wnt-induced 
frizzled LRP complex formation (Semenov et al. 2005). LRP6 itself gets phosphorylated via 
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the glycogen synthase kinase-3 (GSK3) and casein kinase-1 and this dual phoshorylation 
promotes the interaction of LRP6 with the scaffolding protein axin and the stabilization of ß-
catenin in Wnt signalling (Zeng et al. 2008).  
Homozygous Lrp6 null mice die at birth and exhibit a variety of severe developmental 
abnormalities, including the truncation of the axial skeleton, limb defects, microphtalmia, and 
malformations of the urogenital system (Pinson et al. 2000) (Kelly et al. 2004). Also in the 
Lrp6-/- embryo, Fgf8 expression is significantly reduced, suggesting that the AER is 
degenerated as a result of weakened canonical Wnt signalling (Pinson et al. 2000). A single 
human LRP6 missense mutation has so far been identified and linked to a large Iranian family 
with early coronary artery disease and metabolic syndrome (Mani et al. 2007). 
In conclusion, the Lrp-gene family is an evolutionary conserved multifunctional class of 
receptors acting in fundamental signal transduction pathways including BMP, TGFß, and 
canonical Wnt signalling with diverse physiological tasks. 
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3. 3 Human limb malformation syndromes 
Congenital limb malformations belong to a rare group of genetically and clinically 
heterogeneous disorders with a very diverse spectrum in their epidemiology, aetiology and 
anatomy. Limb malformations manifest themselves as an isolated trait or as a part of a 
syndrome. Congenital hand and feet anomalies can be generally classified into malformations, 
deformations, disruptions and dysplasias. Malformations result as a structural defect in the 
embryo or fetus due to an abnormal development. Deformations are defined as a change from 
the normal size or shape of an anatomic structure due to mechanical forces that distort an 
otherwise normal structure. Disruptions are characterized by a destruction of a previously 
normally formed fetal body part due to external influences such as infections, and dysplasias 
refer to an abnormal formation of a body structure or tissue based on disturbed organogenesis. 
Furthermore, inherited hand anomalies are clinically grouped as polydactylies, ectrodactylies, 
brachydactylies and syndactylies.  
Polydactylies are distinguished by the appearance of supernumary digits or parts of them, 
which may be present as a complete duplication of a whole limb or as a duplication of single 
digits (Schwabe and Mundlos 2004). Preaxial polydactyly with extra digits located on the side 
of the hand of the thumb or postaxial polydactyly where the extra digit is found on the side of 
the hand or foot of the fifth digit are common isolated limb malformation traits. As a part of a 
syndrome, they may be detected in e.g. Smith-Lemli-Opitz syndrome, McKusick-Kaufmann 
syndrome, Bardet-Biedl syndrome or Greig cephalosynpolydactyly where the polydactyly is 
present both pre-and postaxial (Schwabe and Mundlos 2004). Another example is Pallister-
Hall syndrome with a rare central or postaxial polydactyly. 
Ectrodactyly involves the deficiency or absence of one or more central digits of the hand or 
foot with the absence of distal segments such as phalanges (aphalangia), fingers (adactyly) or 
the entire limb (acheiria). Ectrodactylies often appear sporadically with only one hand or foot 
affected and most of the cases are considered to be non-genetic but due to disruptions in 
development. A prominent disease in the group of ectrodactylies is split-hand/foot 
malformations, which may occur isolated or in combination with other features and which is 
phenotypically characterized by the deficiency of the central rays with a median cleft. 
Another example is Holt-Oram syndrome where a variable spectrum of the upper limb defects 
with shoulder girdle ranging from thumb hypoplasia to phocomelia is found (Schwabe and 
Mundlos 2004). 
Brachydactylies are defined by shortened digits and are classified on an anatomic and genetic 
background into five groups from A to E. Isolated brachydactylies are often inherited in an 
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autosomal dominant manner and are characterized by a high degree of phenotypic variability. 
Brachydactylies can be also associated with a syndrome, for example Rubinstein-Taybi 
syndrome with short thumbs. A hallmark of type A brachydactylies is hypoplasia or aplasia of 
the middle phalanges in contrast to type B, where distal phalanges are missing, and where nail 
hypoplasia and distal or proximal symphalangism may be present. Type C brachydactylies are 
characterized by brachymesophalangy of the second, third and fifth fingers, hyperphalangy 
and shortening of the first metacarpals. Finally, a shortened distal phalanx of the thumbs is 
observed in type D brachydactylies and type E brachydactylies show a variable shortening of 
the metacarpals. 
 
 
Figure 3: Schematic representation of congenital limb anomalies (Schwabe and Mundlos 
2004). 
 
The last and most frequent congenital limb malformation in Europe and North America are 
snydactylies, which are characterized by the fusion of the soft tissues of fingers and toes with 
or without bone fusion. Syndactylies are due to the lack of apoptosis in the interdigital 
mesenchyme and may also occur isolated or with other symptoms in a syndrome. The 
syndromal forms include Poland syndrome with symbrachydactyly, Saethre-Chotzen 
syndrome, Pfeiffer syndrome, and Fraser syndrome to mention only some of them. Isolated 
forms are grouped in categories from one to five according to the degree of affecting different 
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interdigital spaces (Schwabe and Mundlos 2004). A severe isolated syndactyly is syndactyly 
type IV (also known as Hass type syndactyly) where a total fusion of all fingers is observed. 
 
3.3.1 Phenotypes investigated in this study 
During this Ph.D study, cohorts of different human congenital limb patients were collected 
and the molecular cause of different defects such as Cenani-Lenz syndrome, Werner-
mesomelic syndrome, split-hand/foot malformations and Bardet-Biedl syndrome were 
investigated. All these limb defects are due to mutations in different developmental genes, 
stages and pathways and therefore resemble an overview on the complex genetic concept 
necessary for proper limb development. 
 
3.3.1.1 Cenani-Lenz syndrome 
Cenani-Lenz Syndrome (CLS) was first described in 1967 by Cenani and Lenz (Cenani and 
Lenz 1967) in two brothers. CLS is a rare autosomal recessive disorder mainly characterized 
by total syndactyly of the hand and feet (so called spoon hands), bilateral radioulnar 
synostosis and metacarpal fusion. Additional features include mild facial dysmorphism such 
as a high broad, hypertelorism, a depressed nasal bridge, a short nose, a short prominent 
philtrum and malar hypoplasia (Temtamy et al. 2003). Also bilateral renal hypoplasia 
(Bacchelli et al. 2001) and oligodontia with flat head `screwdriver-shaped` incisors (Elliott et 
al. 2004) have been reported in some patients. The limb abnormalities in CLS closely 
resemble those found in the recessive mouse mutant `limb deformity` (ld) which is suffering 
from syndactyly, bone fusions, radioulnar and radiotarsal synostosis and renal malformations 
(Bacchelli et al. 2001). The ld mouse phenotype is a result of homozygous Formin mutations 
and, therefore, Formin and its downstream targets such as Gremlin were considered to be 
good candidate genes for human CLS. However, no alterations in either FORMIN or 
GREMLIN could be identified in CLS patients (Bacchelli et al. 2001), so the aetiology of this 
rare disorder was unknown at the initiation of this Ph.D thesis. 
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3.3.1.2 Werner mesomelic syndrome 
Werner mesomelic syndrome (WMS), also known as tibial hypoplasia-polysyndactyly-
triphalangeal thumb syndrome, was first reported by Werner in 1912 (Werner et al 1912). 
WMS is an autosmal dominant disorder with hypo- or aplasia of the tibiae resulting in short 
stature, preaxial polydactyly of the hands and feet and/or five-fingered hands and 
triphalangeal thumbs being distinctive features (Werner et al 1912). Triphalangeal thumb is a 
common autosomal dominant hand malformation, which can occur isolated or as a clinical 
feature of different syndromic conditions e.g. Holt Oram syndrome (Basson et al. 1997), 
lacrimo-auriculo-dento-digital syndrome (Rohmann et al. 2006) or Nager acrofacial 
dysostosis (McDonald and Gorski 1993). At the onset of this Ph.D thesis the molecular basis 
for WMS was unknown. 
 
3.3.1.3 Split-hand/foot malformation 
Split-hand/split foot malformation (SHFM), also known as ectrodactyly, is a congenital limb 
malformation involving the central rays of the autopod and characterized by syndactyly, 
median cleft of the hands and feet, aplasia and/or hypoplasia of the phalanges, metacarpals 
and metatarsals (Duijf et al. 2003). SHFM can manifest itself as an isolated entity or as a part 
of a syndrome and is phenotypically highly variable. Familial SHFM is often inherited in an 
autosomal dominant manner with reduced penetrance (Ozen et al. 1999), but also autosomal 
recessive (Gul and Oktenli 2002) as well as X-linked forms (Ahmad et al. 1987) are known. 
Recently the first autosomal recessive mutation in the WNT10B gene causing SHFM6 was 
identified in a large consanguineous family from Turkey (Ugur and Tolun 2008). Wnt10b is 
expressed throughout the mouse limb ectoderm from E.9.5 to E.15.5 (Witte et al. 2009) and a 
well-known regulator of osteoblastogenesis and bone mass (Bennett et al. 2005). However, 
the molecular pathophysiological mechanism of WNT10B mutations causing SHFM6 was 
unknown at the onset of this Ph.D study. 
 
3.3.1.4 Bardet-Biedl syndrome 
Bardet-Biedl syndrome (BBS) is an autosomal recessively inherited cilliopathy with red cone 
dystrophy, postaxial polydactyly, obesity, renal tract anomalies, learning difficulties or mental 
retardation and hypogonadism being distinct features (Beales et al. 1999). Postaxial 
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polydactyly with syndactylies and brachydactylies is observed in about 70% of all cases 
whereas other features such as hearing loss or dental anomalies are rare (Beales et al. 1999). 
In this study, we investigated a consanguineous family from Pakistan with postaxial 
polydactyly and late-onset retinal dysfunction. Adult affected individuals did not display any 
renal or genital anomalies, obesity, mental retardation or learning difficulties and did thus not 
fulfill the proposed clinical diagnostic criteria for BBS. 
 
3.3.2 Molecular pathogenesis of SHH limb phenotypes 
Components of the SHH-PTCH-GLI pathway, which plays a major role in anterior-posterior 
patterning of the limb, are known to cause severe congenital human limb disorders (Figure 4). 
Sporadic and inherited mutations in the human SHH gene itself are causative for 
holoprosencephaly, the most common structural malformation of the human forebrain 
characterized by cleft lip, absent olfactory bulbs, tracts and the corpus callosum, hypotelorism 
and/or a single cyclopic eye (Roessler et al. 1996). 
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Figure 4: Human disorders associated with mutated elements of the SHH signalling pathway 
(Villavicencio et al. 2000).  
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Mutations in human GLI3 have been detected in several types of limb malformation 
syndromes. Structural alterations such as translocations and deletions but also point mutations 
throughout the GLI3 gene cause Greig Cephalopolysyndactyly syndrome, which manifests 
itself by syndactyly, preaxial polydactyly, broad thumbs and first toes, facial anomalies such 
as hypertelorism and frontal bossing (Vortkamp et al. 1991) whereas, GLI3 frameshift and 
nonsense mutations cause the postaxial polydactyly syndactyly Pallister Hall syndrome (Kang 
et al. 1997). Recently, also frameshift, nonsense and missense GLI3 mutations were shown to 
be responsible for human preaxial polydactyly type A, autosomal dominant preaxial 
polydactyly type IV and postaxial polydactyly type A/B (Radhakrishna et al. 1997). 
Mutations in the zone of polarizing activity regulatory sequence (ZRS), a long-range limb-
specific enhancer of SHH, have been identified in patients with preaxial polydactyly type II 
(PPD2) (Lettice et al. 2002; Li et al. 2009), triphalangeal thumb polysyndactyly (TPTPS) 
(Sun et al. 2008; Wu et al. 2009) and syndactyly type IV (SD4, Haas type polysyndactyly) 
(Sun et al. 2008). 
 
3.3.3 Limb phenotypes due to defective Wnt signalling 
Mutations of any element of the Wnt signalling pathway (Table 1) have been shown to cause 
a wide spectrum of limb malformations. For instance, mutations in WNT3 have been found in 
the rare autosomal recessive disorder tetra-amelia, characterized by the absence of all four 
limbs (Niemann et al. 2004) and homozygous nucleotide changes in WNT10B lead to the 
scarce recessive split-hand/split foot malformation (Ugur and Tolun 2008). Furthermore, 
odonto-onycho-dermal-dysplasia which is characterized by hyperkeratosis and hyperhidrosis 
of the palms and soles, atrophic malar patches, hypodontia, conical teeth, onychodysplasia, 
and dry and sparse hair, is caused by a homozygous nonsense mutation in exon 3 of the 
WNT10A gene (Adaimy et al. 2007). 
Also, alterations in Wnt signalling receptors are associated with different diseases. Loss-of- 
function and gain-of-function mutations in LRP5, which are associated with the regulation of 
bone mass and osteoporosis like in osteoporosis pseudoglioma syndrome (Gong et al. 2001), 
demonstrate the receptors´ significance for proper bone development. 
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High bone mass, osteoporosis-pseudogliomaLRP5
Split-hand/foot malformationWNT10B
Odonto-onycho-dermal-hypoplasiaWNT10A
Tetra-ameliaWNT3
Human diseaseGene
 
Table 1: Human limb malformations with mutations in Wnt signalling components 
(MacDonald et al. 2009). 
 
3.3.4 Molecular pathogenesis of split-hand/foot malformation (SHFM) phenotypes 
SHFM is genetically very heterogenous and six loci have been described so far with 
autosomal dominant SHFM1 on 7q21-22, the X-linked form SHFM2 on Xq26, SHFM3 on 
10q24, SHFM4 on 3q28, SHFM5 on chromosome 2q31 and the autosomal recessive SHFM6 
on 12q13.11-13 (Scherer et al. 1994; Ianakiev et al. 2000; Goodman et al. 2002; Roscioli et al. 
2004; Faiyaz-Ul-Haque et al. 2005; Ugur and Tolun 2008). SHFM1 is caused by 
chromosomal deletions on 7q21-22, which abolish the expression of the candidate genes 
DLX5, DLX6 and DSS1 in this region. However, no mutations in the coding region of these 
genes have been identified so far in any SHFM1 patient, indicating a putative long range 
enhancer in this region to cause the phenotype (Crackower et al. 1996). SHFM2 is due to 
translocations or X-chromosomal rearrangements on Xq26 which share the candidate genes 
FGF13 and TONDU (Faiyaz-Ul-Haque et al. 2005). The SHFM3 locus is defined to a 
minimal 325-kb region on 10q24 containing the BTRC gene (Lyle et al. 2006), which is the 
human orthologue of Drosophila Slimb, an F-box/WD40 repeat protein and a regulator of the 
SHH and Wnt signalling pathway (Jiang and Struhl 1998). Also, only chromosomal 
rearrangements like duplications could be found in patients (Kano et al. 2005) but no 
mutations in the BTRC gene itself, again suggesting an regulatory element to cause the 
malformation. Mutations underlying SHFM4 have been detected in the TP63 gene which has 
a fundamental role in embryonic development (Ianakiev et al. 2000). Finally, the critical 
SHFM5 interval includes the candidate genes DLX1 and DLX2, two important genes 
expressed in the AER, but also here only deletions on 2q24-q31 could be identified in patients 
(Faiyaz-Ul-Haque et al. 2005). 
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3.3.5 Molecular pathogenesis of Bardet-Biedl (BBS) syndrome 
Bardet-Biedl syndrome (BBS) is a genetically heterogeneous, pleiotropic ciliopathy disorder 
with recessive inheritance pattern but also triallelic and oligogenic inheritance are known 
(Katsanis et al. 2001). The incidence of BBS has been described with 1 in 150,000 to 175,000 
individuals in European populations but populations with a high level of consanguinity or 
from geographically isolated regions show a much higher frequency of BBS (Farag and Teebi 
1988). The 14 BBS genes (BBS1-BBS14 namely BBS1, BBS2, ARL6, BBS4, BBS5, MKKS, 
BBS7, TTC8, BBS9, BBS10, TRIM32, BBS12, MKS1, CEP290) identified to date account for 
over 75% of affected families (Zaghloul and Katsanis 2009), with BBS1 and BBS10 showing 
the highest frequency in families with European descent (Chiang et al. 2006; Stoetzel et al. 
2007). Most of the known BBS genes are ciliary proteins with important functions in 
development and homeostasis of different tissues (Ross et al. 2005) and play a major role in 
signal transduction including fundamental biological pathways such as Wnt or SHH signalling 
(Marshall and Nonaka 2006; Saxena et al. 2007). Therefore, it is assumed that ciliary 
dysfunction and disturbance of the intraflagellar transport is the main pathophysiological 
mechanism leading to BBS (Katsanis et al. 2001). 
 
4. Aims and major findings of this Ph.D thesis 
4.1 Aims 
The aim of the present Ph.D thesis was to identify novel key factors and new molecular 
mechanisms involved in physiological and pathophysiological processes during limb 
development. In order to identify novel genes and types of mutations, we wanted to focus on 
different human inherited limb malformations, such as Cenani-Lenz syndrome and Werner 
mesomelic syndrome, and used a combination of genome-wide linkage analysis, 
homozygosity mapping, positional cloning, and candidate gene approach to identify the 
disease causing genes. Furthermore, the intention was to investigate the encoded proteins and 
mutations of identified genes by in vitro studies to gain an insight into the molecular 
pathogenesis of these limb malformations and physiology of limb development.  
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4.2 Major findings  
(1) Mapping of the first locus for Cenani-Lenz syndrome (CLS) to chromosome 11p11.2 and 
identification of mutations in LRP4 causing Cenani-Lenz syndrome (Li et al., Am J Hum 
Genet (2010); 86(5):696-706). 
(2) Screening of additional CLS patients and families and thus broadening the mutational 
spectrum of CLS mutations (Li et al., Am J Hum Genet (2010); 86(5):696-706). 
(3) Functional analysis of mutant LRP4 p.D137N, p.C160Y, p.D449N, p.D473N and 
p.D529N proteins. a) Dual-Luciferase Reporter Assays demonstrated that mutant proteins 
abolish the antagonistic LRP4 effect on LRP6-mediated activation of Wnt/ß-catenin 
signalling. b) Cell surface biotinylation displayed that mutant LRP4 receptors fail to be 
efficiently transported to the plasma membrane (Li et al., Am J Hum Genet (2010); 
86(5):696-706). 
(4) Identification of point mutations within the sonic hedgehog (SHH) regulatory region 
(ZRS) causing Werner mesomelic syndrome (Wieczorek et al., Hum Mutat. (2010); 
31(1):81-9). 
(5) Establishment of quantitative gene copy analysis and identification of duplications of the 
ZRS being responsible for polysyndactyly type IV Haas and triphalangeal 
thumbpolysyndactyly (TPTPS) (Wieczorek et al., Hum Mutat. (2010); 31(1):81-9). 
(6) Functional analysis of the Wnt10b p.R332W mutation causing autosomal recessive split- 
hand/foot malformation. Using Dual-Luciferase-Reporter-Assays we show that p.R332W 
causes a loss of function of Lrp6 mediated Wnt signalling (Pawlik et al., submitted). 
(7) Detection of the first direct cross-talk between Wnt and Fgf signalling pathways by 
indicating that Fgf8 is a novel potential Wnt signalling antagonist (Pawlik et al., submitted). 
(8) Mapping the Tentamy preaxial brachydactyly syndrome (TPBS) locus to 15q26 and 
identification of mutations in CHSY1 causing TPBS (Li et al., in Press, Am J Hum Genet 
(2010)). 
(9) Identification of a novel nonsense BBS12 mutation (p.S701X) in a Pakistani family 
diagnosed with postaxial polydactyly and late-onset dystrophy which causes a mild Bardet-
Biedle syndrome (BBS) phenotype (Pawlik et al., Mol Syndromol (2010); 1:27-34). 
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5. Main publications on human limb malformations with own contributions 
5.1 Pawlik B, Mir A, Iqbal H, Li Y, Nürnberg G, Becker C, Qamar R, Nürnberg P, 
Wollnik B. A Novel Familial BBS12 Mutation Associated with a Mild Phenotype: 
Implications for Clinical and Molecular Diagnostic Strategies. Mol Syndromol (2010); 
1:27-34. 
 
Abstract of the publication: 
Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by progressive 
retinal degeneration (rod-cone dystrophy), obesity, postaxial polydactyly, renal tract, genital 
anomalies, and learning difficulties or mental retardation. The phenotype of BBS is highly 
variable, and it has been suggested that the clinical diagnosis is established if at least four of 
the main manifestations are present in a patient. In this study, we investigated a 
consanguineous family from Pakistan with postaxial polydactyly and late-onset retinal 
dysfunction who did not fulfill all clinical diagnostic criteria for BBS. 
 
In order to identify the disease causing gene we first conducted the Affymetrix GeneChip 
Human Mapping 10K Array (CCG, University of Cologne) and mapped the family to the 
BBS12 locus on chromosome 4q27 to a critical region of 21,63 Mb between SNPs rs1390560 
and rs1343812. The critical region on 4q27 was gene rich and contained approximately 80 
known and predicted genes. In total, we tested 6 highly relevant candidate genes of this 
region: FGF2, BBS7, BBS12, NUDT6, SPATA5, and SPRY1. Finally sequencing of the coding 
exon 2 of BBS12 in affected individuals identified a novel homozygous c.2103C >A mutation, 
which is predicted to insert a stop codon at position 701 of the BBS12 protein (p.S701X). 
This nonsense mutation is located at the very C-terminal end of the protein and the truncation 
leads to a loss of 10 amino acids. Co-segregation of the p.S701X mutation with the disease in 
the family could be confirmed. In addition, the mutation was not found in 147 healthy 
controls from Pakistan. 
Thus we provide evidence for a very mild, familial BBS12 phenotype. Clinical diagnosis 
would have been missed when applying the suggested diagnostic criteria for BBS. Therefore, 
we propose the use of less strict diagnostic criteria in familial BBS cases that might also 
influence the molecular testing strategies of BBS. 
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Own contributions: 
Initially, the index patient of the MR-10 family was subjected to a genome-wide scan using 
the Affymetrix GeneChip® Human Mapping 10K array (CCG, University of Cologne, group 
of Prof. Dr. P. Nürnberg). At first, I evaluated and interpreted the Affymetrix GeneChip data 
(Figure 1c, p.30). Genome Scan pointed out that the MR-10 family map to three possible loci 
on chromosome 4q27-4q31.22, 4q25.1-4q35.2 and 11q23.1-11q23.3, respectively (Figure 1c, 
p.30).  
In order to identify the disease causing locus, I first performed fine mapping analysis using 
microsatellite markers and thereby excluded locus 4q25.1-4q35.2 and 11q23.1-11q23.3 and 
mapped the MR10 family to a critical region on 4q27-4q31.22 (Figure 1a, p.29). The critical 
region was gene rich and contained approximately 80 known and predicted genes (Figure 2a, 
p.32).  
In total, I tested 6 highly relevant candidate genes for mutations in the index patient: FGF2, 
BBS7, BBS12, NUDT6, SPATA5 and SPRY.  I identified a novel homozygous c.2103C>A 
mutation in all affected family members which produces a stop codon at position 701 in the 
BBS12 protein (p.S701X) by sequencing the coding exon 2 of BBS12 (Figure 2b, p.32).  
I next confirmed co-segregation of the p.S701X mutation in the MR-10 family and finally 
established a PCR/enzyme digestion method using ApoI to test 147 healthy Pakistani control 
individuals (data not shown). 
In the end, I arranged all figures for the publication and wrote the manuscript, which was 
published in Molecular Syndromology. 
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Bardet-Biedl syndrome (BBS, MIM 209900) is an au-
tosomal recessive disorder characterized by a wide spec-
trum of clinical features, of which the most common ones 
are progressive retinal degeneration (rod-cone dystro-
phy), obesity, postaxial polydactyly, renal tract and geni-
tal anomalies, and learning difficulties or mental retar-
dation [Beales et al., 1999]. The phenotype of BBS is high-
ly variable, and it has been suggested that the clinical 
diagnosis is established if at least four of the main mani-
festations are present in a patient. Clinical evaluation 
during early infancy remains difficult as not all of the 
main manifestations are congenital but may occur later 
during childhood. Congenital postaxial polydactyly in-
cluding syndactyly and/or brachydactyly is present in ap-
proximately 70% of cases and may not affect all limbs. 
Developmental anomalies of the renal tract are also com-
mon and can lead to chronic renal failure [Harnett et al., 
1988]. Further congenital symptoms, which can be diag-
nosed in early infancy, are genital anomalies such as vag-
inal atresia and hypoplasia of the uterus and hypogonad-
ism in males. The appearance of a rod-cone dystrophy, 
which is also described as atypical retinitis pigmentosa 
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 Abstract 
 Bardet-Biedl syndrome (BBS) is an autosomal recessively in-
herited ciliopathy mainly characterized by rod-cone dystro-
phy, postaxial polydactyly, obesity, renal tract anomalies, 
and hypogonadism. To date, 14  BBS genes,  BBS1 to  BBS14 , 
have been identified, accounting for over 75% of mutations 
in BBS families. In this study, we present a consanguineous 
family from Pakistan with postaxial polydactyly and late-on-
set retinal dysfunction. Adult affected individuals did not 
show any renal or genital anomalies, obesity, mental retar-
dation or learning difficulties and did thus not fulfill the pro-
posed clinical diagnostic criteria for BBS. We mapped the dis-
ease in this family to the  BBS12 locus on chromosome 4q27 
and identified the novel homozygous p.S701X nonsense 
mutation in  BBS12 in all three affected individuals of this fam-
ily. We conclude that  BBS12 mutations might cause a very 
mild phenotype, which is clinically not diagnosed by the cur-
rent diagnostic criteria for BBS. Consequently, we suggest 
the use of less strict diagnostic criteria in familial BBS families 
with mild phenotypic expression. 
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with early macular involvement, is characteristic in BBS 
patients and present in over 90% of patients [Green et al., 
1989]. Typically, night blindness is one of the first symp-
toms at the end of the first decade and the progressive 
retinal degeneration often causes total blindness in the 
course of the second decade of life. Although mental re-
tardation is not very common in BBS patients, learning 
difficulties are present in over half of the patients. Trun-
cal and rhizomelic obesity develops in the majority of 
BBS patients before the end of puberty. Developmental 
delay might be present and poor motor coordination is 
described in a subset of patients. Other features such as 
hearing loss, dental anomalies, congenital heart defects, 
diabetes mellitus, and hepatic fibrosis are rare [Green et 
al., 1989; Beales et al., 1999].
 The incidence of BBS has been estimated at 1 in 150,000 
to 175,000 individuals in European populations. How-
ever, populations with a high level of consanguinity or 
from geographically isolated regions like Newfoundland 
show a much higher frequency [Farag and Teebi, 1988, 
1989]. BBS is a genetically heterogeneous disorder and up 
to date 14 genes have been identified ( BBS1 to  BBS14 , 
namely  BBS1, BBS2, ARL6, BBS4, BBS5, MKKS, BBS7, 
TTC8, BBS9, BBS10, TRIM32, BBS12, MKS1, CEP290 ) 
 using traditional genome-wide mapping and positional 
cloning strategies in large consanguineous families or – 
more recently – computational comparative genomic ex-
pression methods [Katsanis et al., 2000; Mykytyn et al., 
2001, 2002; Badano et al., 2003; Chiang et al., 2004; Fan 
et al., 2004; Li et al., 2004; Nishimura et al., 2005; Chiang 
et al., 2006; Stoetzel et al., 2006; Leitch et al., 2008]. While 
the majority of BBS patients do show a classical autoso-
mal recessive inheritance pattern, triallelic and oligogen-
ic inheritance was suggested in some families [Katsanis 
et al., 2001a]. Since then it has been suggested that genet-
ic modifiers exist responsible for the clinical variability 
of phenotypic expression in BBS patients.
 Mutations in  BBS1–14 account for over 75% of affected 
families [Zaghloul and Katsanis, 2009]. In families of Eu-
ropean    descent,    mutations    in     BBS1   and    BBS10   show  
the highest frequency accounting for approximately 20% 
of BBS mutations each [Chiang et al., 2006; Stoetzel et al., 
2006]. The  BBS12 gene is the most recently identified 
gene and the encoded protein belongs to a novel branch 
of type 2 chaperonin superfamily, which includes also 
 BBS6 and  BBS10 [Stoetzel et al., 2007]. In general, most of 
the known  BBS genes are highly conserved in ciliated or-
ganisms, such as  Chlamydomonas , and are absent in non-
ciliated ones such as  Arabidopsis  [Li et al., 2004]. There is 
molecular evidence that BBS proteins are part of primary 
cilia structures arising from the basal body and playing 
an important role in development and homeostasis of 
various tissues, e.g. as mechanosensors in kidney epithe-
lium and in the organization of photoreceptor cells of the 
retina [Ross et al., 2005; Badano et al., 2006a]. Cilia are 
microtubule-based eukaryotic organelles that project 
from the surface of human cells. Beside performing a 
wide variety of functions, they play a major role in extra-
cellular signal transduction including important biologi-
cal pathways such as wnt and hedgehog signalling [Mar-
shall and Nonaka, 2006; Saxena et al., 2007]. It is sug-
gested that ciliary dysfunction and disturbance of the 
intraflagellar transport represent the main pathophysi-
ological mechanism leading to BBS [Katsanis et al., 
2001b]. For this reason, BBS is regarded as a ciliopathy.
 Here we report a novel  BBS12 mutation, p.S701X, 
found in three affected individuals of a consanguineous 
family from Pakistan clinically diagnosed with postaxial 
polydactyly and late-onset retinal dysfunction. Adult af-
fected individuals did not show any renal and genital 
anomalies, obesity, learning difficulties or any other 
symptoms, thus indicating that mutations in  BBS12 can 
cause a very mild phenotype which is clinically not diag-
nosed by the current diagnostic criteria for BBS.
 Material and Methods 
 MR-10 family: Index patient was referred to the hospital due 
to bilateral polydactyly and mild vision impairment. All affected 
family members were clinically examined including general 
physical examination, ophthalmological examination, X-rays of 
hands and feet, and abdominal ultrasound. The study was first 
approved by local institutional review boards of COMSATS Insti-
tute, Islamabad, Pakistan (CIIT Biosciences Review/Ethics Com-
mittee; A.S. 24112008), and followed the Declaration of Helsinki 
protocols. Afterwards, blood samples were taken after written in-
formed consent was given and DNA was isolated using standard 
procedures.
 Linkage Analysis 
 Genomic DNA of the index patient of the MR-10 family (IV-3) 
as well as DNAs of siblings and parents ( fig. 1 , individuals I-1, I-2, 
II-1, II-2, II-3, II-4, III-2, III-3, IV-1, IV-3, IV-4, IV-5, IV-6, IV-8) 
were subjected to a genome-wide mapping using the Affymetrix 
GeneChip Human Mapping 10K Array (Affymetrix, Santa Clara, 
CA). This 10K array comprises a total of 10,204 single-nucleotide 
polymorphisms (SNPs) with a mean intermarker distance of 258 
kb, equivalent to 0.36 cM. Sample processing and labelling were 
performed in accordance with the manufacturers instructions 
(Affymetrix Mapping 10K 2.0 Assay Manual). Genotypes were 
provided by the GeneChip DNA Analysis Software (v.4.1, Af-
fymetrix). Non-parametric linkage analysis using all genotypes 
of a chromosome simultaneously was carried out with MERLIN. 
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 Fig. 1. MR-10 family maps to the  BBS12 locus on chromosome 4q27.  a Pedigree of the MR-10 family and hap-
lotypes of the 4q27 region. The disease-associated haplotype is shown in red.  b X-rays of affected individuals 
showing the postaxial polydactyly of hands and feet. 
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Parametric linkage analysis was performed by the program AL-
LEGRO assuming autosomal recessive inheritance. For fine map-
ping analysis, available MR-10 family members were genotyped 
for the following markers: D4S2975, D4S2277, D4S429, D4S3039, 
D4S1527, D4S2920, D4S3047, D4S2921, D4S426, D11S480, 
D11S4122, D11S1885. Genomic localization and microsatellite se-
quences were obtained from the UCSC Genome Browser (http://
genome.ucsc.edu/, build hg18, March 2006) and the ENSEMBL 
database (http://www.ensembl.org). Polymerase chain reaction 
(PCR) for fluorescent markers was performed on a DNA Engine 
Dyad Thermal Cycler (Bio-Rad, Germany) under standard PCR 
conditions, run on an ABI 3730 DNA Analyzer (Applied Biosys-
tems, Germany), and evaluated with the GeneMarker 1.51 pro-
gram (Soft Genetics LLC).
 Mutation Analysis 
 The following genes of the critical region were tested for muta-
tions in the index patient of family MR-10:  FGF2 ,  BBS7 ,  BBS12 , 
 NUDT6 ,  SPATA5 , and  SPRY . Primer sequences and PCR proto-
cols are available upon request. The 2,144 bp of the coding se-
quence of exon 2 of the  BBS12 gene (123,873,307–123,885,548 Mb, 
UCSC Human Genome Browser, hg 18 assembly) was sequenced 
in the index patients (IV-2, IV-3, IV-9). 20 ng of genomic DNA 
from patients was used to amplify the 4 amplicons of exon 2 by a 
touchdown PCR protocol on a DNA Engine Dyad Thermal Cycler 
(Bio-Rad, Germany). PCR fragments were purified and directly 
sequenced from both sides using the ABI BigDye Terminator v1.1 
Cycle Sequencing Kit and the ABI 3730 DNA Analyzer (Applied 
Biosystems). Co-segregation of the mutation in the family was 
investigated by direct sequencing of all available family members 
and by a PCR/enzyme digestion method using  Apo I (data not 
shown). In addition, the mutation was tested in 147 Pakistani con-
trol individuals by PCR/enzyme digestion method.
 Results 
 Clinical Evaluation of the Family 
 The three affected individuals of family MR-10 from 
Pakistan ( fig. 1 a) were born to consanguineous parents 
(first-degree cousins). Congenital postaxial polydactyly 
of hands and feet were observed in various expressions 
( fig. 1 b). In addition, progressive night blindness started 
between 13–15 years of age in all the patients. Individuals 
IV-2, IV-3, and IV-9 are now 30, 27, and 19 years old, re-
spectively, and all of them have developed severe night 
blindness, while vision is only mildly impaired in day-
time. Ophthalmological examination was performed and 
an atypical retinitis pigmentosa (RP, rod-cone dystro-
phy), myopia and astigmatism were diagnosed. Patients 
history neither showed developmental delay in childhood 
nor mental retardation or learning difficulties. Obesity 
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 Fig. 1. Continued MR-10 family maps to the  BBS12 locus on chromosome 4q27.  c Schematic view of genome-
wide LOD score  calculations. The arrows indicate regions of maximum LOD scores of 1.83. 
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was not present in all three affected individuals either. No 
organ anomaly was found in ultrasound; especially no 
renal tract abnormalities were seen. Furthermore, physi-
cal examination showed hypodontia but did not show 
any genital anomalies or additional symptoms. General 
neurological testing was normal. No signs for hypogo-
nadism was present and individual IV-2 was fertile and 
had 4 children. A summary of clinical findings is listed 
in  table 1 . The initial diagnosis of an autosomal reces-
sively inherited disorder characterized by postaxial poly-
dactyly and atypical RP was given. It is of interest to note 
that a second, independent autosomal recessive disorder, 
namely non-syndromic mental retardation (MR), was 
present in the family, but none of the BBS patients was 
affected by MR (individuals IV-1, IV-5, IV-6, IV-8 had 
MR). The molecular basis of the independent MR pheno-
type will be analyzed in an upcoming study.
 Linkage to the BBS12 Locus on 4q27 and 
Identification of a Novel BBS12 Mutation 
 In order to map the recessive disorder characterized 
by postaxial polydactyly and rod-cone dystrophy in the 
MR-10 family, we performed homozygosity mapping us-
ing the 10K array. Genome-wide LOD score calculations 
resulted in maximum LOD scores of 1.83 at three differ-
ent chromosomal regions located on chromosome 4q27–
4q31.22, 4q35.1–4q35.2, and 11q23.1–11q23.3, respective-
ly ( fig. 1 c). Genotyping of additional microsatellite mark-
ers of these regions clearly excluded the two loci on 
4q35.1–4q35.2 and 11q23.1–11q23.3 (data not shown). For 
locus 4q27–4q31.22, marker analysis confirmed homo-
zygosity and the critical region was defined by SNPs 
rs1390560 (located at 122.07 Mb) and rs1343812 (143.70 
Mb) ( fig. 2 a).
 The 21.63-Mb critical region is gene rich and contains 
approximately 80 known and predicted genes. In total, 
we tested 6 highly relevant candidate genes of this region: 
 FGF2 ,  BBS7 ,  BBS12 ,  NUDT6 ,  SPATA5 , and  SPRY1 . Se-
quencing of the coding exon 2 of  BBS12 in affected indi-
viduals identified a novel homozygous c.2103C 1 A muta-
tion ( fig. 2 b), which is predicted to insert a stop codon at 
position 701 of the BBS12 protein (p.S701X). This non-
sense mutation is located at the very C-terminal end of 
the protein and the truncation leads to a loss of 10 amino 
acids ( fig. 2 c). Co-segregation of the p.S701X mutation 
with the disease in the family could be confirmed. All af-
fected individuals were homozygous for the p.S701X mu-
tation and parents were heterozygous carriers. In addi-
tion, the mutation was not found in 147 healthy controls 
from Pakistan.
 We compared the localisation of this novel  BBS12 mu-
tation with mutations described in the original gene iden-
tification study [Stoetzel et al., 2007]. The p.S701X muta-
tion is located close to the C-terminus in the equatorial 
domain of the BBS12 protein ( fig. 2 b, c). Of the 17 patho-
genic mutations described so far, which include missense, 
nonsense, and frameshift mutations, the p.S701X is the 
most C-terminal one.
 Discussion 
 It is well known that a large clinical variability of phe-
notypic expression exists in Bardet-Biedl syndrome, both 
between and within families. In addition, clinical diag-
nosis is hampered by the fact that not all symptoms are 
congenital but may develop later during childhood or 
within the second decade of life. Therefore, especially in 
early infancy clinical diagnosis is often difficult. Diag-
nostic criteria for the clinical diagnosis of BBS have been 
suggested [Beales et al., 1999] that were modified by To-
bin and Beales in 2007 using a sub-classification of symp-
toms in primary and secondary features [Tobin and 
Table 1. Clinical findings in three affected individuals of family 
MR-10 listed according to the clinical criteria for the diagnosis of 
BBS [Beales et al., 1999]
 IV-2 IV-3 IV-9
Major criteria    
Rod-cone dystrophy + (14 years) + (15 years) + (13 years)
Postaxial polydactyly + + +
Truncal obesity – – –
Hypogonadism – – –
Renal anomalies – – –
Minor criteria
Speech disorder/delay – – –
Development delay – – –
Behaviour normal normal normal
Ataxia/imbalance – – –
Diabetes mellitus – – –
Congenital heart defects – – –
Liver disease – – –
Hearing loss – – –
Facial features – – –
Situs inversus – – –
Hirschsprungs disease – – –
Polyuria/polydipsia – – –
Hypodontia + + +
Anosmia – – –
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Beales, 2007]. Primary features are rod-cone dystrophy, 
postaxial polydactyly, obesity, hypogonadism, and renal 
anomalies, whereas secondary features include speech 
disorder/delay, development delay, diabetes mellitus, 
congenital heart disease, liver disease, situs inversus and 
facial dysmorphism. It was suggested that the clinical di-
agnosis of BBS can be made in a patient if four primary 
features or three primary plus two secondary features are 
present. Using this classification, diagnosis would have 
been missed in all three adult affected individuals in our 
family, because only 2 primary (polydactyly and rod-
cone dystrophy) and 1 secondary criterium (hypodontia) 
are present. It is interesting to point out that this very 
mild form of BBS was present in all three affected indi-
viduals, suggesting a generally mild phenotypic expres-
sion of the disease in this particular family. Therefore, 
strict diagnostic criteria in BBS might lead to false-nega-
tive classification. For this reason, we propose that mo-
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lecular genetic testing for BBS might be considered in fa-
milial forms even if the diagnostic criteria are not ful-
filled. However, the phenotype observed in the three 
affected individuals of our family clearly represents 
symptoms known to be caused by dysfunction of cilia. 
Many human genetic disorders have been described 
which are collectively called the ciliopathies, and symp-
toms associated with ciliary dysfunction include altera-
tions of left-right body axis, polydactyly, kidney, liver and 
pancreas anomalies, retinal degeneration and anosmia, 
neural tube defects as well as cognitive defects.
 Using homozygosity mapping, we linked the disease 
in our family to the  BBS12 locus on chromosome 4q27 
and identified the novel nonsense mutation p.S701X in 
 BBS12 . There is convincing evidence for a causative na-
ture of this mutation: (i) genome-wide mapping identi-
fied only one homozygous locus in this consanguineous 
family, which could be confirmed by subsequent marker 
analysis; (ii) the mutation co-segregated with the dis-
ease in the family and was absent in 147 healthy and
ethnically matched control chromosomes; (iii) the non-
sense mutation is predicted to have a clear effect on the 
BBS12 protein, truncating – even though – 10 amino ac-
ids from the conserved C-terminal end of the equatorial 
domain of the protein. It is estimated that  BBS12 muta-
tions account for up to 5% of families with BBS [Stoetzel 
et al., 2007].  One  frameshift mutation has yet been de-
scribed to alter the equatorial domain of BBS12, namely 
p.G594fsX605 ( fig. 2 c).
 Although clear genotype-phenotype correlations 
could not yet be established in BBS, mutations in  BBS3 
seem to cause more often polydactyly of all four limbs, 
while patients with  BBS4 mutations more frequently 
show polydactyly only of the upper limbs. Moreover, 
 BBS2 -associated cases do not frequently suffer from obe-
sity, whereas patients carrying  BBS3 mutations often de-
velop early-onset obesity [Carmi et al., 1995; Beales et al., 
1997; Bruford et al., 1997]. Polygenic inheritance or ge-
netic modifiers might be an explanation for phenotypic 
variability in BBS. Moreover, epistatic interactions might 
play an important role in phenotypic variability [Badano 
and Katsanis, 2002]. In this context, it was demonstrated 
that certain synergistic effects can modify the penetrance 
or expressivity of phenotype. Badano et al. reported some 
kind of evidence for a novel gene called  MGC1203 , which 
assists epistatically to  BBS1 mutations and also enhances 
the phenotype in a zebrafish model [Badano et al., 
2006b].
 No obvious phenotypic difference of  BBS12 patients 
compared to other  BBS patients was reported in the orig-
inal study, although no detailed information about the 
clinical presentation of the families was given [Stoetzel et 
al., 2007]. Nevertheless, our study showed that mutations 
in  BBS12 can cause a very mild phenotype that is clini-
cally not diagnosed by the proposed diagnostic criteria. 
Only mild phenotypic effects of  BBS12 suppression were 
also reported in a zebrafish model [Stoetzel et al., 2007]. 
In the future, it will be interesting and necessary to fur-
ther delineate the phenotypic expression in other  BBS12 
families.
 In conclusion, we provide evidence for a very mild, fa-
milial BBS12 phenotype. Clinical diagnosis would have 
been missed when applying the suggested diagnostic cri-
teria for BBS. For this reason, we propose the use of less 
strict diagnostic criteria in familial BBS cases that might 
also influence the molecular testing strategies of BBS.
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Abstract of the publication: 
The autosomal recessive Cenani-Lenz syndrome (CLS) is a rare congenital disorder 
characterized by fusion and disorganization of metacarpal and phalangeal bones, radius and 
ulnar shortening, radioulnar synostosis, and severe syndactyly of hands and feet. To identify 
the genetic cause of CLS, we initially genotyped six CLS families with different origin using 
the Affymetrix GeneChip Human Mapping 10K Array (CCG, University of Cologne) and 
mapped the CLS1 locus to chromosome 11p11.2 to a 19.7 Mb critical region between SNPs 
rs1346671 and rs490192. The gene encoding the low-density lipoprotein receptor 4 (LRP4) 
was considered as an excellent positional and functional candidate gene because Lrp4 
knockout mouse displays polysyndactyly of the fore and hind limbs, craniofacial and tooth 
abnormalities. 
 
We sequenced the coding region of all 39 exons of the LRP4 gene and identified homozygous 
mutations in affected individuals in each of the six families. We found one donor splice-site 
mutation, c.547þ1G>A (intron 6, CL-1), and five missense mutations: c.479G>A (p.C160Y, 
exon 5, CL-2), c.409G>A (p.D137N, exon 4, CL-3), c.1417C>T (p.L473F, exon 12, CL-4), 
c.1585G>A (p.D529N, exon 13, CL-5), c.1345G>A (p.D449N, exon 12, CL-6). All missense 
mutations are located in the extracellular domain of LRP4 within highly conserved regions. 
Furthermore we continued the molecular analysis of LRP4 in eight additional CLS families 
and detected that the p.D529N mutation as well as the p.D137N are Turkish and Egypt 
founder mutations. Additional we found two further missense mutations: c.1382A>C 
(p.T461P, exon 11) and c.3049T>C (p.C1017R, exon 22). We further identified compound-
heterozygous splice-site mutations (c.200-9G>A and c.49566G>C) which caused aberrant 
spliced LRP4 transcripts (r.199_200insGATTCAG and r.4952_4987del) in a typically 
affected fetus with CLS. Finally we confirmed that the mutations, which co-segregated with 
  27 
the disease, were present neither in unaffected family members nor in ethnically matched 
control individuals. 
 
To investigate the molecular pathophysiological mechanism of LRP4 mutations leading to 
CLS we analyzed the effect of five missense mutations (p.D137N, p.C160Y, p.L473F, 
p.D449N, and p.D529N) on the transduction and activation of canonical Wnt signalling by 
using a Dual-Luciferase Reporter Assay in transiently transfected HEK293T cells. We could 
show that WNT1 was able to significantly activate LRP6-mediated ß-catenin signalling and 
that additional co-expression of wt LRP4 potently antagonized this activation while the co-
expression of each of the five missense mutations abolished the antagonistic LRP4 effect on 
LRP6-mediated activation of Wnt/ß-catenin signalling. Moreover, we could demonstrate by 
cell-surface biotinylation that mutant LRP4 receptors failed to be efficiently transported to the 
plasma membrane. 
 
Own contributions: 
Genome wide mapping analysis in five CLS families was carried out by the group of Prof. Dr. 
P. Nürnberg (CCG, University of Cologne). A combined parametric LOD score of 7.46 was 
obtained on chromosome 11p11.2 – q13.1 (Figure 1b, p.3). Fine mapping analysis of the 
initial five CLS families was performed by Dr. Yun Li (Figure 1c, p. 3). 
In order to functionally characterize the LRP4 mutations found in our CLS patients, I first 
generated five different mouse mutant LRP4 constructs (C160Y, D137N, L473F, D529N and 
D449N) by site directed mutagenesis on pcDNA3.1/V5-His-TOPO expression vector. 
Mutations corresponded to five homozygous missense mutations identified by Dr. Yun Li in 
patients with CLS (Figure 2a, p.6).  
For transient expression studies, I transfected HEK293T cells using Lipofectamine 2000. 
Then I conducted expression analysis of the mutant proteins by Western Blot analysis and 
showed that all mutant LRP4 proteins are transcribed and expressed (Figure 5a, p.9).  
Next, I established a Dual-Luciferase Reporter Assay in order to determine the 
pathophysiological mechanism of the mutants. Consistent with earlier findings, co-expression 
of LRP6 and WNT1 significantly activated LRP6-mediated ß-catenin signalling and 
additional co-expression of LRP4 antagonized this activation. In contrast, co-expression of 
each of the five LRP4 missense mutations abolished the observed antagonistic LRP4 effect on 
LRP6-mediated activation of Wnt/ß-catenin signalling (Figure 5a, p.9). Therefore, I could 
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demonstrate that homozygous LRP4 mutations cause a loss of protein function and that this is 
the underlying  pathophysiology of CLS (Figure 5a, b, c, p.9). 
Moreover, I established and performed a Biotinylation Assay of wt and mutant LRP4 
proteins. I could show by Western Blot analysis that mutant LRP4 proteins were not 
detectable in the plasma membrane (Figure 5b, p.9). In order to confirm a mis-localisation of 
the LRP4 mutants I also performed immnuoflourescence with specific antibodies (data not 
shown). 
Furthermore, I sequenced the LRP4 gene for additional CLS patients and identified the 
p.E97X, the p.T416P and the p.C1017R mutations in different patients of diverse origins 
(Figure 2a, p.6, p.E97X not published yet). In addition I re-sequenced the identified mutations 
in independent experiments, tested them for co-segregation within the families, and screened 
at least 100 healthy control individuals.  
Finally, I accomplished fine mapping analysis using microsatellite markers for different 
families diagnosed with CLS and detected the founder mutations, p.D529N and p.D137N, in 
Turkish and Egypt CLS patients, respectively (Figure 3a, b, c,d, p.7). 
At last, I constructed the figures concerning the functional data for the publication (Figure 5a, 
b, c, p. 9), prepared Table 1 in discussion with clinicians (p.4-5) and critically read the paper 
before its submission to the American Journal of Human Genetics. 
 
Unpublished data: 
I also analysed and interpreted Next Generation Sequencing (NGS) data from targeted regions 
of a consanguineous CLS patient from Saudi-Arabia who had no mutation in the LRP4 gene 
and who was linked by the GeneChip® Human Mapping 10K SNP Array (CCG, University 
of Cologne) to three putative loci on chromosomes 5q12.3-5q13.3, 5q21.2-5q22.2 and 
11.p15.3-11p15.1. The complete critical regions were subject to NGS. In the beginning, a 
priority list of possible disease causing alterations in different genes on each chromosome had 
been developed. Then I started to confirm the NGS data by sequencing several alterations in 
distinct candidate genes in these regions. So far screening the patient for alterations in 
FCHO2, EPB41C4A, ABCA13, RAD17, FER, NUCB2, GRB10, APC, SOX6 and TRIM26 
found by NGS has not revealed the causative mutation in this family.  
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LRP4 Mutations Alter Wnt/b-Catenin Signaling
and Cause Limb and Kidney Malformations
in Cenani-Lenz Syndrome
Yun Li,1,2,18 Barbara Pawlik,1,2,18 Nursel Elcioglu,3,18 Mona Aglan,4 Hu¨lya Kayserili,5 Go¨khan Yigit,1,2
Ferda Percin,6 Frances Goodman,7 Gudrun Nu¨rnberg,1,8,9 Asim Cenani,10 Jill Urquhart,11
Boi-Dinh Chung,2,9 Samira Ismail,4 Khalda Amr,4 Ayca D. Aslanger,5 Christian Becker,8,9
Christian Netzer,1,2,9 Pete Scambler,12 Wafaa Eyaid,13 Hanan Hamamy,14 Jill Clayton-Smith,11
Raoul Hennekam,7,15 Peter Nu¨rnberg,1,8,9,16 Joachim Herz,17 Samia A. Temtamy,4
and Bernd Wollnik1,2,16,*
Cenani-Lenz syndrome (CLS) is an autosomal-recessive congenital disorder affecting distal limb development. It is characterized mainly
by syndactyly and/or oligodactyly and is now shown to be commonly associated with kidney anomalies. We used a homozygosity-
mapping approach to map the CLS1 locus to chromosome 11p11.2-q13.1. By sequencing candidate genes, we identified recessive
LRP4 mutations in 12 families with CLS. LRP4 belongs to the low-density lipoprotein (LDL) receptor-related proteins (LRPs), which
are essential for various developmental processes. LRP4 is known to antagonize LRP6-mediated activation of canonical Wnt signaling,
a function that is lost by the identifiedmutations. Our findings increase the spectrum of congenital anomalies associated with abnormal
lipoprotein receptor-dependent signaling.
Introduction
Spatial and temporal activation of canonical Wnt/b-cate-
nin signaling is an essential developmental process during
organogenesis and tissue regeneration.1 Wnt ligands bind
to their specific coreceptors, such as frizzled and low-
density lipoprotein-related proteins 5 and 6 (LRP5 [MIM
603506], LRP6 [MIM 603507]), leading to a stabilization
of b-catenin and transcriptional activation.2 Alteration
of the LRP5/6 signaling pathway has been described in
cancer development and human diseases.1,3,4 LRP4 (MIM
604270) is another member of the low-density lipoprotein
receptor family, but has an antagonistic effect on LRP5/6
signaling. Recent results of GWAS in bonemineral density5
and the finding that Lrp4 serves as a receptor for sclerostin
regulating bone metabolism in mice6 highlight the impor-
tance of LRP4 in the regulation of bone mineral density
and the development of osteoporosis. In mice, Lrp4
dysfunction also causes syndactyly.7
The genetic identification of factors regulating limb
formation provided important insights into the role of
major signaling pathways, such as sonic-hedgehog (SHH)
and fibroblast growth factor (FGF), during limb develop-
ment.8,9 Cenani-Lenz syndrome (CLS [MIM 212780]) is an
autosomal-recessive congenital anomaly affecting mainly
distal limb development. CLS is characterized by fusion
and disorganization of metacarpal and phalangeal bones,
radius and ulnar shortening, radioulnar synostosis, and
severe syndactyly of hands and feet.10,11 Kidney hypo-
plasia has been described in one patient with CLS,12 but
is not yet regarded as an associated trait.
Here, we map the CLS1 locus to chromosome 11p11.2-
q13.1 and identify mutations in the LRP4 gene in 12 CLS
families. We show that LRP4 function is required for the
physiological regulation of Wnt signaling, and we identify
mutations that cause loss of LRP4 function, which is
important for normal limb and kidney development.
Therefore, loss of human LRP4 function causes syndactyly,
synostosis, and renal agenesis in Cenani-Lenz syndrome.
Material and Methods
Subjects
All subjects or their legal representatives gave written informed
consent for participation in the study. The study was performed
in accordance to the Declaration of Helsinki protocols and
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approved by the local institutional review boards. We collected
peripheral blood samples from the affected children and parents,
after informed consent was obtained, according to the protocols
approved by the participating institutions. All of the research
procedures followedwere in accordance with the ethical standards
of the responsible national and institutional committees on
human subject research. Fourteen families with the clinical diag-
nosis of CLS were included in the study. In 12 of them, mutations
were identified in LRP4. Clinical features of some of the families
have already been published; see families CL-1,12 CL-2,13 CL-3,14
CL-6,15 CL-7.16 DNA from participating family members was
extracted from peripheral blood lymphocytes by standard extrac-
tion procedures.
Linkage Analysis
We performed genome-wide linkage analysis in six families (CL-1
to CL-6; not all family members could be initially included into
the genome scan), using the Affymetrix GeneChip Human
Mapping 10K Array (version 2.0). This version of the 10K Chip
Array comprises a total of 10,204 SNPs with a mean intermarker
distance of 258 kb, equivalent to 0.36 cM. Genotypes were called
by the GeneChip DNA Analysis Software (GDAS version 2.0, Affy-
metrix). We verified sample genders by counting heterozygous
SNPs on the X chromosome. Relationship errors were evaluated
with the help of the program Graphical Relationship Representa-
tion.17 The program PedCheck was applied to detect Mendelian
errors,18 and data for SNPs with such errors were removed from
the data set. Non-Mendelian errors were identified by use of the
program MERLIN,19 and unlikely genotypes for related samples
were deleted. Nonparametric linkage analysis using all genotypes
of a chromosome simultaneously was carried out with MERLIN.
Parametric linkage analysis was performed by a modified version
of the program GENEHUNTER 2.120 through stepwise use of
a sliding window with sets of 150 or 300 SNPs. Haplotypes were
reconstructed with GENEHUNTER 2.1 and presented graphically
with HaploPainter.21 This program also reveals informative SNP
markers as points of recombination between parental haplotypes.
All data handling was performed with the use of the graphical user
interface ALOHOMORA,22 developed at the Berlin Gene Mapping
Center to facilitate linkage analysis with chip data.
Mutation Screening
We identified candidate genes in the critical region by using the
ENSEMBL and UCSC human genome databases. We amplified
the 38 exons of the LRP4 gene (primers are listed in Table S1, avail-
able online) from DNA of index patients from all 14 families and
sequenced the PCR products via the BigDye Terminator method
on an ABI 3100 sequencer. We resequenced all identified muta-
tions in independent experiments, tested for cosegregation within
the families, and screened at least 200 healthy control individuals
from Turkey, 150 from Pakistan, 50 from Germany, and 50 from
Egypt for each mutation by PCR and/or restriction digestion or
direct sequencing. We analyzed all identified alterations by using
the server PolyPhen. The LRP4 protein structure was analyzed
with the server Pfam in order to determine different protein
domains of LRP4.
cDNA Analysis
RNA was extracted from fresh whole-cell blood through use
of the Paxgene Blood RNA system. After cDNA transcription,
nested PCR was used to amplify LRP4 cDNA (primers are listed
in Table S1). Primers were designed according to the reference
sequence.
Generation of Lrp4 Constructs
Five Lrp4 mutant constructs were generated by site-directed
mutagenesis with the use of wild-type mouse Lrp4 in the
pcDNA3.1/V5-His-TOPO vector (Invitrogen, Karlsruhe, Germany)
as template. The correct sequence of all PCR amplicons and
constructs was confirmed by direct sequencing from both sides
with the use of the ABI BigDye Terminator v1.1 Cycle Sequencing
Kit and the ABI 3730 DNA Analyzer (Applied Biosystems, Foster
City, CA, USA).
Cell Culture and Transfections
Human embryonic kidney (HEK)293T cells were cultured in Dul-
becco’s Modified Eagle Media (DMEM) containing 10% fetal
bovine serum (FBS), amphothericin B, streptomycin, and peni-
cillin. Cells were transfected with the use of Lipofectamine 2000
(Invitrogen, Karlsruhe, Germany) according to the manufacturer’s
instructions.
Luciferase Assay
One day before transfection, approx. 400.000 HEK293T cells were
plated out in 12-well plates and grown up to 50% confluency in
10% FBS and DMEM. Transfections were performed in triplicate
with the use of the TOP-Flash reporter system and the indicated
expression plasmids with the following concentrations: 500 ng
wild-type (WT) Lrp4 or 500 ng mutants, 250 ng Lrp6, 250 ng
Wnt1, 100 ng Topflash Vector, 5 ng Renilla (p-RL-TK). Cells were
transfected with the use of Lipofectamine 2000 (Invitrogen, Karls-
ruhe, Germany) according to themanufacturer’s instructions. Two
days after transfection, cells were lysed and Luciferase activity was
measured with the use of the Dual-Luciferase Reporter Assay Kit
and a Glomex 96-microplate luminometer (Promega, Mannheim,
Germany). Each transfection was also measured in triplicate.
Immunoblot
Immunoblot analysis was performed according to standard proto-
cols. Detection of LRP4 was conducted with a C-terminal Lrp4
mouse monoclonal antibody (1:1000).
Cell-Surface Biotin-Labeling Assay
One day before the experiment, 50% confluent HEK293T cells
were cotransfected with 1.5 mg LRP4, WT or mutant, and 1.5 mg
insulin receptor (IR) in T75 cm2 flasks. Biotinylation was carried
out with the use of the Cell Surface Protein Isolation Kit (Pierce,
Bonn, Germany) according to the manufacturer’s instructions.
Protein concentrations were measured with the use of the BCA
Protein Assay Kit (Pierce). Immunoblot analysis was performed
according to standard protocols. Detection of LRP4 and IR was
conducted with a C-terminal LRP4 mouse monoclonal antibody
(1:1000) and an insulin-receptor rabbit monoclonal antibody
(Abcam, Berlin, Germany) (1:1000).
Results
Clinical Findings in CLS Families
We have examined 14 CLS families presenting with a vari-
able expression of clinical symptoms. In twelve of themwe
identified the molecular basis of the disease (Figure 1A,
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Table 1). We observed mild facial dysmorphism in the
majority of CLS cases, with prominent forehead, hyperte-
lorism, downslanting palpebral fissures, andmicrognathia.
Typical limb malformations included total to partial
syndactyly of hands and feet, as well as distal bone malfor-
mations affecting the radius and ulna as well as the meta-
carpal and phalangeal bones (Figure 1A, Table 1). Interest-
ingly, we also found kidney anomalies, including renal
agenesis and hypoplasia, in over 50% of CLS families.
Mapping of the CLS1 Locus and Identification
of LRP4 Mutations
Initially, we genotyped DNA samples from six CLS families
(CL-1 to CL-6, Figure 1) by using the Affymetrix GeneChip
Human Mapping 10K Array. Affected individuals were
born to consanguineous parents in all families. A com-
bined parametric LOD score of 7.46 was obtained for
a single region located on chromosome 11p11.2-q13.1
between SNPs rs1346671 and rs490192 (Figure 1B),
defining a shared critical interval of about 19.7 Mb. Subse-
quent analysis of microsatellite markers and inclusion of
additional family members confirmed homozygous haplo-
types for the linked region in all affected individuals
(Figure 1C). We considered LRP4 as a highly relevant posi-
tional and functional candidate gene. No additional gene
from the critical region was tested. Sequencing of the 38
coding exons of LRP4 (Table S1) revealed different homo-
zygous mutations in affected individuals in each of the
six families. The mutations cosegregated with the disease
in the families and were not found in at least 250 healthy
control individuals. We found one donor splice-site muta-
tion, c.547þ1G>A (intron 6, CL-1), and five missense
mutations: c.479G>A (p.C160Y, exon 5, CL-2), c.409G>A
(p.D137N, exon 4, CL-3), c.1417C>T (p.L473F, exon 12,
CL-4), c.1585G>A (p.D529N, exon 13, CL-5), c.1345G>A
(p.D449N, exon 12, CL-6) (Figure 2A). All missense
Figure 1. Clinical Findings in Families with CLS and Mapping of the CLS1 Locus
(A) Typical hand and feet anomalies seen in CLS patients.
(B) Graphical view of additive LOD-score calculations of genome-wide SNPmapping in families CL-1 to CL-6. Ideogram of chromosome
11 showing the localization of linked region.
(C) Haplotypes of CLS families included in the initial linkage analysis.
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Table 1. Clinical Findings in CLS Families Carrying LRP4 Mutations
Family Data CL-1 CL-2 CL-3 CL-4 CL-5 CL-6 CL-7 CL-8 CL-9 CL-10 CL-11 CL-12
Consanguinity þ þ þ þ þ þ þ þ þ þ - þ
No. of affected
individuals
1 1 3 3 1 2 1 6 2 2 1 1
Mutation c.547þ1G>A C160Y D137N L473F D529N D449N T461P C1017R D529N D529N c.200-9G>A,
c.4959G>C
D137N
Origin Pakistan Turkey Egypt Egypt Turkey Turkey Pakistan Jordan Turkey Turkey Turkey Egypt
Facial dysmorphism
Prominent forehead þ - þ þ - - þ þ þ þ þ þ
Hypertelorism þ - þ þ - - þ - þ - þ þ
Downsl. palpebral
fissures
- - þ þ - - - þ - - - þ
Micro-, retrognathia þ - þ þ - - - þ - - þ þ
Teeth findings
Hypodontia - - - - - - - - þ - ? ?
Malar hypoplasia þ - þ þ - - þ þ - - þ þ
Enamel hypoplasia - - þ þ - - - - - - ? ?
Early loss of
permanent teeth
- - þ þ - ? - - ? ? ? ?
Upper limb findings
Typical syndactyly þ þ/ þ þ þ þ þ/ þ þ - þ þ
Short forearms þ - þ þ þ þ - - - - þ þ
Radius-ulnar
synostosis
þ - þ þ þ þ - - ? ? þ þ
Disorganized /
missing
metacarpals
and phalanges
þ þ þ þ þ þ þ þ þ þ þ þ
Fused metacarpals þ þ þ þ þ þ - þ þ þ þ þ
Nail aplasia þ þ/ þ þ þ þ þ þ þ - þ þ
Lower limb
findings
Syndactyly 2/3 2/3 þ þ 2/3–2/5 þ þ 1/2/3 R 2/3 2/3 1/2 þ
Tibia-fibula
synostosis
- - - - - - - - - - - -
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Table 1. Continued
Family Data CL-1 CL-2 CL-3 CL-4 CL-5 CL-6 CL-7 CL-8 CL-9 CL-10 CL-11 CL-12
Disorganized /
missing metatarsals
and phalanges
- - þ þ þ/ - þ þ þ - -/þ þ
Nail aplasia /partial - - þ þ þ/ þ þ þ -/þ - þ þ
Kidney anomalies
Agenesis - - - - - - unilateral - bilateral bilateral bilateral -
Hypoplasia bilateral - - - - unilateral - unilateral - - - -
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mutations are located in the extracellular domains of LRP4
within highly conserved regions, as shown by LRP4 pro-
tein alignments of various species (Figure S1). p.C160Yand
p.D137N mutations lie within the ligand-binding (class A)
repeat-containing domain of the receptor, p.D449N and
p.L473F are located within calcium-binding epidermal
growth factor (EGF) repeats, and D529 is located within
the YWTD domain (Figure 2C).
We continued the molecular analysis of LRP4 in eight
additional CLS families (Figures 3A and 3C). In fami-
lies CL-9 and CL-10, we found the same homozygous
p.D529N mutation as identified before in the CL-5 family.
All three families originated from Turkey, and haplotype
analysis confirmed that p.D529N is a common founder
mutation in Turkish CLS patients (Figure 3C). It is also
interesting to note that the p.D137N mutation is repeat-
edly found in CLS families from Egypt, as we could identify
a second family, CL-12, carrying this mutation. p.D137N
in both families was located on identical haplotypes
(Figure 3D), suggesting that p.D137N is a founder muta-
tion. Two additional missense mutations were found:
c.1382A>C (p.T461P, exon 11, CL-7) in a Jordanian patient
and c.3049T>C (p.C1017R, exon 22, CL-8) in a large CLS
family from Pakistan with six affected family members
(Figure 2B, Figure 3A). These mutations also cosegregated
with the disease, were not found in matched controls,
and were located in highly conserved regions (Figure S1).
Furthermore, no LRP4 mutation was found in two other
consanguineous CLS families, and haplotype analysis did
not show homozygosity of the LRP4 region in affected
individuals from both families, supporting the idea of
further locus heterogeneity (Figure 3B).
We found initial evidence for an impairment of LRP4
function as the underlying pathomechanism of CLS by
identifying compound-heterozygous splice-site mutations
in a typically affected fetus with CLS. Both mutations,
c.200-9G>A and c.4959G>C (Figure 2C), caused aber-
rantly spliced LRP4 transcripts (r.199_200insGATTCAG
and r.4952_4987del, respectively), and both mutations
lead to a truncated protein (Figures 4A and 4B).
LRP4 Mutations Cause Loss of Protein Function
To investigate whether the identified missense mutations
confer loss of function or whether they are functionally
hypomorphic with biochemically detectable residual pro-
tein activity, we analyzed the effect of five missense
mutations (p.D137N, p.C160Y, p.L473F, p.D449N, and
p.D529N) on the transduction and activation of canonical
Wnt signaling by using a Dual Luciferase Reporter Assay in
transiently transfected HEK293T cells. Consistent with
earlier findings,5 we found that WNT1 was able to signifi-
cantly activate LRP6-mediated b-catenin signaling and
that additional coexpression of LRP4 potently antagonized
this activation (Figure 5A). In contrast, coexpression of
A
B
CL-1
c.547 +1 G>A 
CL-4
L473F
CL-2
C160Y
CL-3, -12
D137N
CL-5, -9, -10
D529N
CL-6
D449N
CL-7
T461P
CL-8
C1017R
C
father
mother
patient
CL-11
c.200 -9G>A c.4959G>C
wt/wt
wt/mt
mt/mt
n. a.
Figure 2. Mutations Identified in LRP4
(A) Electropherograms of identified homozygous LRP4 mutations compared with heterozygous carrier and WT sequences (n.a., not
available).
(B) Electropherograms of identified compound-heterozygous splice-site mutations in LRP4 causing aberrant splicing and premature
protein truncation.
(C) Schematic view of LRP4 receptor domains and localization of identified CLS mutations.
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each of the fivemissensemutations abolished the observed
antagonistic LRP4 effect on LRP6-mediated activation of
Wnt/b-catenin signaling. Moreover, mutant LRP4 recep-
tors failed to be efficiently transported to the plasma mem-
brane, as shown by cell-surface biotinylation (Figure 5B).
Discussion
We report the mapping of the CLS1 locus to chromosome
11p11.2-q13.1 and present convincing evidence that
mutations in the LRP4 gene cause CLS. Clinical findings
in our CLS patients showed that in addition to the well-
described distal limb malformations (ranging from total
to partial syndactyly and bone malformations of both
hands and feet), patients presented with facial features
such as prominent forehead, hypertelorism, downslanting
palpebral fissures, and micrognathia. Previously, renal
hypoplasia has been reported in only one case16 and was
therefore not regarded as an associated trait of CLS. Our
finding that over 50% of CLS families present with renal
agenesis and/or hypoplasia adds kidney anomalies to the
clinical spectrum of CLS. In this context, it is interesting
to note that a subpenetrant phenotype of kidney agenesis
was observed in Lrp4 homozygous null mice. In the
Lrp4/ homozygous kidneys the ureteric budding is often
delayed, resulting in insufficient stimulation of the mesen-
chyme. This results in destruction of prenephric mesen-
chymal structures, and no kidneys are formed (J. Herz,
personal communication). These findings clearly show
that Lrp4 has an important function for kidney develop-
ment in mice and humans.
Recently, murine LRP4 was shown to serve as a corecep-
tor for agrin in the formation of the neuromuscular junc-
tion.23 Mutations in genes encoding other members of
this complex have been associated with akinetic andmyas-
thenic syndromes in humans (MIM 288150 and MIM
254300).24,25 Given that we did not observe a clinically
Figure 3. Additional CLS Families and Genetic Heterogeneity
(A) Pedigrees of additional CLS families.
(B) The LRP4 locus was excluded in families CL-13 and CL-14 by haplotype analysis.
(C and D) Identification of an LRP4 founder mutation, p.D529N, in three Turkish CLS families (C) and of p.D137N in two families from
Egypt (D). Identical haplotypes are shown in red.
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detectable neuromuscular phenotype in our CLS patients,
the role of LRP4 in the development and function of the
neuromuscular junction in humans (as opposed to mice)
will require further investigation. In the case that the
LRP4 mutations found in CLS patients are not complete
loss-of-function mutations and do have minor residual
functionality in vivo, there could be a different but over-
lapping phenotype caused by, for example, homozygous
nonsense mutations or deletions in LRP4, and this could
include neuromuscular symptoms.
TheLRP4mutations identified inour study are frequently
missensemutations, which are located in the large extracel-
lular domain of LRP4 within the ligand-binding (class A)
repeat-containing domain, calcium-binding EGF repeats,
and the YWTD domain of the receptor (Figure 2C). These
changes might cause structural alterations of the extracel-
lular LRP4 domain that interfere with normal folding and
thus prevent the efficient export of the protein through
the secretory pathway, but this hypothesis has to be proven
in future experimental studies. Our functional analysis of
five of themissensemutations clearly demonstrated a func-
tional impairment of LRP4mutant proteins. LRP4 is impor-
tant for control and modification of Wnt signaling by its
antagonistic effect on LRP6-mediated activation of WNT
signaling (Figure 5C). This antagonistic function is com-
pletely lost in four out of five LRP4 mutants, as shown in
our in a Dual Luciferase Reporter Assay. The p.D137N
mutant seems to show some residual antagonistic function
in the Reporter Assay experiment, and the biotinylation
experiments clearly demonstrated that p.D137N mutant
protein is not getting to the cell surface. Whether a yet
unknown function of LRP4, which is not dependent on
its membrane integration, could be responsible for this
residual function remains to be elucidated.
We also found that WNT1 was able to significantly acti-
vate LRP6-mediated b-catenin signaling, which is consis-
tent with earlier findings.7 We demonstrated that the
main reason for the loss-of-function effect is the failure
of mutant LRP4 receptors to be efficiently transported
to the plasma membrane. In addition, the heterozygous
splice-site mutations identified in the CL-11 fetus, c.200-
9G>A and c.4959G>C, caused aberrantly spliced LRP4
transcripts and premature protein truncations. Conclu-
sively, we suggest complete or near-complete loss of LRP4
function as the underlying pathogenetic mechanism of
CLS. As a result, developmental limb and kidney malfor-
mations in patients occur through amechanism that likely
also involves excessive LRP6-mediated Wnt/b-catenin acti-
vation (Figure 5C).
It has been previously shown that Lrp4 dysfunction also
causes polysyndactyly in mice7 and syndactyly with vari-
able penetrance in bovines, termed mulefoot disease.26
Lrp4 was shown to be expressed in the apical ectodermal
ridge (AER) in the developing limb bud,7 a structure impor-
tant for coordination of patterning and growth of the
distal limb.8 Various signaling molecules are secreted from
the AER, such as sonic hedgehog (Shh), bonemorphogenic
proteins (Bmps), fibroblast growth factors (Fgfs), andWnts,
Exon 34Exon 33 Exon 35
Exon 33 Exon 35
CL-11: c.4959G>C
c. 4952_4987del; p.V1651DfsX1691
P_cDNA_topo
P_cDNA
Exon 3Exon 2
Exon 3Exon 2
CL-11: c.200 -9G>A
c.199_200insGATTCAG; p.I67RfsX77
wt
A B
Figure 4. Splicing Effects of Mutations in Family CL-11
(A) Analysis of the heterozygous c.200-9G>A mutation. cDNA sequences of the exon 2-exon 3 boundary of wild-type (wt) and patient
cDNA are shown (without [P_cDNA] and after subcloning via the TOPO-Vector system [P_cDNA_topo]).
(B) Analysis of the heterozygous c.4959G>C mutation. Electropherograms show the cDNA sequences of LRP4 transcripts encoded by
exon 33 to exon 35 of wild-type (wt), and skipping of exon 34 in the patient cDNA.
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and the complex interactions of these signaling pathways
are essential for normal limb development.27,28 Extensive
analysis of the limb phenotype in Lrp4/ knockout
mice showed that loss of Lrp4 causes structural AER alter-
ations as well as ectopic expression of different key signal-
ing molecules (e.g., Fgf8, Bmp4, and Shh).7 Whether Lrp6
expression was upregulated during limb development in
the AER of Lrp4/mice was not analyzed. Given the facts
that (1) Lrp4 was described as an integrator of Wnt and
Bmp signaling,29 (2) Lrp4 has an antagonistic function
on Lrp6-mediated Wnt/b-catenin activation, and (3) Lrp6
is critical for Wnt signaling during limb development in
mice,30 it is a reasonable working hypothesis that loss of
LRP4 during limb development in CLS patients could
lead to an overactivation of LRP6, which then causes
altered Wnt signaling. Future approaches are needed to
show that knocking down LRP4 expression upregulates
Wnt/b-catenin in vivo.
In two CLS families, we did not find LRP4 mutations,
and haplotype analysis did now show homozygosity in
affected individuals born to consanguineous parents.
In the CL-13 family with only a single affected individual,
homozygosity is only an assumption due to parental con-
sanguinity, but lack of homozygosity does not completely
exclude LRP4 as causative gene. In the CL-14 family, haplo-
type analysis of microsatellite markers as well as results
from 250K arrray analysis excluded common haplotypes
in both affected individuals, suggesting further locus het-
erogeneity in CLS. Future identification of a causative
gene(s) in these families will highlight additional key pro-
teins for distal limb development.
We conclude that LRP4 function is required for the phys-
iological regulation of Wnt signaling, which is important
for normal limb and kidney development. Homozygous
loss of human LRP4 function causes syndactyly, synos-
tosis, and renal agenesis in Cenani-Lenz syndrome.
Supplemental Data
Supplemental Data include one figure and one table and can be
found with this article online at http://www.ajhg.org.
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FR, Balci S, Gillessen-Kaesbach G, Wollnik B. A specific mutation in the distant sonic 
hedgehog cis-regulator (ZRS) causes Werner mesomelic syndrome while complete ZRS 
duplications underlie Haas type polysyndactyly and preaxial polydactyly with or 
without triphalangeal thumb. Hum Mutat. (2010); 31(1):81-9. 
 
Abstract of the publication: 
Werner mesomelic syndrome (WMS) is an autosmal dominant disorder characterized by 
hypo- or aplasia of the tibiae, preaxial polydactyly of the hands and feet and/or five fingered 
hands and triphalangeal thumbs. Triphalangeal thumb is a common hand malformation, which 
can occur isolated as autosomal dominant inherited, nonopposable triphalangeal thumb or as a 
clinical sign of well-characterized syndromic conditions; e.g., Holt-Oram syndrome. 
Recently, mutations in the zone of polarizing activity regulatory sequence (ZRS), a long-
range limb-specific enhancer of the sonic hedgehog (SHH) gene, have been identified in 
patients with preaxial polydactyly type II (PPD2), triphalangeal thumb polysyndactyly 
(TPTPS), and syndactyly type IV (SD4, Haas type polysyndactyly). Thus, we regarded the 
ZRS enhancer, which lies within the intron 5 of the LMBR1 gene, to be an excellent candidate 
gene for WMS. 
 
Initially, we sequenced the ZRS within the index patients of one Turkish and another Brasil 
family with WMS. Furthermore we tested the enhancer in a sporadic female patient diagnosed 
with Haas type polysyndactly and another family with TPTPS by using a quantitative PCR 
technique for the detection of Copy Number Variations (CPVs) of the ZRS.  
We identified heterozygous single base pair alterations at position 404 of the ZRS in the 
Turkish index (404G>A) and in six affected individuals of the second Brasil family with 
WMS (404G>C). The mutations are affecting a highly conserved nucleotide position within 
the ZRS region and were absent in all tested healthy family members as well as in 100 
Turkish control individuals. Moreover, based on the applied ∆Ct method, we detected ZRS 
duplications in the index patient with Haas type polysyndactyly and in eight affected 
individuals of the family with TPTPS. In contrast, unaffected family members from this 
family did not show any quantitative changes and the duplication was not detected in 35 
Turkish controls. 
 
 
  30 
Own contributions: 
The patients´ DNAs for this study was kindly provided Dr. Dagmar Wieczorek (Institut für 
Humangenetik, Universitätsklinikum, Essen). The complete molecular data presented in this 
paper were done by myself.  
I started with primer design and PCR amplification of the 772 bp long ZRS-DNA-fragment in 
all affected family members. I could elucidate the molecular basis of WMS by identifying the 
404G>A and the 404G>C mutation in distinct patients (Figure 4, p.4). I was able to confirm 
co-segregation of the mutations in the families by direct sequencing of all family members 
and by a PCR/enzyme digestion method using TaalI (data not shown). In addition, I 
performed control studies of 100 healthy Turkish control individuals. In conclusion, I could 
demonstrate that the 404G position of the ZRS is highly conserved among species using 
sequence alignment (Figure 4, p.4). 
Next, I evaluated and interpreted the Array-CGH data (Figure 5, p.5) using genome databases. 
According to the CGH data I designed ZRS primers and probes for quantitative Real-Time 
PCR and performed TaqMan analysis with patients. After subsequent analysis of the qPCR 
data, I could detect duplications in one sporadic patient with Haas-type syndactyly and in 
eight affected family members of a family diagnosed with TPTPS. Furthermore these copy 
number changes were not present in 35 control individuals (Figure not shown).  
Moreover, I designed ZRS containing constructs for FISH analysis by cloning ZRS-PCR 
fragments into TOPO vector and performed breakpoint PCR for the sporadic patient with type 
Haas syndactyly and for one patient of the family diagnosed with TPTPS.  
Finally, I prepared all experimental figures (Figure 4, 5) for the publication and critically read 
the manuscript before its submission to Human Mutation. 
 
Unpublished data: 
Very recently I have been able to identify a novel ZRS mutation (405T>A) in a female WMS 
patient from Birmingham, UK. Promotor analysis of the ZRS transcription binding site 
predicted that the mutation might cause a loss of binding of the PLZF transcription factor. 
Because it is suggested that mutations in the ZRS cause a changed transcription factor-binding 
affinity and that this could be the disease-causing mechanism for triphalangeal thumb, I 
started to confirm this hypothesis for WMS by generating a mutant 405T>A construct on the 
wt mouse ZRS in the pBGZ40/p1230 vector. A Band-Shift Assay with the mutant ZRS-DNA 
fragment and the purified PLZF transcription factor in the near future might show the 
importance of the ZRS in the pathophysiology of WMS. 
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ABSTRACT: Werner mesomelic syndrome (WMS) is an
autosomal dominant disorder with unknown molecular
etiology characterized by hypo- or aplasia of the tibiae in
addition to the preaxial polydactyly (PPD) of the hands
and feet and/or five-fingered hand with absence of
thumbs. We show that point mutations of a specific
nucleotide within the sonic hedgehog (SHH) regulatory
region (ZRS) cause WMS. In a previously unpublished
WMS family, we identified the causative G4A transition
at position 404 of the ZRS, and in six affected family
members of a second WMS family we found a 404G4C
mutation of the ZRS. The 404G4A ZRS mutation is
known as the ‘‘Cuban mutation’’ of PPD type II (PPD2).
Interestingly, the index patient of that family had tibial
hypoplasia as well. These data provide the first evidence
that WMS is caused by a specific ZRS mutation, which
leads to strong ectopic SHH expression. In contrast, we
show that complete duplications of the ZRS region lead
to type Haas polysyndactyly or triphalangeal thumb-
polysyndactyly syndrome, but do not affect lower limb
development. We suggest the term ‘‘ZRS-associated
syndromes’’ and a clinical subclassification for the
continuum of limb malformations caused by different
molecular alterations of the ZRS.
Hum Mutat 30:1–9, 2009. & 2009 Wiley-Liss, Inc.
KEY WORDS: WMS; Haas polysyndactyly; triphalangeal
thumb polysyndactyly syndrome; ZRS
Introduction
Triphalangeal thumb is a common hand malformation, which
can occur isolated as autosomal dominant inherited, nonoppo-
sable triphalangeal thumb (MIM] 190600) or as a clinical sign of
well-characterized syndromic conditions; e.g., Holt-Oram syn-
drome [Basson et al., 1997], lacrimo-auriculo-dento-digital
syndrome [Rohmann et al., 2006], or Nager acrofacial dysostosis
[McDonald and Gorski, 1993]. Recently, mutations in the zone of
polarizing activity regulatory sequence (ZRS; MIM] 605522), a
long-range limb-specific enhancer of the sonic hedgehog (SHH)
gene (HHG1, SMMCI, TPT, TPTPS, MCOPCB5; MIM] 600725),
have been identified in patients with preaxial polydactyly type II
(PPD2) [Lettice et al., 2002, 2003; Li et al., 2009], triphalangeal
thumb polysyndactyly (TPTPS; MIM] 174500) [Sun et al., 2008;
Klopocki et al., 2008], and syndactyly type IV (SD4, Haas type
polysyndactyly; MIM] 186200) [Sun et al., 2008; Wu et al., 2009;
Furniss et al., in press]. The ZRS is located on human
chromosome 7q36.3 within intron 5 of the LMBR1 gene (ACHP,
FLJ11665; MIM] 605522) [Lettice et al., 2003] and it has been
shown that it regulates the timely and spatial expression of the
SHH gene, which is located approximately 1Mb downstream.
PPD2 is characterized by a triphalangeal thumb with or without
preaxial polydactyly (PPD), sometimes leading to the appearance
of a five-fingered hand. Characteristic clinical findings in TPTPS
are triphalangeal thumb, syndactyly of hands, and pre- and
postaxial polysyndactyly of the feet. Some patients show a more
severe phenotype with complete syndactyly of all fingers giving a
‘‘cup-like’’ shape to the hands. This severe end of TPTPS, complete
syndactyly with polydactyly, is the typical anomaly seen in
patients with SD4. Werner mesomelic syndrome (WMS) (tibial
hypoplasia-polysyndactyly-triphalangeal thumb, THPSTPT; MIM]
188770) was first described by Werner [1912] and the hallmark of
this syndrome is the affection of tibia development leading to
aplasia or hypoplasia of tibiae often accompanied with remarkable
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short stature. In addition, patients with Werner syndrome present
with polydactyly of hands and feet and digitalization of the
thumbs. The molecular basis for WMS is unknown.
We report on the molecular etiology of WMS in two families.
Our results show that a specific point mutation in the ZRS is
responsible for the abnormal development of tibiae seen in
patients with WMS. In addition, we describe two different
duplications of the ZRS region in a patient with Haas type
polysyndactyly [Gillessen-Kaesbach and Majewski, 1991] and in a
family with overlapping clinical signs of TPTPS and syndactyly
type IV [Balci et al., 1999].
Materials and Methods
Mutation Analysis
The 772 bp of the predicted ZRS region (156277329–
156276557Mb; University of California, Santa Cruz [UCSC]
Human Genome Browser; http://genome.ucsc.edu; hg18 assembly;
g.104811–105583 in reference sequence AC007097.4) was
sequenced in the index patients of the families presented in our
study after informed consent was obtained from the patients.
Genomic DNA from patients was used to amplify the ZRS
region by a touchdown PCR protocol on a DNA Engine Dyad
Thermal Cycler (Bio-Rad, Munich, Germany). The following
primers were used: 50-CTGGCCAGTGTTTAAATGGT-30 (F1) and
50-TGATCCATAACCATTTCTAAG-30 (R1). PCR fragments were
purified and directly sequenced from both sides using the ABI
BigDye Terminator v3.1 Cycle Sequencing Kit and the ABI 3730 DNA
Analyzer (Applied Biosystems, Darmstadt, Germany). Additional
internal primers were used for sequencing, and primer sequences are
available upon request. Cosegregation of the mutations in the families
was confirmed by direct sequencing of all available family members
and by a PCR/enzyme digestion method using Taal1. In addition, the
mutations were not detected in 100 Turkish control individuals.
Array–Comparative Genomic Hybridization Analysis
Oligonucleotide array–comparative genomic hybridization
(array-CGH) was performed on a Human Genome CGHMicroarray
244A platform (Agilent Technologies, Santa Clara, CA). One
microgram (1mg) of the test DNA and 1 mg of reference DNA from
a pool of 10 healthy donors with either male or female karyotype
were hybridized using the manufacturer’s protocol with slight
modifications. Slides were scanned with a GenePixs 4000B
microarray reader (Molecular Devices Corporation, Union City,
CA) at a resolution of 5 mm/pixel. Signal intensities from the
generated images were measured and evaluated with the Feature
Extraction v9.1 and CGH Analytics v3.5 software packages,
respectively (Agilent Technologies). Except for the LMBR1 locus,
statistically significant imbalances spanning a region of 10
sequential probes with a transformed log2 ratio beyond 0.5 and
mapping outside known copy number variations (CNVs) were
Figure 1. Family 1 with Werner mesomelic syndrome. A: Pedigree of Family 1. B–J: Index patient of Family 1 (Patient III/2). K: Right hand of
father of the index patient (Patient II/2).
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considered aberrant. The position of the array targets was mapped
to the UCSC genome browser release March 2006.
Quantitative Real-Time PCR
We established a quantitative real-time polymerase chain
reaction (qPCR) method for the detection of structural alterations
of the ZRS region. Primers and probes located in the ZRS region
and in the albumin gene (ALB) used as internal were designed
using the Primer Express Software (Applied Biosystems) and
were purchased from Applied Biosystems (ZRS forward primer:
50-TGAGTGATTAAGGAAGTGCTGCTTAG-30; reverse primer:
50-GGCTTCCCTTTTGTCTGTGATTT-30 and probe: 50-FAM-
TGCGCATATTTGGC CTGGTTCTGG-BHQ-30; ALB: forward
primer 50-CTTGTGGGCTGTAATCATCGTC TAG-30; reverse
primer: 50-AGCTGCTGGTTCTCTTTCACTGAC-30 and probe
50-VIC-CACACAAATCTCTC-MGB-30). Each reaction was carried
out in 20ml volume containing 10ml of 2 universal master mix
buffer, 700nM of the ZRS and ALB primers, and 400nM of both ZRS
and ALB probes. Ten nanograms (10ng) of genomic DNA was used
as templates. For detection of quantitative changes of DNA amounts,
we used 5, 10, and 15 and 20ng of DNA samples in separated
replicates. Thermal cycling was performed for 2min at 501C, 10min
at 951C, and then 40 cycles for 15 s at 951C and for 1min at 601C.
The threshold cycle parameter (Ct) was defined as the point at which
the amplification plot—representing the fluorescence generated by
cleavage of the probe as a function of the cycle number—passed a
fixed threshold above baseline. Each replicate was normalized to ALB
in order to obtain a DCt (VIC dye Ct-FAM dye Ct). To imitate the
DCt created by one copy, two copies, and three copies of the ZRS
gene, two control samples with different DNA amounts were used.
All samples were then normalized to the calibrator to determine the
DDCt (DCt of each sample – DCt of two copies).
Results
Clinical Reports
Family 1
The Turkish index patient was examined for diagnostic
evaluation at the age of 43 years. He presented with short stature
(height: 135 cm, –6.7 SD), shortening of forearms and PPD of
both hands. The additional fingers were surgically removed and
the residual state is five-fingered hands with a triphalangeal first
ray on the left hand. The femora are mildly shortened and his
lower legs are severely shortened. He had PPD of both feet (Fig.
1A–J). The clinical diagnosis WMS [Werner, 1912] was estab-
lished. The index patient’s father only presented with right-sided
PPD of the hand (Fig. 1K). The index patient’s wife was pregnant
with twins after intracytoplasmic sperm injection (ICSI). Ultra-
sound examination in one of the fetuses revealed severely
shortened legs with aplasia of fibulae and tibiae as well as
syndactyly of the right hand. An elective feticide was done, the
other child, a female, was born healthy. All other family members
did not show any anomalies. DNA was available from Family
Members III/2 and II/1–4.
Family 2
The clinical data of this family with WMS were published by
Vargas et al. [1995]. Ten affected family members in three
generations were described. All affected patients presented with
triphalangeal thumbs and PPD of the feet, two had tibial defects,
and one duplicated fibulae. We add previously unpublished
radiographs and clinical photographs of members of this family
depicting severe hypoplasia of tibia and bowing of fibula in Patient
II/3 (Fig. 2A), right-sided triphalangeal thumb in Patient III/9
(Fig. 2B), and radiographs of triphalangeal thumbs in Patient
III/11 (Fig. 2C). DNA was available from Family Members II/3,
III/9, III/11, III/16, and IV/7–9.
Family 3
The proposita, a sporadic female patient with Haas type
polysyndactyly, was published by Gillessen-Kaesbach and
Majewski [1991]. We examined her again as an adult woman.
Figure 2. Family 2 with Werner mesomelic syndrome published by
Vargas et al. [1995]. A: Radiographs of the legs of Patient II/3 showing
severe shortening of tibiae and bowing of fibulae. B: Hands of Patient
III/9 with triphalangeal thumbs bilaterally. C: Hand radiographs of
Patient III/11 showing triphalangeal thumbs bilaterally.
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The photographs are depicting the primary state with complete
cutaneous syndactyly of all fingers and polydactyly (Fig. 3A), the
hands after 18 surgical corrections (Fig. 3B), and the feet with
right-sided III–IV and left-sided IV–V skin syndactyly (Fig. 3C).
There were no other congenital anomalies, and mental develop-
ment was normal. DNA was available from the proposita and her
healthy parents.
Family 4
This family with triphalangeal thumb-polysyndactyly syndrome
was published by Balci et al. [1999]. The characteristic findings in
this family were triphalangeal thumbs, webbing between the 3rd,
4th, and 5th fingers associated with bony synostosis in the distal
phalanges of the same fingers, and pre- and postaxial poly-
syndactyly of feet. Some of the family members, especially Person
29 in this work, had clinical signs very similar to syndactyly type
IV. DNA was available from the following Family Members: II/2,
III/1, III/3, III/6, IV/1, IV/2, IV/6, and IV/8.
The research was reviewed and approved by the ethics
committee of the medical faculty, University Duisburg-Essen,
Germany.
A Specific Mutation in the ZRS Causes WMS
We used the reference sequence from the UCSC Human
Genome Browser hg18 assembly to amplify the predicted ZRS
region (according to Lettice and Hill [2005]) that is located in
intron 5 of the LMBR1 gene on chromosome 7q36.3. This region
is highly conserved and single nucleotide changes as well as
structural alterations were previously described to cause various
distal limb malformations. Sequencing of the 772 bp of ZRS in the
index patient of Family 1 revealed a heterozygous single-basepair
alteration at position g.105213G4A in accordance with reference
sequence AC007097.4 within the ZRS (named here 404G4A).
This mutation affecting a highly conserved nucleotide position
within the ZRS region (Fig. 4), was also present in the affected
Figure 4. Molecular basis of Werner mesomelic syndrome.
Chromatograms of index patients of Family 1 and 2 showing the
404G4A and 404G4C mutations in comparison to wild-type (wt)
sequence. The location of the mutation in the ZRS within intron 5 of
the LMBR1 gene is indicated. Sequence alignment shows the high
conservation of the altered 404G position.
Figure 3. Family 3. Patient with polysyndactyly type IV Haas,
previously published by Gillessen-Kaesbach and Majewski [1991]. A:
Complete syndactyly of left hand and partially surgically corrected
right hand. B: Hands after 18 surgical corrections. C: Feet with right-
sided III–V syndactyly and left-sided IV/V syndactyly.
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father (Family 1, Patient II-2), and was absent in all tested healthy
family members (II-1–4) and in 100 Turkish control individuals.
The 404G4A mutation was previously described in a family from
Cuba [Lettice et al., 2003] diagnosed with PPD phenotype, but
evaluating the published clinical data of this family showed that
the index patient had also tibial hypoplasia consistent with the
diagnosis of WMS. Strikingly, we found the same nucleotide
position mutated in six affected family members (II/3, III/9,
III/11, III/16, and IV/7–9) of Family 2 with WMS. The highly-
conserved guanine at position 404 of the ZRS was substituted by
cytosine in the Brazilian family (404G4C). No ZRS point
mutation was found in Families 3 and 4.
Duplications of ZRS Underlie Syndactyly Type IV
and TPTPS
We used a qPCR technique for the detection of CNVs of the
ZRS to test a previously described patient with syndactyly type IV
(Family 3) and the Turkish index patient of Family 4 suffering
from TPTPS. Based on the applied DCt method we detected ZRS
duplications in both index patients and subsequently in eight
(II/2, III/1, III/3, III/6, IV/1, IV/2, IV/6, and IV/8) affected family
members of Family 4. In contrast, unaffected individuals from this
family did not show any quantitative changes (data not shown)
and the duplication was not detected in 35 Turkish controls.
In the array-CGH analysis, the index patient of Family 3
showed an approximately 73-kb duplication involving parts of the
LMBR1 gene in 7q36.3. The aberration can be described as
arr7q36.3(156,265,512x2,156,265,453–156,354,638x3,156,354,579-
x2) (Fig. 5). In the index patient of Family 4 (Patient IV-2) a more
centromeric breakpoint was observed. The 276-kb spanning
duplication, including the ZRS, can be described as arr7q36.3
(156,061,302x2,156,088,827–156,354,638x3,156,354,579x2) (Fig. 5).
Except for known CNVs no further abnormalities were detected.
On the basis of these data, we tried to map the exact breakpoints
of the duplications by the extensive use of long-range PCR
experiments and various primer pair combinations. Due to the
complex and repetitive nature of this genomic region, we were not
able to determine the exact orientation of both duplications.
Discussion
ZRS and Its Role in the Development of Limb Buds
The SHH protein is expressed and secreted in the zone of
polarizing activity (ZPA) in the early limb bud and its expression is
regulated by the ZPA regulatory region (ZRS) a long-range cis-
regulator of the SHH gene, which is located 1Mb away from the
SHH gene and contains 800bp conserved from mammals to fish
(Fig. 4) [Lettice et al., 2003]. SHH is a major determinant of cell fate
and identity during early limb development, thereby controlling digit
formation [Hill, 2007]. SHH is a secreted morphogenic protein
expressed in a specific region in the posterior margin of the limb bud
within the ZPA; it has been shown in different model organisms that
disruption, ectopic expression, or changes in the timely expression of
Shh can cause different types of distal limb anomalies [Maas and
Fallon, 2005; Hill, 2007]. In human, PPD2 [Lettice et al., 2003;
Furniss et al., 2008; Gurnett et al., 2007] is caused by point mutations
of the ZRS. Transgenic assays revealed [Masuya et al., 2007] that
some of these point mutations found in patients redirect Shh
expression leading to an ectopic expression; e.g., at the anterior site of
the limb bud. Very recently it was shown that TPTPS and Haas type
Figure 5. Array comparative genomic hybridization indicating a microduplication of 7q36.3 in Family 3 (A) and Family 4 (B).
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Table 1. Comparison of Clinical Signs in Patients With Different ZRS Point Mutations
Reference Lettice et al.
[2003]
Furniss et al.
[2008]
Lettice et al.
[2003]
Lettice et al.
[2003]
Semerci et al.
[2009]
Present study Present study;
Vargas et al. [1995]
Lettice et al. [2003];
Zguricas et al. [1999];
Morales-Peralta [1994]
Gurnett et al.
[2007]
Gurnett et al. [2007];
Dobbs et al. [2000]
Mutation ref.
AC007097.4
105C4G;
g.104914C4G
295T4C;
g.105104T4C
305A4T;
g.105114A4T
323T4C;
g.105132T4C
396C4T;
g.105205C4T
404G4A;
g.105213G4A
404G4C;
g.105213G4C
404G4A;
g.105213G4A
621C4G;
g.105430C4G
739A4G;
g.105548A4G
Syndrome clinical
description
PPD PPD PPD PPD PPD Werner mesomelic
syndrome
(THPTTS/PPD)
Werner mesomelic
syndrome
(THPTTS)
Werner mesomelic
syndrome
(PPD)
PPD PPD
Hands affected 1 1 1 1 1 1 1 1 1 1
Triphalangeal thumb 1 1 1 1 1 1 1 1 1 1
Preaxial polydactyly 1 1 1 1 1 1 1 1 1 1
Postaxial polydactyly          
Partial syndactyly        1  
Complete syndactyly          
Mirror hands      1    
Arms affected        1  
Radial dysplasia     1  
Feet affected      1 1   
Preaxial polydactyly      1 1 1 1 
Postaxial polydactyly          
Partial syndactyly          
Complete syndactyly          
Mirror feet       1   
Legs affected      1 1 1  
Tibial a-/hypoplasia      1 1 1  
Fibula hypoplasia      1 1   
Fibula duplication       1   
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Table 2. Comparison of Clinical Signs in Patients With Different ZRS Duplications
Size of duplication 73 kb 97 kb 131 kb 158 kb 235 kb 246 kb 276 kb 291 kb 398 kb 588 kb Unknown
References Present study;
Gillessen-Kaesbach
and Majewski [1991]
Wu et al. [2009];
Sato et al. [2007]
Sun et al.
[2008];
Family 1
Sun et al.
[2008];
Family 3
Sun et al.
[2008];
Family 5
Sun et al. [2008];
Family 4
Present study;
Balci et al.
[1999]
Sun et al.
[2008];
Family 2
Sun et al. [2008];
Family 6;
Wang et al. [2007]
Klopocki et al.
[2008]
Furniss et al.
[2009]
Clinical description SD4 SD41 TPTPS TPTPS/SD4 TPTPS/SD4 TPTPS/SD4 SD4/TPTPS TPTPS/SD4 TPTPS/SD4 TPTPS SD41
Hands affected 1 1 1 1 1 1 1 1 1 1 1
Triphalangeal thumb  1 1 1 1 1 1 1 1 1
Preaxial polydactyly 1 1 1 1  1 1 1 1 1 1
Postaxial polydactyly  1 1     1 1 
Partial syndactyly   1 1  1 1 1 1 1 1
Complete syndactyly 1 1  1 1 1 1 1   
Mirror hands           
Arms affected           1
Radial dysplasia           
Fixed flexion at wrist           1
Feet affected 1 1     1 1  1 1
Preaxial polydactyly 1     1   n.r. 1
Postaxial polydactyly  1     1   n.r. 
Partial syndactyly 1 1  1   1 1  n.r. 1
Complete syndactyly  1     1   n.r. 
Mirror feet  1        n.r. 1
Legs affected          
Tibial a/hypoplasia  1         
Fibula hypoplasia           
Fibula duplication           
Talipes           1
n.r., not recorded.
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polysyndactyly are caused by duplications of the ZRS, though the
consequences on SHH expression are not yet known [Wu et al., 2009;
Sun et al., 2008; Klopocki et al., 2008; Furniss et al., in press]. We now
add WMS to these conditions caused by mutations within the ZRS.
Specific Point Mutations Affecting Position 404 of the ZRS
Cause WMS
Our data provide genetic evidence that altering nucleotide position
404 of the ZRS underlies WMS. We found the 404G4A and 404G4C
mutations in two families, respectively, and interestingly, though the
404G4A mutation was described as causative for PPD in this Cuban
family, the Cuban index case did show tibial hypoplasia in addition
consistent with the diagnosis of WMS. Table 1 summarizes the clinical
and mutational data of patients described with PPD2 and WMS. Point
mutations are scattered throughout the ZRS region, indicating the
importance of the whole ZRS region in SHH regulation [Lettice et al.,
2008]. No overt genotype–phenotype correlation is observed in PPD
with specific respect to the location of point mutations, but mutations
lead to highly variable Shh expression patterns during early limb
development, dependent on the position and the sequence context of
the mutation within the ZRS [Lettice et al., 2008; Hill, 2007]. It is
striking that the mutation showing the strongest ectopic Shh
expression in the reporter gene assay of the study of Lettice et al.
[2008] was the 404G4A (‘‘Cuban’’) mutation. These functional data
support our finding that specific alteration of position 404 leads to a
more severe clinical phenotype with the affection of tibial develop-
ment, namely WMS. It is not clear why the 404G4A and 404G4C
Werner mutations have a stronger functional effect on Shh expression
compared to other ZRS point mutations. Preliminary computational
analysis of transcription factor binding sites within the affected region
indicated that both 404G4A and 404G4Cmight lead to an increased
binding probability of additional transcription factors (data not
shown) [Cartharius et al., 2005; Werner et al., 2003]. Therefore, a
specific change in transcription factor binding is an attractive working
hypothesis for future studies aiming to identify the underlying
molecular mechanism of altered Shh expression by Werner mutations.
In addition, it is still an open debate as to which factors are
responsible for the reduced penetrance of WMS, as milder affected
family members, e.g., the father of Patient 1, only presented with
PPD2. One might discuss modifying factors or variations in the
transcription factors.
Spectrum of ZRS-Associated Syndromes and Mutational
Mechanisms
No systematic evaluation of ZRS phenotypes and mutations
exists. Results of evaluation of clinical data of all families with ZRS
mutations published so far (n5 21) are shown in Tables 1 and 2.
In general, we observe an overt genotype–phenotype correlation:
point mutations within the ZRS predominantly cause PPD2 and
specific point mutations of position 404 are found in WMS, but
no point mutations are yet described in Haas type polysyndactyly
or TPTPS.
The clinical spectrum of ZRS disorders is very similar, although
clinically distinguishable: patients with PPD2 do not present with
involvement of feet or lower extremities, whereas patients with
WMS characteristically show tibial a-/hypoplasia and additional
foot anomalies. In addition, patients with Haas type polysyndac-
tyly or patients with TPTPS and a causative ZRS duplication
identified mostly have involvement of feet and in some cases show
lower limb anomalies.
The clinical spectrum and type of ZRS mutation being distinct,
we suggest separating the OMIM numbers of PPD2 and TPTPS,
which currently are summarized under a single OMIM number.
In addition, not only is the molecular testing strategy different,
but so is the impact on genetic counseling of patients on the
expected clinical spectrum and prognosis.
The so-far-described duplications of the ZRS are of different sizes
without recurrent breakpoints. There is no obvious genotype–
phenotype correlation concerning the size of the duplications.
All duplication patients do have similar clinical phenotypes, either
SD4 or TPTPS. In some large families (e.g., Balci et al. [1999]) both
phenotypes are present; thus, these two conditions are allelic
expressions of the identical molecular cause. It will be interesting in
the future to compare the expression profiles of SHH in patients
with point mutations versus duplications.
Based on our detailed review of described ZRS mutations and
phenotypes we suggest classifying ZRS-associated syndromes into
two subtypes (Table 3): type I for point mutations and type II for
duplications. Type I itself has two subdivisions, a and b. Table 3 is
arbitrarily extensible as soon as new phenotypes evolve; e.g., the
phenotypic consequences of ZRS deletions. In mice, the phenotype
associated with a complete deletion of the ZRS region is
acheiropodia, a limb truncation phenotype, which was published
by Sagai et al. [2005]. To the best of our knowledge, a ZRS deletion
and the resulting phenotype has not yet been described in human.
In summary, we identified the molecular basis of WMS. This
autosomal dominant condition is caused by specific point
mutations in the ZRS at position 404. In contrast to the hitherto
existing literature, we could show that tibial a-/hypoplasia is not
exclusively present in patients with duplication of the ZRS, but is
also present in patients with WMS. In contrast, Haas type
polysyndactyly (MIM] 186200) and TPTPS (MIM] 174500) are
allelic and caused by duplications of the ZRS. We demonstrate that
different mutational mechanisms affecting ZRS predispose to
different phenotypic outcomes. Consequently, we suggest the
generic term ‘‘ZRS-associated syndromes’’ for different limb
malformations caused by alterations of the ZRS.
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5.4 Pawlik B, Yigit G, Wollnik B. Reduced LRP6-mediated WNT10B signalling in the 
pathogenesis of SHFM6. (submitted) 
 
Abstract of the publication: 
Split-hand/foot malformation (SHFM) is a human congenital limb malformation characterized 
by an abnormal development of the central digit rays, with a deep median cleft and syndactyly 
of fingers and toes. SHFM can develop as an isolated condition or as a part of other 
syndromes and is phenotypically very variable. Familial SHFM is generally inherited in an 
autosomal dominant manner with reduced penetrance but also autosomal recessive forms as 
well as X-linked inheritance have been reported. SHFM is very heterogenious and six 
different loci (SHFM1-SHFM6) have been described so far. Recent investigations report on 
the first autosomal recessive p.R332W mutation in the WNT10b gene causing SHFM6. 
However, the underlying molecular basis of the mutation leading to SHFM6 is still unknown.  
 
In this study we functionally characterize the p.R332W mutation in Wnt10b leading to 
SHFM6. Therefore we first performed expression analysis by Western Blot and second 
conducted a Dual-Luciferase Assay with co-expression of Lrp6, Wnt1, Wnt10b wild-type (wt) 
and Wnt10b mutant p.R332W in transiently transfected HEK293T cells. We could show that 
mutant p.R332W Wnt10b is expressed but fails to activate canonical Wnt signalling. 
Furthermore we accomplished co-immunoprecipitation assay of wt and mutant p.R332W with 
Lrp6 and demonstrate that both wt and mutant Wnt10b protein interact with Lrp6 receptor. 
Interaction was confirmed by Western Blot analysis of Sulfo-SBED Biotin Label Transfer of 
human LRP6 protein and purified wt and p.R332W mutant protein. Hence, we conclude that 
the p.R332W Wnt10b mutation causes a loss of function of Lrp6 mediated Wnt signalling and 
that this is the pathophysiological mechanism leading to SHFM6. 
 
We next examined the ability of the putative SHFM3 candidate gene Fgf8 to alter Lrp6 
mediated Wnt signalling by using a Dual-Luciferase Assay. Luciferase Assay after co-
expression of Lrp6, Wnt10b (wt) and Flag-tagged Fgf8 revealed that Fgf8 reduces Wnt10b 
mediated Wnt signalling activation. We were also able to reveal that the Wnt signalling 
reduction is reversible by increasing the amount of wt Wnt10b. To exclude any unspecific 
signal reduction in our system we furthermore tested other small secreted proteins such as 
FGF21 and Bmp4. Dual-Luciferase-Reporter assay after co-expression of Lrp6, wt Wnt10b, 
GFP-tagged FGF21 and c-myc-tagged Bmp4 pointed out that FGF21 also reduces Wnt10b 
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mediated Wnt signalling activation while Bmp4 does not. To define the molecular basis of the 
signal reduction from the Luciferase Assay, we next conducted a co-immnunoprecipitation 
assay. Flag-tagged Fgf8 was transiently co-expressed with either Wnt10b or Lrp6 in 
HEK293T cells and immunoprecipitated with specific antibodies. Western Blot analysis of 
co-immnoprecipitation Assay clearly showed that Flag-tagged Fgf8 interacts with Wnt10b 
while it does not interact with Lrp6 receptor. Thus the Fgf8 mediated canonical WNT 
signalling reduction results from the binding of Fgf8 to Wnt10b.  
 
In conclusion, we show that the described SHFM6 mutation p.R332W in WNT10B is a loss-
of-function mutation. We further provide evidence that Wnt10b can bind Lrp6 and activate 
Lrp6-mediated Wnt/ß-catenin signalling and that the mutant protein lost this ability. 
Moreover, we propose that Fgf8 has an additional yet unknown function as Wnt-antagonist by 
binding to Wnt10b. Therefore, we suggest a direct cross-talk between Fgf and Wnt signalling 
important during limb development and in the pathogenesis of SHFM 
 
Own contribution: 
All functional analyses described in the paper were performed by myself. The aim of this 
study was to functionally characterize the p.R332W mutation in the WNT10b gene leading to 
SHFM6. Therefore, I started with the generation of the mutant p.R332W Wnt10b expression 
plasmid by using site directed mutagenesis PCR on wt mouse pcDNA3.1 Wnt10b construct. I 
confirmed the insertion of the mutation by sequencing the fragment from both sides using the 
ABI BigDye Terminator v1.1 Cycle Sequencing Kit and the ABI 3730 DNA Analyzer (data 
not shown). Next, I constructed the expression plasmid for murine Fgf8 by amplification of 
Fgf8 from a full length mammalian gene collection and a cloning strategy into pCMV-SC-CF 
vector according to manufacturer´s instructions. 
Initially, I transfected HEK293T cells using Lipofectamine 2000 with wt and mutant Wnt10b 
expression construct and showed by Western Blot analysis that mutant p.R332W Wnt10b was 
expressed (Figure 1B). Then I implemented the Dual-Luciferase Assay with wt and mutant 
Wnt10b in order to investigate the mutant´s ability to activate Lrp6 mediated canonical Wnt 
signalling. I was able to demonstrate that co-expression of Lrp6 and Wnt10b resulted in an 
activation of Wnt/ß-catenin signalling, while in contrast the p.R332W mutant lost the ability 
of activating Wnt signalling (Figure 1A). 
Next, I conducted co-immunoprecipitation assays with wt and p.R332W Wnt10b with the 
Lrp6 receptor (Figure 1C, 1D) and confirmed both interaction by Western Blot analysis of 
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Sulfo-SBED Biotin Label Transfer of human LRP6 protein with purified wt and mutant 
Wnt10b protein (Figure 1E).  
Taken together, I could exhibit that the p.R332W mutant is efficiently transcribed and 
translated, and, moreover, mutant Wnt10b protein can still bind to the Lrp6 receptor when 
transiently co-expressed in HEK293T cells but fails to activate canonical Wnt signalling and 
is therefore a loss-of-function mutation in the pathogenesis of SHFM6. 
 
Furthermore, I used the Luciferase Assay to test the effect of murine Fgf8 and human FGF21 
on the transduction and activation or inhibition on canonical Wnt signalling. The results 
showed that the putative SHFM3 candidate gene Fgf8 as well as FGF21 but not Bmp4 reduce 
the Wnt10b mediated activation of canonical Wnt signalling (Figure 2, 3, 4A).  
Finally, I performed a co-immnunoprecipitation assay with murine Flag-tagged Fgf8 and wt 
Wnt10b or Lrp6 and specific antibodies. I was able to demonstrate by Western Blot analysis 
that Flag-tagged Fgf8 interacts with Wnt10b while it does not interact with the Lrp6 receptor 
(Figure 4B, 4C). Thus, I was able to show first evidence that different Fgfs might share a 
specific inhibitory effect on canonical Wnt/ß-catenin signalling.  
I completed this study by preparing all figures (Figures 1-5) for the publication and by finally 
writing the first version of the manuscript. 
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Abstract 
Split-hand/split-foot malformation (SHFM) is a congenital limb malformation characterized 
by an abnormal development of the central digit rays, deep median cleft and syndactyly of the 
affected hands and feet. A recent report described the first autosomal recessive inheritance of 
SHFM (SHFM6) caused by the homozygous p.R332W mutation in the WNT10B gene. 
However, the underlying molecular mechanism of this mutation is unknown. Here, we 
functionally characterized the described p.R332W mutation in Wnt10b. We show that the 
mutant protein is stable and still has the ability to bind to the low-density lipoprotein receptor-
related protein 6 (Lrp6). In contrast to wild-type Wnt10b, the p.R332W mutant is not able to 
activate Lrp6-mediated Wnt signalling providing evidence for a reduced Wnt/ß-catenin 
signalling in the pathogenesis of SHFM.  Moreover, we observed that Fgf8, likely involved in 
the pathogenesis of SHFM3, can bind Wnt10b and leads to a dosage-dependent suppression 
of Lrp6-mediated Wnt signalling. Our data give novel insights into the pathogenesis of 
SHFM6 and suggest a direct cross-talk between Wnt and Fgf signalling pathways.  
Introduction 
Split-hand/split-foot malformation (SHFM, MIM 183600, 313350, 600095, 605289, 606708, 
and 225300), also named ectrodactyly, is a complex congenital limb malformation involving 
the central rays of the autopod and characterized by syndactyly, median clefts of hands and/or 
feet, aplasia and/or hypoplasia of the phalanges, metacarpals and metatarsals (1). SHFM can 
occur as an isolated trait or as part of a more complex syndrome (2). Familial forms of SHFM 
are mainly inherited in an autosomal dominant manner (3), though autosomal recessive (4) 
and X-linked inheritance (5) have been described. SHFM is genetically heterogeneous with 
six loci described to date: SHFM1 located at 7q21-22 and structural alterations near DLX5/6, 
SHFM2 at Xq26 and no gene yet known, SHFM3 at 10q24 and duplications near FGF8, 
SHFM4 at 3q28 and mutations in TP63, SHFM5 at 2q31 and structural alterations near EVX2 
and the HOXD cluster (6-11). Recently, the first autosomal recessive locus was mapped in a 
large consanguineous family from Turkey to chromosome 12q13 (SHFM6) and, 
subsequently, a homozygous missense mutation in WNT10B, p.R332W, was identified in 12 
affected and one unaffected family member (11). WNT10B consists of four coding exons and 
encodes a 389 amino acid protein, which is expressed throughout the mouse limb ectoderm 
during embryogenesis from day E.9.5 to E.15.5 (12). It was suggested that Wnt10b acts as an 
agonist in canonical Wnt signalling during various developmental processes (13). 
The p.R332W alteration affects a highly conserved arginine in WNT10B and was not found in 
200 healthy control individuals suggesting a causative nature of this missense mutation. No 
functional study was done and therefore, the functional consequences of the p.R332W 
WNT10B mutation as well as the pathophysiological mechanism underlying SHFM in the 
family are unknown. 
In our study, we functionally characterized the Wnt10b p.R332W mutation. We show that 
wild-type Wnt10b can bind low-density lipoprotein receptor-related protein 6 (Lrp6) and 
activate canonical Wnt/ß-catenin signalling. In contrast, the p.R332W mutant is not able to 
activate Lrp6-mediated Wnt signalling providing evidence for a reduced Wnt signalling in the 
pathogenesis of SHFM. Moreover, we demonstrated that Fgf8, likely involved in the 
pathogenesis of SHFM3, can bind Wnt10b and thereby alter Lrp6-mediated activation of Wnt 
signalling.  
 
Material & Methods  
Materials 
Primers for site directed mutagenesis and sequencing of constructs were purchased from 
Metabion (Martinsried, Germany).  
 
Plasmid Construction 
Mutant p.R332W Wnt10b expression plasmid was generated using site directed mutagenesis 
PCR on wt mouse Wnt10b in the pcDNA3.1 vector as template (kindly provided by Ormond 
MacDougald). Insertion of mutagenesis was confirmed by sequencing using the ABI BigDye 
Terminator v1.1 Cycle Sequencing Kit and the ABI 3730 DNA Analyzer (Applied 
Biosystems, Foster City; CA, USA). Expression plasmid for murine Fgf8 was generated by 
amplification of Fgf8 from a full length mammalian gene collection (Invitrogen, Karlsruhe, 
Germany) and cloning into pCMV-SC-CF vector (Agilent Technologies, La Jolla, CA, USA). 
Human FGF21 in pCMV6-AC-GFP expression plasmid was purchased from OriGene 
(Darmstadt, Germany). Murine Lrp6 in the pcDNA3.1 expression vector was kindly provided 
by Matthew L. Warman and murine myc-tagged Bmp4 in the pcS2+ expression vector was a 
kind gift from N. Itasaki. 
 
Cell Culture and Transfections  
HEK293T cells were cultured in Dulbecco´s Modified Eagle Media (DMEM) containing 10% 
fetal bovine serum (FBS, Gibco) and antibiotics. Cells were transfected using Lipofectamine 
2000 (Invitrogen, Karlsruhe, Germany) according to manufacturer´s instructions. 
 
Dual Luciferase Reporter Assay 
Luciferase Reporter assay was performed as described previously (13). In brief, HEK293T 
cells were plated out in 12-well plates, grown up to 50% confluency and transfected in 
triplicates using the TOP-Flash reporter system and the indicated expression plasmids with 
the following concentrations: 100 ng Topflash vector, 5 ng Renilla (p-RL-TK), 750 ng Lrp6, 
750 or 375 ng Wnt10b, 750 or 375 ng Fgf8, 750 or 375 ng FGF21 and 750 or 375 ng Bmp4. 
Two days after transfection, cells were lysed and luciferase activity was measured using the 
Dual-Luciferase® Reporter Assay Kit by a Glomex™ 96-microplate luminometer (Promega, 
Mannheim, Germany). Each transfection was measured in triplicate. 
 
Immunoprecipitation & Western Blot Analysis 
Forty-eight hours after transfection, HEK293T cells were washed with cold PBS and 
solubilized using ice-cold lysis buffer containing 50mM HEPES, 150mM NaCl, 1% Triton X-
100, 10% Glycerol, 10ug/ml Aprotinin, 5ug/ml Leupeptin, 1mM Na3VO4 and 1mM PMSF. 
Lysates were briefly centrifuged and total protein concentration of extracts was determined by 
BCA Protein Assay Kit (Pierce Protein Research Products, Thermo Fischer Scientific, 
Rockford, IL, USA). Equal amounts of total protein were incubated over night with protein 
A/G Plus-agarose (Santa Cruz Biotechnologies, Heidelberg, Germany) and the indicated 
antibodies [anti-Wnt10b (Abcam, Cambrige, UK), anti-Lrp6 (Abcam), anti-FLAG M2 
(Stratagene, CA, US)]. After extensive washing, the immunoprecipitates were taken up in 
loading buffer, separated by 4-12% SDS-PAGE (Invitrogen, Germany) and blotted on 
nitrocellulose membrane (GE Healthcare, Freiburg, Germany). Immunoblots were blocked in 
5% low-fat milk powder in Tris-buffered saline containing 0,2% Tween 20 and then probed 
with specific antibodies (1:1000 dilutions). Peroxidase conjugated secondary antibodies were 
purchased from Santa Cruz and blots were developed using an enhanced chemiluminescence 
system, ECL Plus (Amersham, UK), followed by exposure on autoradiographic film (GE 
Healthcare). 
 
 
Sulfo-SBED Biotin Label Transfer  
ProFound Sulfo-SBED Biotin Label Transfer Kit for Western Blot application was purchased 
from Pierce (Rockford, IL, USA). Label transfer and cross-linking were conducted according 
to manufacturer´s instructions using 3 µg of human LRP6 protein (R&D Systems, Wiesbaden, 
Germany). Western blot analysis was accomplished using streptavidin-HRP (Pierce). 
Following detection, the membrane was stripped for 20 min using Restore TM Western Blot 
Stripping Buffer (Thermo Scientific, Bonn, Germany) according to manufacturer´s 
instructions, washed three times with TBST and re-probed with anti-Lrp6 antibody (1:1000) 
and anti-Wnt10b (1:1000) antibodies. 
 
Results 
The p.R332W mutation in Wnt10b causes loss of protein function 
Functional characterization of the described WNT10B mutation p.R332W is important (i) to 
provide additional evidence for the causative nature of this mutation in the molecular 
pathogenesis of SHFM6 and (ii) to gain insights into the pathophysiology of SHFM6. 
Therefore, we generated the p.R332W mutant by site directed mutagenesis PCR on wild-type 
(wt) Wnt10b. To analyze whether the homozygous missense mutation confers loss or gain of 
function we tested its transduction and activation of canonical WNT signalling using a Dual 
Luciferase Reporter Assay in transiently transfected HEK293T cells. Initially, we were able to 
demonstrate that – as previously described – Wnt1 significantly activates Lrp6-mediated 
Wnt/ß-catenin signalling (Fig. 1A). Also, co-expression of Lrp6 and Wnt10b resulted in a 
comparable activation of Wnt/ß-catenin signalling, while in contrast over expression of the 
p.R332W mutant did not lead to activation of Lrp6-mediated Wnt signalling. We showed that 
the p.R332W mutant is efficiently transcribed and translated, and, moreover, mutant Wnt10b 
protein can still bind to the Lrp6 receptor when transiently co-expressed in HEK293T cells 
using a co-immunoprecipitation approach (Fig. 1B, 1C, 1D). Furthermore, the interaction of 
wt and mutant Wnt10b with Lrp6 was confirmed by Western Blot analysis of a Sulfo-SBED 
Biotin Label Transfer assay (Fig. 1E). These findings clearly demonstrated that the p.R332W 
mutant is stable and although binding to the Lrp6 receptor, this interaction is no longer 
sufficient to activate Lrp6-mediated Wnt/ß-catenin signalling.   
 
Fgf8 expression inhibits Wnt10b induced activation of Wnt/ß-catenin signalling  
Fgf8 belongs to the fibroblast growth factor family and is a known key regulator of vertebrate 
limb development and essential for the induction of limb bud outgrowth and patterning. 
Interestingly, common duplications of the SHFM3 critical region occur physically nearby the 
chromosomal location of FGF8 on 10q24 and, therefore, FGF8 (among others) is regarded as 
one of the candidate genes responsible for SHFM3, although no mutation in the coding region 
of FGF8 has yet been identified in SHFM patients. We examined the potential role of Fgf8 in 
altering canonical WNT signalling by co-expression of Lrp6, Flag-tagged Fgf8 and Wnt10b in 
transiently transfected HEK293T cells. Co-expression of Fgf8 and Lrp6 alone did not have 
any effect on signalling while co-expression of Lrp6, Wnt10b and Ffg8 led to a significant 
reduction of relative luciferase activity as readout for Wnt/ß-catenin signalling (Fig. 2).  
In order to determine the mechanism by which Fgf8 can inhibit Wnt10b induced Lrp6-
mediated Wnt/ß-catenin signalling, we transfected HEK293T cells with different ratios of 
Fgf8/Wnt10b (1:1, 1:10 and 1:50) and observed that an increasing amount of Wnt10b rescued 
this inhibition suggesting either a competition of Fgf8/Wnt10b binding to Lrp6 binding or 
direct Fgf8/Wnt10b interaction (Fig. 3). To exclude any unspecific mechanism for this finding 
caused by the use of our cellular system and the overexpression of proteins, we tested the 
effects of two additional small secreted proteins, FGF21 and Bmp4. Dual Luciferase Reporter 
assay after co-expression of Lrp6, wt Wnt10b, GFP-tagged FGF21 and c-myc-tagged Bmp4 
indeed indicated that also FGF21 reduces Lrp6-mediated Wnt10b signalling, while Bmp4 
does not (Fig.4A). Thus, these data suggest that different Fgfs might share a specific 
inhibitory effect on canonical Wnt/ß-catenin signalling. 
 
Fgf8 can bind Wnt10b: a putative cross-talk between both signalling pathways  
An important hallmark of spatial and temporal activation of canonical Wnt/ß-catenin 
signalling during development is the ability of various secreted antagonists to down-regulate 
and suppress its activation. The results of our Luciferase-Reporter Assays demonstrated that 
co-expression of Fgf8 together with Wnt10b and Lrp6 results in a significant suppression of 
Wnt10b-induced canonical Wnt signalling. To define the molecular mechanism of Fgf8-
mediated suppression, we conducted different co-immnunoprecipitation experiments. Flag-
tagged Fgf8 was transiently co-expressed in HEK293T cells with either Wnt10b or Lrp6 and 
immunoprecipitated with specific antibodies. Western Blot analysis of co-immnoprecipitation 
assays clearly demonstrated that Fgf8 interacts with Wnt10b (Fig. 4B), while no direct 
interaction was observed between Fgf8 and the Lrp6 receptor (Fig. 4C). Thus, the Fgf8-
mediated suppression of Wnt10b-activated canonical Wnt signalling likely results from a 
direct binding of Fgf8 to Wnt10b. As shown for other secreted Wnt antagonists, bound 
Wnt10b looses its ability to bind Lrp6 and, thereby, to activate the Wnt/ß-catenin signalling 
pathway. 
 
Discussion 
Pathophysiological mechanism of SHFM6 
Recently, a homozygous missense mutation in the WNT10b gene was found to cause SHFM6 
in a large consanguineous Turkish family (11), but the molecular mechanism and functional 
effects of the identified mutations remained unknown.   
Previous studies on SHFM-related proteins suggested that alteration of the apical ectodermal 
ridge (AER) plays an important role in the development of SHFM (1). The formation and 
maintenance of the AER throughout limb development is a complex process, which depends 
on the orchestrated spatial and temporal expression of various transcription factors, secreted 
morphogens, and signalling proteins. The role of some of them has been defined in detail, 
such as signalling molecules belonging to the Fgf, Wnt, and Bmp families and their receptors 
(14-16). The Wnt signalling pathway is an evolutionary highly conserved pathway that 
regulates fundamental aspects of cell fate determination and cell migration in vertebrate limb 
development (reviewed by (17)). The canonical Wnt/ß-catenin pathway is activated by 
binding of specific Wnt ligands to their receptors, e. g. Lrp6 or frizzled (Fz) receptors. 
Binding of a Wnt to Lrp6 results in the stabilisation of cytosolic ß-catenin, which then 
translocates to the nucleus where it associates with members of the Tcf/Lef family of 
transcription factors regulating the expression of target genes. In this study, we functionally 
characterized the described WNT10B missense mutation p.R332W and determined its impact 
on Wnt/ß-catenin signalling. 
Initially, we showed for the first time that Wnt10b can bind Lrp6 and activate Wnt/ß-catenin 
signalling. Wnt10b itself is known to play a major role in the regulation of osteoblastogenesis 
and bone mass (18) as well as in the differentiation of epithelial cells in the hair follicle (19). 
Furthermore, it inhibits the development of white and brown adipose tissues (20). The finding 
that Wnt10b binds Lrp6 together with the fact that mutation in WNT10B cause limb 
malformation in SHFM6 suggests that Wnt10b/Lrp6 activation plays an essential role in 
normal limb development, which is further supported by the finding that Wnt10b is expressed 
throughout the mouse limb ectoderm during embryogenesis from E.9.5 to E.15.5 (12). 
Wnt10b p.R332W mutant protein failed to activate the Lrp6-mediated Wnt signalling 
pathway in our in vitro system. It is interesting to note that distal limb malformations are also 
observed in a Lrp6 knockout mouse model (21). Since the crystal structure of Wnt10b protein 
is not available, we were unable perform protein modelling of the mutant protein in order to 
predict possible steric hindrances caused by the mutation. Although overexpressed mutant 
protein was still able to bind to Lrp6, we suggest that this binding is either not efficient 
enough or takes place in an inappropriate way explaining the failure of Lrp6-mediated ß-
catenin activation.  
 
Putative cross-talk between Fgf and Wnt signalling pathways  
One key regulatory mechanism of Wnt signalling during development is the expression of 
various secreted Wnt antagonists, such as Dickkopf (DKK), Wise, Wnt-inhibitor protein 
(WIF) or Sost (22-26). One of the known mechanisms underlying this antagonistic function is 
the binding of these proteins directly to a specific Wnt, which then looses its ability to bind to 
its receptor. We now observed that Fgf8 is another putative Wnt antagonist (Fig. 5). Fgf8 does 
not directly bind to Lrp6, but to Wnt10b and this binding result in a dosage-dependent lack of 
Lrp6-mediated Wnt/ß-catenin activation. During limb bud formation and limb development, a 
tight regulation between Wnt and Fgf signalling is fundamental, e. g. to initiate and specify 
limb outgrowth and identity (27). However, an underlying cross-talk between both pathways 
was thought to exist only in an indirect manner (for example by inducing and regulating the 
expression of specific target genes).  
We now provide the first link for a possible direct cross-talk between Fgf and Wnt pathways, 
although we admit that the evidence for this is based on in vitro data and has to be confirmed 
in the future in in vivo systems. In humans, FGF8 is located in close proximity to the 
frequently duplicated SHFM3 region. Due to its known expression during limb bud formation 
and limb development (28, 29), several authors regard FGF8 – beside others - as an excellent 
candidate gene for SHFM3. Dimitrov et al. suggested that duplications within the 10q24 
region may alter a putative regulatory element of the FGF8 gene (30) similarly to alterations 
of SHH expression by mutations or duplications of the ZRS region regulating the expression 
of SHH (31). Therefore, a physical interaction between both SHFM-related proteins Fgf8 and 
Wnt10b, as shown in our study, further supports a close balance and regulation of Fgf and 
Wnt signalling pathways during development of the median limb ray. Whether a specificity of 
Fgf/Wnt binding exists (which means that only specific Fgfs can bind to specific Wnts), 
remains to be elucidated in future experiments, though we were able to show that also FGF21 
can bind to Wnt10b.  
Furthermore, we excluded that Fgf/Wnt binding is a general in vitro artefact simply caused by 
overexpression of these small proteins by demonstrating that another small signalling 
molecule, Bmp4, does not cause any alteration of Wnt/ß-catenin signalling in our in vitro 
system. 
 
In conclusion, we show that the described SHFM6 mutation p.R332W in WNT10B is a loss-
of-function mutation. We further provide evidence that Wnt10b has the ability to bind Lrp6 
and activate Lrp6-mediated Wnt/ß-catenin signalling and that the mutant protein lost this 
ability. Moreover, we propose that Fgf8 has an additional yet unkown function as a Wnt 
antagonist by binding to Wnt10b, a link for a direct cross-talk between Fgf and Wnt signalling 
important during limb development. 
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Figure Legends 
Figure 1: Pathophysiological mechanism of p.R332W mutation in Wnt10b. (A) Results of 
Dual Luciferase assay after co-expression of Lrp6, Wnt1, wt Wnt10b and Wnt10b p.R332W 
variant. Expression and stability of mutant Wnt10b protein was analyzed by western blotting 
(B). The p.R332W variant is expressed but fails to activate canonical Wnt signalling. Each 
experiment was performed 3 times with each transfection measured in triplicate. (C) Anti-
Wnt10b precipitates of HEK293T cells expressing Lrp6 alone or together with wt Wnt10b or 
the Wnt10b p.R332W variant were analyzed by anti-Lrp6-immunoblotting. (D) Lysates of 
HEK293T variant described in (C) were subjected to anti-Lrp6 immunoprecipitation and 
proteins so obtained were analyzed by anti-Wnt10b immunoblotting. (E) Western Blot 
analysis of Sulfo-SBED Biotin Label Transfer experiments. Whole cell lysates of cells 
expressing wild-type Wnt10b or p.R332W variant were incubated with labeled human LRP6 
protein and separated by reducing SDS-PAGE. Following transfer to nitrocellulose 
membranes, proteins were analyzed using streptavidin-HRP. After membrane stripping 
detection of Wnt10b was verified by re-probing the membrane with antibodies against 
Wnt10b. 
 
Figure 2: Fgf8 suppresses Wnt10b-mediated Wnt signalling. Result from Dual Luciferase 
assays after co-expression of Lrp6, Wnt10b (wt) and flag-tagged Fgf8. Comparable steady-
state expression levels of Lrp6, Wnt10b and Fgf8 were verified by western blot analysis of 
total cell lysates. Each transfection (n=3) was measured in triplicate. 
 
Figure 3: Dose-dependent suppression of Wnt10b-mediated Wnt/ß-catenin activation by 
Fgf8. Results from Dual Luciferase assay after co-expression of Lrp6, wild-type Wnt10b, and 
flag-tagged Fgf8 with different ratios of Wnt10b/Fgf8 plasmid concentrations (+ = 1:1, ++ = 
10:1, +++ = 50:1). Fgf8-dependent suppression of canonical Wnt signalling could be reversed 
by increasing amounts of Wnt10b. Expression levels of were confirmed by western blot 
analysis of total cellular lysates and each experiment was performed 3 times with each 
transfection measured in triplicate. 
 
Figure 4: FGF21 suppresses Wnt10b-mediated Wnt/ß-catenin activation while Bmp4 
does not. (A) Dual Luciferase assay after co-expression of Lrp6, wt Wnt10b, GFP-tagged 
FGF21 and c-myc-tagged Bmp4. FGF21 has a similar effect as Fgf8 on Wnt10b-mediated 
Wnt signalling, whereas Bmp4 does not show any inhibition. Each transfection (n=3) was 
measured in triplicate. (B) HEK293T cells expressing Wnt10b and Flag-tagged Fgf8 were 
lyzed and subjected to immunoprecipitations with antibodies to Fgf8 or Wnt10b. Purified 
proteins were analyzed by immunoblotting with antibodies to Flag peptide tag (left panel) or 
Wnt10b (right panel). (C) Anti-Lrp6 and anti-Fgf8 precipitates prepared from HEK293T cell 
expressing Lrp6 and Flag-tagged Fgf8 were analyzed by immunoblotting with antibodies to 
Lrp6 (left panel) or Flag peptide tag (right panel). 
 
Figure 5: Model of Fgf8 inhibiting Wnt signalling. Both, Wnt1 and Wnt10b are known 
Wnt signalling agonists, which can bind to Lrp6 receptor. Lrp4 is a known Wnt antagonist 
acting in a so far unknown way. We propose that Fgf8 has an additional function and is a 
novel Wnt signalling antagonist via binding of Wnt10b and thereby repressing Wnt/ß-catenin 
activation. 
 
 
 
α-Wnt10b
IP: Wnt10b
W
T
p.
R
33
2W
W
T
p.
R
33
2W
α-Lrp6
IP: Wnt10b
W
T
p.
R
33
2W
co
n
tro
l
W
T
p.
R
33
2W
co
n
tro
l
α-Wnt10b
IP: Lrp6
W
T
p.
R
33
2W
co
n
tro
l
W
T
p.
R
33
2W
co
n
tro
l
α-Lrp6
Lrp6
Wnt10b WT 
p.R332W
-
+
-
α-Streptavidin
WCL
+
-
-
+
+
-
+
-
+
α-Wnt10b
Wnt10b
0
20
40
60
80
100
120
Lrp6
Wnt1
Wnt10b WT
p.R332W
+
-
-
-
+
+
-
-
+
-
+
-
+
-
-
+
re
la
tiv
e 
Lu
c
ife
ra
se
a
c
tiv
ity
in
 
%
A                                                               B
E
C                                     D              
Figure 1
α-Lrp6
α-Wnt10b
0
20
40
60
80
100
120
Lrp6
Wnt10b WT
Fgf8
+
-
-
+
+
-
+
-
+
+
+
+
re
la
tiv
e 
Lu
ci
fe
ra
se
ac
tiv
ity
in
 
%
α-Fgf8
Figure 2
020
40
60
80
100
120
?-Wnt10b
?-Lrp6α
?-Fgf8
Lrp6
Wnt10b WT
Fgf8
+
-
-
+
+
-
+
-
+
+
+
+
+
++
+
+
+++
+
re
la
tiv
e 
Lu
ci
fe
ra
se
ac
tiv
ity
in
 
%
re
la
tiv
e 
Lu
ci
fe
ra
se
ac
tiv
ity
in
 
%
α
α
Figure 3
020
40
60
80
100
120
Lrp6
Wnt10b WT
FGF21
Bmp4
+
-
-
-
+
+
-
-
+
-
+
-
+
+
+
-
re
la
tiv
e
 
Lu
ci
fe
ra
se
ac
tiv
ity
in
 
%
+
+
-
+
IP
α-Wnt10b
α
-
W
n
t1
0b
α
-
Fg
f8
co
n
tro
l
α-Flag
IP
α
-
Fg
f8
α
-
W
n
t1
0b
co
n
tro
l
A
B                                                               C
α-Lrp6
IP
α
-
Lr
p6
α
-
Fg
f8
co
n
tro
l
IP
α-Flag
α
-
Fg
f8
α
-
Lr
p6
co
n
tro
l
Figure 4
LRP6
WNT10B
WNT signalling
WNT1
FGF8
LRP4
Figure 5
  34 
5.5 Li Y, Laue K, Temtamy S, Aglan M, Kotan L.D, Yigit G, Husniye C, Pawlik B, 
Nürnberg G, Wakeling EL, Quarrell OW, Baessmann I, Lanktree MB, Yilmaz M, 
Hegele RA, Amr K, May KW, Nürnberg P, Topaloglu AK, Hammerschmidt M, Wollnik 
B. Temtamy preaxial brachydactyly syndrome is caused by loss-of-function mutations in 
Chondroitin synthase 1, a potential target of BMP signalling (In Press, Am J Hum Genet 
(2010)). 
 
Abstract of the publication:   
The Temtamy preaxial brachydactyly syndrome (TPBS) is an autosomal recessively inherited 
congenital syndrome mainly characterized by bilateral, symmetric preaxial brachydactyly, 
facial dysmorphism, dental anomalies, sensorineural hearing loss, delayed motor and mental 
development as well as growth retardation. Brachydactylies can occur either as an isolated 
trait or as part of a syndrome and recent investigations have identified mutations in 
components of the Bone Morphogenetic Protein (BMP) signalling pathway in different types 
of brachydactylies, which is crucial for normal limb development, to be disease causing. 
 
In this study we examined in total five TPBS families with a variable expression of clinical 
symptoms. In order to map the TPBS locus we first performed the Affymetrix GeneChip® 
Human Mapping 10K SNP Array (CCG, University of Cologne) with two TPBS families 
from Egypt. Two possibly linked loci on chromosomes 1p33 and 15q26 were identified with a 
combined parametric LOD score of 2.37 and 2.51, respectively. Extensive analysis of 
microsatellite markers of these regions finally mapped the TPBS locus to chromosome 15q26-
qterm between SNPs rs1480952 and rs352744 defining a shared homozygous critical interval 
of approximately 3.8 Mb in affected individuals. Further mapping data of one additional 
TPBS family, TPB3, from Turkey, confirmed the TPBS locus. The critical region on 15q25 
contained 20 annotated genes of which we tested ADAMTS17, CHSY1, PCSK6, and SELS as 
highly relevant candidate genes. Sequencing of the three coding exons of the chondroitin 
synthase 1 gene (CHSY1), revealed different homozygous mutations in affected individuals in 
each of the three linked families as well as in two additional families diagnosed with TPBS. 
We were able to detect three mutations in exon 1 of CHSY1, a 30-bp deletion, c.55-84del 
(p.G19_L28del, TPB1 family), a 1-bp deletion, c.14delG (p.G5AfsX29, TPB2 family), and 
the c.205C>T nonsense mutation (p.Q69X) in all three affected individuals of the TPB3 
family. An acceptor splice site mutation, c.321-3C>G was identified in TPB4 family, while 
the only missense mutation, c.1616C>G (p.P539R, TPB5 family) was located in exon 3 of the 
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gene. All mutations co-segregated with the disease in the families and were not found in over 
150 healthy control individuals. 
 
Next we functionally characterized the mutant CHSY1 protein which is a key player in the 
biosynthesis of chondroitin sulfate (CS) by using different approaches and showed that 
complete or nearby complete loss of CHSY1 function causes brachydactyly, progressive 
skeletal anomalies, craniofacial dysmorphism, and hearing loss in humans. 
In order to address the developmental functions of CHSY1 and CS, and their possible relation 
to BMP signalling, we turned to the zebrafish model system. Whole mount in situ 
hybridization revealed widespread expression of chsy1 in the head and prominent expression 
in the floor plate of wild-type zebrafish embryos at 24 hours post fertilisation (hpf). 
Expression was also detected in the heart, distal regions of the pectoral fin buds, chondrocytes 
of the developing head skeleton, and epithelial protrusions of the inner ears.  
Additional knock-down of Chsy1 activity as well as gain-of-function studies displayed a 
significant reduction of body length, compromised pectoral fin formation, and severe midline 
deficiencies in the cartilage of the neurocranium. In the inner ears, formation of epithelial 
protrusions and semicircular canals was severely affected. To determine the effect of BMP 
signalling on the expression of chsy1 we accomplished further co-expression analysis. We 
could show that at 56 hpf, bmp2b expression is strongest in the developing cristae of the inner 
ear, where chsy1 expression is very weak. In contrast, the epithelial protrusions exhibit strong 
expression of chsy1 and the BMP inhibitor dan, but weak bmp2b expression. Consistently, 
transgenic overexpression of bmp2b during the second day of development or MO-mediated 
knock-down of dan led to impaired semicircular canal formation similar to that caused by 
knock-down of chsy1. Furthermore, both treatments compromised chsy1 expression in the 
epithelial protrusions.  
Taken together, our data indicates that BMP signalling has a negative effect on chsy1 
expression, and that Dan is required to inhibit BMP signalling and to de-repress chsy1 
expression in epithelial protrusions, thereby allowing semicircular canal morphogenesis. We 
therefore conclude that both loss and gain of CHSY1 function lead to similar defects during 
various morphogenetic processes in the zebrafish, some of which might be equivalent to the 
distal limb malformations, craniofacial dysmorphism, shorter stature, and hearing loss caused 
by the homozygous loss of human CHSY1 function in Temtamy preaxial brachydactyly 
syndrome. 
 
  36 
Own contributions: 
Initially, the two TPB1 and TPB2 families from Egypt were subjected to a genome-wide scan 
using the Affymetrix GeneChip® Human Mapping 10K Array (CCG, University of Cologne, 
group of Prof. Dr. P. Nürnberg).  
First of all I evaluated and interpreted the Affymetrix GeneChip data which showed linkage 
of the families to two possible different loci on chromosomes 1p33 and 15q26 (Data not 
shown). In order to map the TPBS locus I designed primers for microsatellite marker analysis 
for these loci and performed fine mapping analysis by using PCR technique. Finally, I 
interpreted the microsatellite marker analysis and established the corresponding haplotypes 
for the families (Figure 1a). 
 
 
ARTICLE
Temtamy Preaxial Brachydactyly Syndrome Is Caused
by Loss-of-Function Mutations in Chondroitin Synthase 1,
a Potential Target of BMP Signaling
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Ingelore Baessmann,7 Matthew B. Lanktree,11 Mustafa Yilmaz,12 Robert A. Hegele,11 Khalda Amr,4
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Altered Bone Morphogenetic Protein (BMP) signaling leads to multiple developmental defects, including brachydactyly and deafness.
Here we identify chondroitin synthase 1 (CHSY1) as a potential mediator of BMP effects. We show that loss of human CHSY1 function
causes autosomal-recessive Temtamy preaxial brachydactyly syndrome (TPBS), mainly characterized by limb malformations, short
stature, and hearing loss. After mapping the TPBS locus to chromosome 15q26-qterm, we identified causative mutations in five consan-
guineous TPBS families. In zebrafish, antisense-mediated chsy1 knockdown causes defects in multiple developmental processes, some of
which are likely to also be causative in the etiology of TPBS. In the inner ears of zebrafish larvae, chsy1 is expressed similarly to the BMP
inhibitor dan and in a complementary fashion to bmp2b. Furthermore, unrestricted Bmp2b signaling or loss of Dan activity leads to
reduced chsy1 expression and, during epithelial morphogenesis, defects similar to those that occur upon Chsy1 inactivation, indicating
that Bmp signaling affects inner-ear development by repressing chsy1. In addition, we obtained strikingly similar zebrafish phenotypes
after chsy1 overexpression, which might explain why, in humans, brachydactyly can be caused by mutations leading to either loss or to
gain of BMP signaling.
Introduction
Brachydactylies are characterized by finger and toe short-
ening caused by short or absent metacarpus or metatarsus
and/or phalanges. They can occur either as an isolated trait
or as part of a syndrome in combination with other devel-
opmental malformations. Recent analyses have identified
mutations in components of the Bone Morphogenetic
Protein (BMP) signaling pathway or its modulators as the
cause of different types of brachydactyly. According to
current concepts, loss of BMP signaling, as for example
caused by loss-of-function mutations in the BMP ligand
GDF5 (MIM 601146) or the GDF5 high-affinity receptor
BMPR1B (MIM 603248), leads to reduced bone formation
and brachydactyly type A2 (BDA2 [MIM 112600]) or type
C (BDAC [MIM 113100]),1 whereas gain of BMP signaling,
as manifested by loss-of-function mutations in the BMP
inhibitor Noggin (MIM 602991), can result in compro-
mised joint formation between the different bony hand
and foot elements and in the development of symphalan-
gism (SYM1 [MIM 185800]) and/or multiple synostosis
syndrome (SYNS1 [MIM 186500]).2 However, the effects
of BMP signaling seem to be more complex and subject
to intensive fine tuning. For instance, in addition to being
caused by loss of GDF5 activity, BDA2 can also be caused by
gain of BMP2 signaling, and brachydactyly type B2 (BDB2
[MIM 611377]) can be caused by missense mutations
in Noggin (Mundlos1 and references therein). Similarly,
both GDF5 and Noggin mutations are linked to deafness
in SYNS1.3 In light of this, the exact roles of BMP signaling
and the nature of mediators accounting for the differential
effects remain largely obscure.
The Temtamy preaxial brachydactyly syndrome (TPBS
[MIM 605282]) is an autosomal-recessive congenital syn-
drome mainly characterized by bilateral, symmetric pre-
axial brachydactyly and hyperphalangism of digits, facial
dysmorphism, dental anomalies, sensorineural hearing
loss, delayed motor and mental development, and growth
retardation.4
Here we mapped the TPBS locus to chromosome 15q26-
qterm and identified causative mutations in CHSY1 (MIM
608183) in five TPBS families. The zebrafish has recently
emerged as a suitable animal model for human develop-
ment and disease.5 We show that in developing zebrafish,
1Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany; 2Institute of Human Genetics, University Hospital Cologne, Univer-
sity of Cologne, Cologne, Germany; 3Institute of Developmental Biology, University of Cologne, Cologne, Germany; 4Departments of Clinical and Molec-
ular Genetics, Division of Human Genetics and Human Genome Research, National Research Centre, Cairo, Egypt; 5Department of Biotechnology, Insti-
tute of Sciences, Cukurova University, Adana, Turkey; 6Department of Forensic Medicine, Faculty of Medicine, Cukurova University, Adana, Turkey;
7Cologne Center for Genomics, University of Cologne, Cologne, Germany; 8Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated
Diseases, University of Cologne, Cologne, Germany; 9North West Thames Regional Genetic Service, Harrow, London, UK; 10Sheffield Clinical Genetics
Service, Sheffield Children’s Hospital, Sheffield, UK; 11Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, University of Western
Ontario, London, Ontario, Canada; 12Department of Pediatric Allergy and Immunology, Faculty of Medicine, Cukurova University, Adana, Turkey;
13Genomatix Software GmbH, Mu¨nchen, Germany; 14Department of Pediatric Endocrinology, Faculty of Medicine, Cukurova University, Adana, Turkey
15These authors contributed equally to this work
*Correspondence: mhammers@uni-koeln.de (M.H.), bwollnik@uni-koeln.de (B.W.)
DOI 10.1016/j.ajhg.2010.10.003. 2010 by The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics 87, 1–11, December 10, 2010 1
AJHG 757
Please cite this article in press as: Li et al., Temtamy Preaxial Brachydactyly Syndrome Is Caused by Loss-of-Function Mutations in Chon-
droitin Synthase 1, a Potential Target of BMP..., The American Journal of Human Genetics (2010), doi:10.1016/j.ajhg.2010.10.003
loss and gain of chsy1 function leads to defects similar to
those in human TPBS patients. Such defects include
reduced body length, compromised formation of the
pectoral fin, severe midline deficiencies in the cartilage of
the neurocranium, and compromised formation of epithe-
lial protrusions and semicircular canals in the inner ear.
Moreover, we demonstrate that Bmp signaling has a nega-
tive effect on chsy1 expression and that Dan is required for
inhibition of Bmp signaling and derepression of chsy1
expression in epithelial protrusions, and it thereby allow-
ing allows semicircular canal morphogenesis.
Material and Methods
Subjects
All subjects or their legal representatives gave written informed
consent to the study. The study was performed in accordance to
the Declaration of Helsinki protocols and approved by the local
institutional review boards. Five families with the clinical diag-
nosis of Temtamy preaxial brachydactyly (TPBS) were included
in the study. Clinical features of some of the families have been
already published: TPB1,4 TPB4,6 and TPB5.7 Patients underwent
general otological examinations and pure-tone audiometry with
air and bone conduction at 250 Hz, 500 Hz, 1000 Hz, 2000 Hz,
4000 Hz, and 8000 Hz. Vestibular evaluation in affected individ-
uals did not reveal any symptoms of vestibular dysfunction.
Moderate to profound sensorineural hearing impairment was
diagnosed in families TPB1 (individual II-2), TPB2 (individual
II-2), TPB3 (individuals II-3 and II-5), TPB4 (individual II-2), and
TPB5 (individuals II-5 and II-6). DNA from participating family
members was extracted from peripheral blood lymphocytes by
standard extraction procedures.
Linkage Analysis
Genome-wide linkage analysis in available members of the TB1
and TB2 families was performed with the Affymetrix GeneChip
Human Mapping 10K SNP Array Xba142 (version 2.0). Genotypes
were called by the GeneChip DNA Analysis Software (GDAS v3.0,
Affymetrix). We verified sample genders by counting heterozy-
gous SNPs on the X chromosome. Relationship errors were
evaluated with the help of the program Graphical Relationship
Representation.8 The program PedCheck detected Mendelian
errors,9 and data for SNPs with such errors were removed from
the data set. Non-Mendelian errors were identified with the
program MERLIN,10 and unlikely genotypes for related samples
were deleted. Linkage analysis was performed under the assump-
tion of autosomal-recessive inheritance, full penetrance, consan-
guinity, and a disease gene frequency of 0.0001. Multipoint
LOD scores were calculated with the program ALLEGRO.11 Haplo-
types were reconstructed with ALLEGRO and presented graphi-
cally with HaploPainter.12 All data handling was performed
with the graphical user interface ALOHOMORA.13 For the TPB3
family, an independent genome-wide 250K NspI Affymetrix
SNP Array (Affymetrix, CA, USA) analysis was done on all mem-
bers of the nuclear family at the Genome Sciences Laboratory
of the Ankara University Biotechnology Institute. SNP Array
data were analyzed by Genespring GT (Agilent, Santa Clara, CA,
USA). For subsequent fine mapping, known and newly designed
microsatellite markers for the critical region were genotyped
(Table S2).
Mutation Screening
We searched databases to identify candidate genes in the critical
region on chromosome 15q26-qterm (GeneDistiller, Ensemble
Genome Server, and UCSC Genome Bioinformatics). Four candi-
date genes, ADAMTS17 (MIM 607511), CHSY1, SELS (MIM
607918), and PCSK6 (MIM 167405), were chosen for mutation
screening on the basis of their expression pattern and presumed
functional properties (OMIM and Unigene). Primers were
designed according to the reference sequences. The coding exons
and adjacent splice sites of these candidate genes were sequenced
in the index patients of TPB1 and TPB2 families. We amplified
the three exons of CHSY1 (CHSY1, NC_000015.9; CHSY1,
NP_055733.2; Table S2) from DNA of all affected members of the
five families and sequenced the PCR products by BigDye Termi-
nator method on an ABI 3100 sequencer. We resequenced all
identified mutations in independent experiments and tested for
cosegregation within the families. We tested 150 healthy control
individuals from Turkey, 30 from Morocco, and 30 from Egypt
for the mutations in exon 1 (c.55-84del30, c.14delG, and
c.205C>T) by direct sequencing. One hundred twenty controls
from Pakistan and 40 from Turkey were tested for the mutation
of c.3213C>G by PCR and restriction digestion, and 150 con-
trols from Pakistan were tested for the mutation of p.P539R.
CHSY protein sequence was analyzed with the server Pfam for
protein domains. All primer sequences of designed polymorphic
markers on 15qter and primer sequences for genomic and cDNA
amplification of CHSY1 can be found in Table S2.
CHSY1 cDNA Analysis
RNA was extracted from fresh blood with the Paxgene Blood RNA
system (QIAGEN). Reverse-transcriptase polymerase chain reac-
tion (RT-PCR) was performed with RevertAid First Strand cDNA
synthesis Kit (Fermentas). The primers for amplification were
designed according to the reference sequence and located in
exon 1 and exon 3 (CHSY1 mRNA, NM_014918.4; Table S2).
Histology
Whole-mount in situ hybridizations, immunostainings, and dou-
ble in situ hybridizations were carried out as described.14,15 For
chsy1 probe synthesis, a 1030 bp fragment of zebrafish chsy1
cDNA (GenBank accession number BC064670;16) was amplified
via RT-PCR, cloned into pCRII (Invitrogene), linearized with Hin-
dIII, and transcribed with T7 RNA polymerase. Sense control probe
was generated with NotI and SP6 RNA polymerase. The bmp2b,
msxc, and sox9a probes were generated as described.17–19 Fluores-
cein-phalloidin staining of hair cells in sensory patches of inner
ears was carried out as described.17
Morpholino Injection
Two sequence-independent antisense morpholino oligonucleo-
tides (MOs) targeting the translational start codon (chsy1-ATG
MO) or 50 untranslated region (chsy1-UTR MO) were purchased
from GeneTools. Sequences were as follows: chsy1-ATG MO, 50-AA
GATCTGCGACTCCTTCCTGCCAT-30 (identical to MO in Zhang
et al.16 and Peal et al.20); and chsy1-UTR MO, 50-CTAGTCGCTT
TAATTTGTCAGAGTT-30. MOs were injected into 1- to 4-cell-stage
embryos, as described;21 per embryo,1.5 nl was injected at con-
centrations ranging from 66–333 mM (ATG MO) and from 333–
500 mM (UTR MO). To avoid unspecific toxicity, we coinjected
the UTR MO with p53-MO.22 To control knockdown efficacy, we
cloned the 50 UTR and the first 46 nucleotides of the coding region
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into pCS2þ vector23 and fused it to GFP. The plasmid was linear-
ized with NotI, and chsy1-gfp hybrid mRNA was generated with
the SP6 MessageMachine Kit (Ambion, Austin, TX). Injection of
thismRNA into zebrafish embryos yielded strongGFP fluorescence
at late gastrula stages (Figure S3). However, fluorescence was com-
pletely suppressed upon subsequent coinjection of the mRNA
with chsy1-ATG MO or chsy1-UTR MO (Figure S3). dan MO injec-
tions were done as described.24
Overexpression Studies
For chsy1 overexpression, the coding region of human CHSY1 was
cloned into the Cla1 and XhoI sites of pCS2þ.23 The plasmid was
linearized with NotI, and capped sense RNA was synthesized
in vitro via the SP6 MessageMachine Kit (Ambion, Austin, TX).
mRNA (1.5 nl) was injected into 1- to 4-cell-stage embryos at
a concentration of 100 ng/ml. For temporally controlled bmp2b
overexpression, the offspring of Tg(hsp70l:bmp2b)fr13 transgenic
fish were subjected to a 30 min heat shock (transfer from 28C
to 39C) at 48 hpf, as described.25
Results
Clinical Findings in CLS Families
We have examined five TPBS families presenting with
a variable expression of clinical symptoms (Figure 1A, B,
and Table 1). We observed mild facial dysmorphism,
including round face and craniosynostosis, mild hyperte-
lorism, and micrognathia, in the majority of TPBS cases
(Table 1). Distal limb anomalies affected both hands
and feet and were characterized by short and abducted
thumbs, short and deviated halluces, and syndactyly.
Typical preaxial brachydactyly of digits 1–3 was seen in
all affected individuals and, in addition, hyper- and sym-
phalangism, radio-ulnar synostosis, and carpal or tarsal
fusions were observed in X-rays of some cases. Further
skeletal anomalies showed a progressive course in TPBS
patients and included growth retardation, kyphoscoliosis,
and pectus excavatum. Interestingly, we found moderate
Figure 1. Clinical and Molecular Findings in Families with TPBS
(A) A haplotype analysis of the 15q26-qterm critical region indicates homozygosity in affected individuals of the TPB1, TPB2, and TPB3
families.
(B) Typical hand anomalies and skeletal findings seen in our patients with TPBS.
(C) Genomic overview of the 15q26 critical region and genomic localization of the genes tested.
(D) Electropherograms of identified homozygous CHSY1 mutations compared to wild-type sequences.
(E) Schematic view of CHSY1 protein domains, coding exons, and localization of identified CHSY1 mutations.
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Table 1. Clinical Findings in TPBS Families Carrying CHSY1 Mutations
Family Data TB-1 TB-2 TB-3 TB-4 TB-5
Consanguinity þ þ þ þ þ
Number of affected individuals 1 2 3 1 3
Mutation (nucleotide change) c.55-84del c.14delG c.205C>T c.3213C>G c.1616C>G
Mutation (protein change) G19_L28del G5AfsX30 Q69X  P539R
Origin Egypt Egypt Turkey Sri Lanka Pakistan
Facial Dysmorphism
Plagiocephaly þ þ þ/  
Hypertelorism þ þ  þ 
Micro- or retrognathia þ þ   
Dental Anomalies
Microdontia þ þ þ þ þ
Talon cusps þ þ þ þ 
Hearing loss
Sensorineural þ þ þ þ þ
Conductive     þ
Malformed ears þ þ þ ? 
Hand or foot anomalies
Short fingers or toes I, II, III þ þ þ þ þ
Syndactyly þ þ þ þ þ
Abducted thumbs þ þ þ þ þ
Lateral/medial deviations of fingers/toes þ þ þ þ þ
Clinodactyly þ þ þ þ þ
Radiological findings
Preaxial brachydactyly þ þ þ þ þ
Short metacarpals/metatarsals þ þ þ þ þ
Hyperphalangism þ þ þ þ þ
Symphalangism þ þ þ þ þ
Phalangeal duplications þ þ þ þ þ
Radioulnar synostosis    þ 
Skeletal anomalies
Kyphoscoliosis þ þ þ/  
Pectus excavatum þ    
Generalized osteoporosis þ þ þ n.a. n.a.
Additional findings
Developmental delay þ þ þ ? 
Mental retardation þ þ þ ? 
MRI findings n.a. partial
agenesis
of the
cerebellar
vermis
cerebellar
degeneration,
mild brain
stem atrophy
n.a. n.a.
Optic atrophy    þ 
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to profound sensorineural hearing loss in almost 80% of
the cases.
Mapping of the TPBS Locus and Identification
of CHSY1 Mutations
Initially, we genotyped DNA samples from available family
members of the originally described TPB1 family (4) and
one additional family, TPB2, which both originated from
Egypt, by using the Affymetrix GeneChip Human Map-
ping 10K SNP Array (version 2.0). Affected individuals
were born to consanguineous parents in both families.
Two possibly linked loci on chromosomes 1p33 and
15q26 were observed and had a combined parametric
LOD score of 2.37 and 2.51, respectively (Figure S1). Exten-
sive analysis of microsatellite markers of these regions
mapped the TPBS locus to chromosome 15q26-qterm
between SNPs rs1480952 and rs352744 (Figure 1A; see
also Figure S2), defining a shared homozygous critical
interval of approximately 3.8 Mb and excluding the 1p33
region (Figure 1C; see also Figure S2). Mapping data of
one additional TPBS family, TPB3 from Turkey, confirmed
TPBS locus without reducing the critical region (Figure 1A).
Among the 20 annotated genes within this region, we
sequenced four of them as highly relevant positional
candidate genes (ADAMTS17, CHSY1, PCSK6, and SELS;
Table S1). Sequencing of the three coding exons of the
chondroitin synthase 1, CHSY1, gene revealed different
homozygous mutations in affected individuals in each of
the three linked families as well as two additional families
with TPBS, which were subsequently tested. CHSY1 is tran-
scribed to a 4549 bp transcript (NM_014918.4), which
encodes a protein of 803 amino acids. All mutations cose-
gregated with the disease in the families and were not
when more than 150 healthy control individuals were
tested. We found three mutations in exon 1 of CHSY1:
a 30 bp deletion, c.55-84del (p.G19_L28 del, TPB1 family);
a 1 bp deletion, c.14delG (p.G5AfsX30, TPB2 family); and
the c.205C>T nonsense mutation (p.Q69X) in all three
affected individuals of the TPB3 family (Figures 1D and
1E). An acceptor splice-site mutation, c.321-3C>G, was
identified in the TPB4 family, whereas the only missense
mutation, c.1616C>G (p.P539R, TPB5 family), was located
in exon 3 of the gene (Figures 1D and 1E).
The acceptor splice-site mutation c.3213C>G is pre-
dicted to cause skipping of CHSY1 exon 2 and lead to the
loss of 496 bp on the transcript level and a thus frame shift
and premature protein truncation. We confirmed skipping
of exon 2 on cDNA of the affected individual (Figures S2A
and S2B). The only missense mutation identified, p.P539R,
affects a highly conserved proline (Figure 2C).
Expression of chsy1 in Zebrafish
No Chsy1 knockout mice have been reported yet. However,
consistent with the phenotypic traits of TPBS, our in situ
hybridization analysis revealed Chsy1 expression in chon-
drocytes and the developing inner ear of e12.5 and e14.5
mouse embryos (data not shown). To address the develop-
mental functions of CHSY1 and CS, and their possible rela-
tionship to BMP signaling, we turned to the zebrafish
system. Whole-mount in situ hybridization revealed wide-
spread expression of chsy1 in the head (data not shown)
and prominent expression in the floor plate (Figure 3A)
and the fin epithelium (Figures 3B and 3D) of wild-type ze-
brafish embryos at 24 hr postfertilization (hpf). During the
second day of development, prominent expression was
also detected in the heart (data not shown), chondrocytes
of the developing head skeleton (Figure 3E), pharyngeal
endoderm of the branchial arches (Figure 3F,G), distal
regions of the pectoral fin buds (Figure 3H), and epithelial
protrusions of the inner ears (Figure 3I), These protrusions
later fuse to form the semicircular canal ducts; the central
components of the vestibular system contribute to angular
motion sensing and body balancing.26 After this fusion has
occurred, chsy1 transcript levels appear to drop (Figure 3J).
Phenotypes of Zebrafish after Loss and Gain of chsy1
Activity and the Correlation of chsy1 to bmp2b
and dan
To knock down Chsy1 activity, we injected zebrafish
embryos with antisense morpholino oligonucleotides
(MOs; for efficacy control; see Figure S3). In addition, for
gain-of-function studies, we injected in vitro synthesized
human CHSY1 mRNA. Surprisingly, both treatments led
to similar defects, including a significant reduction of
body length (Figures 4A–4C), compromised pectoral fin
formation (Figures 4D–4F), severe midline deficiencies in
the cartilage of the neurocranium (Figures 4G and 4H),
notochord undulation (Figures 4K and 4L), and later, noto-
chord degeneration (Figures 4I and 4J), which could be
correlated with the aforementioned chsy1 expression in
the overlying floorplate cells (see above; Figure 3A) and
with the shorter body length (Figure 4B). Furthermore,
chsy1 morphants displayed reduced eye distances, as well
as slight cyclopia in severe cases (Figures 4M–4O), which
is linked with the neurocranial deficiencies (Figures 4G
and 4H). In addition, the eyes developed colobomas (Fig-
ures 4P–4R).
In the inner ears, formation of epithelial protrusions and
semicircular canals was severely compromised (Figures 5A–
5D). However, according to msxc in situ hybridization
and FITC-phalloidin staining of hair cells, the cristae and
maculae, semicircular canal- and otolith-associated sen-
sory patches of the ear, respectively, did not show major
alterations in chsy1 morphants (Figures 5K–5N). This
suggests that, rather than being important for hair cell
development itself, Chsy1 might be instrumental for
proper morphogenesis of the vestibular organ.
Positive and negative effects on semicircular canal
development have also been reported for BMP signaling.
Although according to genetic analysis, late loss of
Bmp2b function leads to defective semicircular canal mor-
phogenesis,27 another report describes similar effects
under Bmp2b/4 gain-of-function conditions.28 bmp2b and
chsy1 are expressed in a largely complementary manner.
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At 56 hpf, bmp2b expression is strongest in the developing
cristae of the inner ear (Figure 5J), where chsy1 expression
is very weak (Figure 5G). In contrast, the epithelial protru-
sions display strong expression of chsy1 (Figure 5G) and
the Bmp inhibitor dan24 but weak bmp2b expression (Fig-
ure 5J). Consistently, transgenic overexpression of bmp2b
during the second day of development or MO-mediated
knockdown of dan led to impaired semicircular-canal for-
mation similar to that caused by knockdown of chsy1
(Figures 5E and 5F). Furthermore, both treatments compro-
mised chsy1 expression in the epithelial protrusions
(Figures 5H and 5I). Together, this suggests that Bmp
signaling has a negative effect on chsy1 expression and
that Dan is required for inhibition of Bmp signaling and
derepression of chsy1 expression in epithelial protrusions;
Dan thereby allows semicircular canal morphogenesis.
It is tempting to speculate that Bmp inhibition and
Chsy1 play a similar role during morphogenesis of the
cochlea, the central auditory structure in mammals, and
that they possibly underlie the hearing loss in human
TPBS patients.
Discussion
In the present study we showed that congenital bilateral,
symmetric preaxial brachydactyly and hyperphalangism
of digits, facial dysmorphism, dental anomalies, sensori-
neural hearing loss, and growth retardation in the Temt-
amy preaxial brachydactyly syndrome (TPBS) is caused
by recessive mutations in CHSY1. The encoded protein,
chondroitin synthase 1, is a key protein in the biosynthesis
of chondroitin sulfate (CS). It belongs to the glycosamino-
glycans (GAGs) and is composed of alternating glucuronic
Figure 2. Additional Molecular Findings in TPBS
(A) Amplification of CHSY1 cDNAs of the TPB4 patient carrying the c.3213C>G splice-site mutation and of a healthy control. The
forward primer was located in exon 1, and the reverse primer was located in exon 3. Complete loss of the normal amplicon size in
the patient’s cDNA was due to the skipping of exon 2. Abbreviations are as follows: M, marker; WT, wild-type control; Pat, patient;
and C, water control without DNA.
(B) Electropherograms of CHSY1 transcripts from the wild-type control and patient TPB4 show the skipping of exon 2 in the patient.
(C) An amino acid sequence alignment of CHSY1 proteins of different species shows the highly conserved proline at position 539.
(D) A PCR and enzyme-digestion method was used as a second independent method of showing the cosegregation of the c.1616C>G
(p.P539R) missense mutation in the TPB5 family. The mutation abolishes one of the two Bsl I restriction sites in the amplicon. Parents
were heterozygotes, and all of three patients (II3, II5 and II6) were homozygotes for the mutation, whereas none of the three healthy
siblings had the homozygous mutation. Abbreviations are as follows: M, Marker; C, healthy control individual; and UF, undigested
PCR fragment.
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acid (GlcUA) and N-acetyl galactosamine (GalNAc) resi-
dues.29 CS can be synthesized in multistep processes
as covalently bound side chains of proteins known as
proteoglycans.30 CHSY1 has both the glucuronyltransfer-
ase II and N-acetylgalactosaminyl-transferase II activities
required for the synthesis of the repeating disaccharide
unit of CS. Both deletions and the p.Q69X nonsense
mutation, all located in exon 1 of CHSY1, can be expected
to cause structural alterations and disruption of the CHSY1
protein structure. We also confirmed that the acceptor
splice-site mutation c.3213C>G causes skipping of
CHSY1 exon 2 and leads to the loss of 496 bp on the
transcript level and a frame shift and premature protein
truncation. Therefore, it is likely that the c.3213C>G
mutation also leads to a nonfunctional CHSY1 protein.
We only identified one missense mutation, p.P539R,
which affects a highly conserved proline within the func-
tionally important chondroitin N-acetylgalactosaminyl-
transferase (CHGN) domain of CHSY1 (Figure 1E). The
substitution of proline by arginine might interfere with
the normal folding of this domain and thus prevent effi-
cient protein function. Taken together, these findings
demonstrate that complete or nearby complete loss of
CHSY1 function underlies autosomal-recessive TPBS.
Our zebrafish study demonstrated that both loss and
gain of Chsy1 function lead to similar defects during
various morphogenetic processes in the zebrafish; some
of these processes might be equivalent to the distal limb
malformations, craniofacial dysmorphism, shorter stature,
and hearing loss caused by the homozygous loss of human
CHSY1 function in TPBS. The similarity of the zebrafish
inner-ear phenotype after loss and gain of Chsy1 or Bmp
activity, together with the loss of chsy1 transcription after
gain of Bmp signaling, further suggests that a similar dereg-
ulation of CHSY1 might at least partly underlie the
different defects caused by aberrant BMP signaling in
mammals. Such defects include craniofacial and inner-
ear dysmorphologies31–33 and the different types of
Figure 3. Expression of chsy1 during Zebrafish Development
Ages of embryos and larvae (in hpf) are indicated in the lower right corners, and the in situ hybridization probes (A–F and H–J) or anti-
body (G) are indicated in the lower left corners. (A–C, F–J) Lateral views. Anterior is to the left. (D) A transverse section through the tail.
Dorsal is to the top. (E) A ventral view of the head region.
(A–F and H–J) Whole-mount in situ hybridization with a chsy1 antisense probe to detect chsy1mRNA (A, B, D, E, F, H, I, and J), sox9a
antisense probe19 to colabel chondrocytes (E, in red), and a chsy1 sense control probe (C). (G) Whole-mount anti-Zn5 immunostaining,
marking the pharyngeal endoderm (compare with Piotrowski and Nu¨sslein-Volhard 40). chsy1 is expressed in the floor plate (fp), located
between the spinal cord and the notochord (nc) (A), in the basal keratinocyte layer of the fin epithelium (B and D), in somatic cells close
to the myosepta (B), in chondrocytes of the neurocranium and pharyngeal arches of the visceral skeleton (E), in the pharyngeal endo-
derm (pe) of the branchial arches (F), and in epithelial protrusions of forming semicircular canals in the inner ear (I). When these epithe-
lial protrusions have fused in the center of the otic vesicle, chsy1 transcript levels drop (J).
Abbreviations are as follows: ep, epithelial protrusions; et, ethmoid plate (neurocranium); fep, fin epithelium; fp, floor plate; hy, hyoid
(second pharyngeal arch); md, mandibular (first pharyngeal arch); nc, notochord; pe, pharyngeal endoderm; pfb, pectoral fin bud; s,
somite; and tc, trabeluca cranii (neurocranium).
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human brachydactylies, caused by either gain or loss of
BMP signaling.1 Future studies will have to reveal the
molecular mechanisms of chsy1 repression by Bmp sig-
naling and of Chsy1 and CS function. Computational
analysis of human CHSY1 revealed the presence of several
Smad transcription-factor binding sites (data not shown),
suggesting that the effect of BMP signaling on CHSY1
expression might be direct. CS, in turn, could have
Figure 4. Phenotypes of Zebrafish Larvae after Loss and Gain of chsy1 Function
Ages of zebrafish larvae (in hpf) are indicated in the lower right corners, and treatments are indicated in the upper right corners. Abbre-
viations are as follows: MO, embryo injected with antisense morpholino, loss of function; RNA, embryo injected with synthetic mRNA,
gain of function; and wt, unjected wild-type control).
(A–C) Lateral views of live animals, displaying reduced body length and altered head morphology after chsy1 loss and gain of function.
(D–F) Dorsal views of the anterior trunk of live larvae, displaying pectoral fins with variably reduced outgrowth. Upper fin in (F) is of
normal size and shape. Compared to the other phenotypic traits, impaired fin development was only moderately penetrant (approxi-
mately 30%), and it often occurred in a unilateral manner (as in F). (G and H) Alcian blue staining of cartilage of the neurocranium.
For a better appreciation of the neurocranial deficiencies, the visceral skeleton was manually removed.
(I and J) Lateral view of the trunk of live animals, revealing degeneration of notochord cells in the morphant. In several zebrafish
mutants, notochord degeneration is linked to and most likely causative of reduced body length,41 as also seen in the chsy1 morphants
described here.
(K and L) View of the trunk of live embryo. The notochord undulation of the morphant indicates that the shortened body length cannot
be solely caused by notochord degeneration. Similar notochord undulation has been observed in several zebrafish mutants, e.g., those
carrying loss-of-function mutations in wnt5a,36 pointing to a possible additional role of Chsy1 in modulating noncanonical Wnt
signaling.
(M–O) Dorsal view of the heads of live larvae. Medial expansion of the eyes and loss of midline forebrain tissue leads to partial cyclopia.
Note that in the morphants shown here, the pectoral fins are not or only moderately affected.
(P–R) Lateral view of the eyes, revealing lack of dorsal retinal tissue and failed closure of the choroid fissure (coloboma). This phenotypic
trait is linked to the above-described medial-forebrain deficiencies and shifts of the eyes to more medial positions, and it might be
a secondary consequence of the overall alterations in head and head-skeleton morphology.
Abbreviations are as follows: cf, choroid fissure of eye; et, ethmoid plate (neurocranium); pf, pectoral fin bud; and tc, trabeluca cranii
(neurocranium).
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a structural role during morphogenetic processes, consis-
tent with its expression in the tips of the epithelial pro-
jections of the forming semicircular canals and with the
described role of other GAGs such as hyaluronic acid
during zebrafish inner-ear morphogenesis.34 In addition,
as a component of proteoglycans-like aggrecan or versican,
CS might feed back to BMP or other growth-factor sig-
naling, consistent with the described activities of proteo-
glycans as growth-factor binding proteins and/or corecep-
tors.35 For instance, an undulated notochord phenotype as
in zebrafish chsy1 morphants is also displayed by wnt5a
mutants,36 pointing to a possible involvement of CHSY1
in noncanonicalWNTsignaling. Furthermore, as described
in detail in the accompanying work by Tian et al.,37CHSY1
could modulate signaling through the Notch receptor.
CHSY1 has a Fringe domain, which is possibly involved
in glycosylation of Notch receptors and thus modifying
their ligand specificity and signaling efficiency.38 Consis-
tent with a role of Chsy1 in reducing Notch signal-
ing, we found that conditional expression of the constitu-
tively active intracellular domain of Notch in zebrafish
causes compromised semicircular-canal formation, as
does loss of Chsy1 activity (K.L. and M.H., unpublished
data). Together, the negative role of Bmp signaling
on chsy1 expression and the negative role of Chsy1 on
Notch signaling are in line with the synergistic effect of
Notch function downstream of Bmp signaling as reported
in many different developmental and physiological
scenarios.39
In conclusion, we show that loss of human CHSY1 func-
tion causes autosomal-recessive Temtamy preaxial brachy-
dactyly syndrome and that antisense-mediated chsy1
knockdown in zebrafish causes similar defects in multiple
developmental processes. In the inner ears of zebrafish
larvae, unrestricted Bmp2b signaling or loss of Dan activity
leads to reduced chsy1 expression and, during epithelial
morphogenesis, defects similar to those that occur upon
Chsy1 inactivation, indicating that Bmp signaling affects
inner-ear development by suppressing Chsy1.
Supplemental Data
Supplemental Data include three figures and two tables and are
available with this article online at http://www.cell.com/AJHG/.
Figure 5. Interaction between chsy1, bmp2b, and dan during Inner-Ear Morphogenesis.
Ages of larvae (in hpf) are indicated in lower right corners, and treatments are indicated in upper right corners. Abbreviations are as
follows: MO, embryo injected with antisense morpholino; RNA, embryo injected with synthetic mRNA; tg(bmp), transgenic after heat-
shock induction of ubiquitous bmp2b expression;25 and wt, unjected or nontransgenic wild-type control).
(A–F) Lateral views of the inner ear of live animals. In the wild-type control (A), the walls of the semicircular canals are outlined by dots.
(G–H) Inner ears after whole-mount in situ hybridization for chsy1 (t-v) or bmp2b (w) mRNA. For details, see text.
(G–L) Lateral views of the inner ears after whole-mount in situ hybridization for chsy1 (G–I), bmp2b (J), or msxc (K and L). (G–I) chsy1
mRNA levels in epithelial protrusions (ep) are strongly reduced after overexpression of bmp2b (H) and after inactivation of the BMP
inhibitor DAN (I). The much weaker expression in the cristae primordia (cr) remains unaltered (compare G and H). (J) In contrast to
chsy1 (see G), bmp2b is strongly expressed in the cristae of the wild-type inner ear. (K and L)msxc expression in cristae of the chsy1mor-
phant is unaltered (L). Becausemsx genes are known transcriptional targets of BMP signaling, these data also suggest that, in contrast to
the BMPs upstream of chsy1, Chsy1 does not act upstream of BMP signaling.
(M and N)Merged stacks of confocal images of inner ears after fluorescein (FITC)-phalloidin staining. Cristae (indicated by white arrows)
of wild-type and morphant larvae contain hair cells of indistinguishable numbers and morphology.
Abbreviations are as follows: cr, crista (sensory patch of inner ear); ep, epithelial protrusions; o, otolith; and pc, posterior semicircular
canal.
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6.1 Elçioglu NH, Pawlik B, Colak B, Beck M, Wollnik B. A novel loss-of-function 
mutation in the GNS gene causes Sanfilippo syndrome type D. Genet Couns (2009); 
20(2):133-9.    
 
Abstract of the publication: 
Mucopolysaccharidosis type IIID (MPS3D) is the least common form of the four subtypes of 
Sanfilippo Syndrome which is a rare autosomal recessive lysosomal disorder mainly 
characterized by progressive neurodegeneration and caused by a deficiency of the N-
acetylglucosamine-6- sulphatase (GlcNAc-6S sulphatase, GNS), a hydrolase, which is one of 
the enzymes involved in heparan sulphate catabolism leading to lysosomal storage. So far 
only twenty patients have been described in the literature and only seven causative mutations 
in the GNS gene encoding GlcNAc-6S sulphatase have been reported to date. 
 
In this study we report on 10 year old boy of Turkish orign with mental retardation of 
unknown aetiology. Phenotypically he had relative macrocephaly with a long, coarse facies, 
thick lips and eyebrows mild synophrys, low nasal bridge, high palate and an open mouth 
with salivary overproduction. Diagnostic analyses from serum, leucocyte and cultured 
fibroblast regarding the different Muccopolysaccharide groups were performed and displayed 
that the GlcNAc-6S sulphatase activity in cultured skin fibroblast cells was nearly zero. 
Therefore the diagnosis of MPS3D was established. 
In order to confirm diagnosis we sequenced all 14 exon/introns boundaries of the GNS gene 
and identified the novel homozygous single base pair insertion, c.1226insG, which leads to a 
frame-shift and a premature truncation of the GNS protein (p.R409Rfs21X). In addition, we 
analyzed 100 controls individuals for the mutation by PCR /restriction digestion and the 
mutation was not detected. In conclusion we provide further evidence that loss-of-function of 
the GNS gene is the underlying pathophysiological mechanism of the rare Sanfilippo 
phenotype. 
 
  38 
Own contributions: 
In order to sequence the GNS gene, I first designed and ordered primers for PCR 
amplification for all 14 coding exons. Then I established PCR conditions and sequenced all 
exon and introns boundaries of the GNS gene. 
I identified a novel homozygous base pair insertion, c.1226insG in exon 11, which leads to a 
frame-shift and a premature truncation of the GNS protein (Figure 2a, p.137). This mutation 
was re-sequenced in the patient and also in both parents.  
In addition, I established an enzyme restriction method with Hpy 1881 to detect the mutation 
and performed restriction with 100 healthy control individuals (Figure 2b, p.137). 
Finally, I completed the study by preparing the mutation and enzyme restriction pictures 
(Figure 2, p.137) for the submission to Genetic Councelling. 
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 INTRODUCTION
The mucopolysaccharidoses (MPS) are a family of lysosomal storage 
fkugcugu" ecwugf" d{" fgÝekgpekgu" qh" ugxgtcn" gp¦{ogu" tgswktgf" hqt" vjg"
catabolism of glycosaminoglycans (GAG). The defects result in accu-
mulation of excessive intralysosomal GAG in various tissues, causing 
distended lysosomes to accumulate in the cell and interfere with cell 
function. Multiple types with subgroups caused by different enzyme 
defect have been characterized (10).
Vjg" hqwt" fgÝekgpv" gp¦{ogu" kp" UcpÝnkrrq" fkugcug" *ORU/5+." yjkej"
inhibit the catabolism of heparan sulphate and resulting an indistin-
guishable clinical picture, are heparan N-sulphatase (type-A), alpha-
N-acetylglucosaminidase (type-B), acetyl-CoA-glucosaminide acetyl-
transferase (type-C) and N-acetylglucosamine-6-sulphatase (type-D). 
Type A is the most common form and type D is the less common one. 
All four enzymes are involved with the stepwise degradation of hepa-
ran sulphate. Heparan sulphate (HS) is primarily found in the central 
nervous system whereas the storage of HS is also abundant in connec-
tive tissue and liver. There is little clinical difference among the four 
v{rgu"qh"UcpÝnkrrq"u{pftqog."ukpeg"cnn"hqwt"v{rgu"ceewowncvg"vjg"ucog"
GAG, heparan sulphate. In contrast to the other mucopolysaccharido-
ugu."v{rkecn"rj{ukecn"hgcvwtgu"ctg"pqv"crrctgpv"cpf"UcpÝnkrrq"rcvkgpvu"
Summary: C" pqxgn" nquu/qh/hwpevkqp" owvcvkqp" kp" vjg" IPU" igpg" ecwugu" UcpÝnkrrq" u{pftqog" v{rg" F< 
Oweqrqn{uceejctkfquku" v{rg" KKKF" *OKO" 474;62+" ku" vjg" ngcuv" eqooqp" hqto" qh" vjg" hqwt" uwdv{rgu" qh" UcpÝnkrrq"
u{pftqog0" Kv" ku" cp" cwvquqocn" tgeguukxg" n{uquqocn"fkuqtfgt" ecwugf"d{" c" fgÝekgpe{"qh" vjg"P/cegv{ninwequcokpg/8/
sulphatase (GlcNAc-6S sulphatase, GNS), a hydrolase, which is one of the enzymes involved in heparan sulfate 
catabolism leading to lysosomal storage. The clinical features of this disorder are progressive neurodegeneration with 
relatively mild somatic symptoms. Twenty patients have been described in the literature and only seven causative 
mutations in the GNS gene encoding GlcNAc-6S sulphatase have been reported to date. We present the clinical 
cpf"oqngewnct" tguwnvu"qh"c"pgyn{"fkcipqugf"Vwtmkuj"rcvkgpv"ykvj"ORU"KKKF0"Yg" kfgpvkÝgf" vjg"pqxgn"jqoq¦{iqwu"
single base pair insertion, c.1226GinsG, which leads to a frame-shift and a premature truncation of the GNS protein 
(p.R409Rfs21X). Conclusion: This novel mutation provides further evidence that loss-of-function is the underlying 
pathophysiological mechanism of this rare phenotype.
Key-words<"ORU"v{rg"5F"Î"UcpÝnkrrq/F"Î"P/cegv{ninwequcokpg/8/uwnhcvcug"Î"IPU"igpg
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reach almost normal body height. The only clinical sign seen early 
might be thick and coarse hair and synophrys of the eye brows. The 
Ýtuv" u{orvqou"oc{"dg"qdugtxgf"gctnkgt"qt" ncvgt"fwtkpi" vjg"fgxgnqr-
ogpv."tgictfnguu"qh"vjg"v{rg"qh"gp¦{og"fgÝekgpe{0"Cnvjqwij"rcvjqnq-
ikecn"Ýpfkpiu"oc{"dg"cdugpv"wpvkn"vjg"ejknftgp"tgcej"gctn{"uejqqn"cig."
some affected children with an age of 2 to 4 years may already attract 
attention by restless behavior, sleeping problems, speech disorders and 
slowing of learning abilities. Later, body temperature irregularity, sei-
zures and spasticity may develop. Major issues in the care of patients 
with MPS-IIID include behavioral problems, sleep problems, recurrent 
infections, dysphagia, and pain from orthopedic complications. To date 
there is no enzyme treatment for MPS-III and life expectancy is varia-
ble, but less than one decade (1, 3-5, 9, 10).
Yg"rtgugpv"jgtg"vjg"enkpkecn."dkqejgokecn"Ýpfkpiu"qh"c"pgyn{"kfgpvkÝgf"
MPS IIID patient with a novel homozygous mutation. This will be the 
vygpv{/Ýtuv"rcvkgpv"cpf"vjg"gkijvj"owvcvkqp"tgrqtvgf"hqt"vjku"n{uquqocn"
disorder so far. 
 CASE REPORT
Patient MSC is a 10 years old boy with mental retardation of unknown 
origin and has been referred for genetic counseling and diagnostic as-
sistance. He was the second child from unrelated parents originating 
from a small region of Turkey. He was born after uncomplicated preg-
nancy and delivery at term with a birth weight 3050 gr. He had an 
operation to correct an inguinal hernia at 2 years of age. Early motor 
development was normal. He was able to sit up without support at 
6 months, walk independently at 12 months and started to talk at 12 
months with nearly normal speech development. Toilet training was 
uweeguuhwn"kp"vkog0"Jg"ycu"cdng"vq"tgcf"cpf"ytkvg"cfgswcvgn{"cdqwv"vjg"
age of six years and followed the mainstream school program, although 
ykvj"uqog"ngctpkpi"fkhÝewnvkgu"cpf"ujqtv"cvvgpvkqp"urcp0"D{"vjg"cig"qh"
9"{gctu."jku"Ýpg"oqvqt"cpf"ncpiwcig"umknnu"unqyn{"dgicp"vq"fgvgtkqtcvg."
‘clumsiness’ was reported and he tended to walk on tiptoe. A progres-
sive dementing encephalopathy followed and, as mental decline, motor 
fgvgtkqtcvkqp"cpf"fgchpguu"fgxgnqrgf."jg"tgswktgf"urgekcnkuv"ectg0"Ewt-
rently, he has moderate mental retardation, sleep disturbances, temper 
vcpvtwou"cpf"j{rgtcevkxkv{"ykvj"cvvgpvkqp"fgÝekv"fkuqtfgt."yjkej"ycu"
treated with Risperidol.
Physical examination at the age of 10 yrs revealed weight 37 kg (25-
50th percentile), length 137 cm (25-50th percentile), head circumference 
51.5 cm (50th percentile).
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Phenotypically he had relative macrocephaly with a long, coarse fa-
cies, thick lips and eyebrows mild synophrys, low nasal bridge, high 
palate, open mouth with salivary overproduction (Fig.1a). Hypertri-
chosis was present on the back. Lordosis was absent from the lumbar 
tgikqp."cpf"vjg"rcvkgpv"gzjkdkvgf"kpetgcugf"vgpfqp"tgÞgzgu"ykvj"Þgzkqp"
eqpvtcevwtgu"qh"vjg"cpmng"cpf"jcoogtujcrgf"vqgu"ykvj"oknf"gswkpqxc-
rus deformity on feet. Visceral examination was normal without orga-
nomegaly or any heart murmur. No corneal opacities were present. He 
ycu"j{rgtcevkxg"ykvj"ujqtv"cvvgpvkqp"urcp"cpf"fkhÝewnv"vq"eqpvtqn0"Jg"
understood simple verbal instructions but his speech was not clearly 
wpfgtuvcpfcdng"cpf"jku"Ýpg"oqvqt"cevkxkv{"ycu"ugxgtgn{"korcktgf0
Skeletal survey revealed mild dysostosis multiplex. There was a thic-
kened diploe, ground glass opacity, sclerosis on basis cranii, wide ribs, 
ovoid vertebraes on the thoracal region, irregular end plates on the 
lumbal vertebrae region with enlargement and mild irregular shapes on 
the spinal processes (Figs.1b-c). Cranial MRI was normal. Hearing test 
eqpÝtogf"ugpuqtkpgwtcn"fgchpguu"ykvj"vjg"tkijv"gct"oqtg"ugxgtgn{"ch-
fected than the left ear. Biochemical and metabolic screening, tandem 
MS, serum ammonia and lactate level, were normal except a strong 
positive urine MPS screening test.
Hkiwtg"3< Phenotype of the patient. (a) Face: coarse facial structures and hirsutism; (b) Craniography: thick calvaria, 
ground glass opacity; (c) Thoracolumbar graphy: wide ribs and ovoid vertebral bodies.
Enzymatic results on urine analyses revealed negative oligosaccharides 
and free neuraminic acid by thin layer chromatography, but positive 
Berry test, elevated GAG (glycosaminoglycans) excretion as 21.41mg/
mmol Cre (N<5.6). GAG electrophoresis showed elevated heparan 
sulphate and chondroitin sulphate what indicated MPS-3 group. Enzy-
ocvke"cpcn{ugu"htqo"ugtwo."ngweqe{vg"cpf"ewnvwtgf"Ýdtqdncuv"tgictfkpi"
a b c
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the different MPS group were performed The GlcNAc-6S sulphatase 
cevkxkv{"kp"ewnvwtgf"umkp"Ýdtqdncuv"egnnu"ycu"pgctn{"¦gtq"eqpÝtokpi"vjg"
diagnosis MPS 3D, in contrast to different enzymes related to other 
types of MPS which were normal (Table I).
The family received genetic counseling and after informed consent 
molecular studies were performed. Primers to amplify the promoter 
and all 14 exons and intron/exon boundaries of the GNS gene (MIM 
829886+"kp"vjg"kpfgz"ecug"ygtg"fgukipgf"*rtkogt"ugswgpegu"ctg"cxck-
ncdng"wrqp"tgswguv+0"Chvgt"RET"cornkÝecvkqp"qh"cnn"gzqpu."ugswgpekpi"
was performed from both strands. In the patient, the homozygous sin-
ing"dcug"rckt"kpugtvkqp"e03448IkpuI"kp"gzqp"33"*Hki0"4+"ycu"kfgpvkÝgf0"
Vjku"owvcvkqp"ycu"tgugswgpegf"kp"vjg"rcvkgpv"cpf"cnuq"kp"dqvj"rctgpvu"
and found the parents heterozygous for the c.1226GinsG mutation. In 
addition, 100 controls were analyzed for the mutation by PCR /restric-
tion digestion and the mutation was not detected. The c.1226GinsG 
mutation is predicted to cause a frame-shift and a premature truncation 
of the protein (p.R409Rfs21X). Therefore, the mutant protein lacks the 
C-terminal part and is likely to cause loss of protein function. 
Sample ENZYME Results  Normal ranges Related Disorder
Serum Iduronate-Sulfatase 572.9 nM/ml/4h 300- 800 MPS- 2
Serum 〈/Inwewtqpkfcug 0.8968 mU/ml 0.281-1.99 MPS- 7
Serum P/Ce/g/Inwequcokpg 1.911 mU/ml 0.320-2.64 MPS- 3B
Leucocyte Sulfamidase 2.299 nmol/mg/17h 3-9 MPS- 3A
Leucocyte N-Ac-Transferase 12.89 nmol/mg/17h 8-32 MPS- 3C
Fibroblast GlcNAc-6S sulphatase 0.2 nmol/mg/17h 31-135 MPS- 3D
Fibroblast g/Kfwtqpkfcug 4.89 mU/mg 1.36-4.40 MPS- 1
 
Vcdng"K< Results of Lysosomal enzymes related to mps group
 DISCUSSION
UcpÝnkrrq" u{pftqog" v{rg" F" ku" cp" cwvquqocn" tgeguukxg" n{uquqocn"
uvqtcig"fkugcug"vjcv"ku"ecwugf"d{"c"fgÝekgpe{"qh"vjg"cevkxkv{"qh"P/ceg-
v{ninwequcokpg/8/uwnrjcvcug"*IPU+."yjkej"ku"tgswktgf"hqt"fgitcfcvkqp"
of heparan sulphate. The clinical features include an initial period of 
hyperactivity and aggressive behavior, followed by progressive neu-
rodegeneration, with relatively mild somatic symptoms and skeletal 
involvement. Biochemical features of type D include accumulation 
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of HS and N-acetylglucosamine-6-sulphate in the brain and viscera. 
Fkcipquku"qh"vjku"tctg"eqpfkvkqp"tgswktgu"c"urgekÝe"gp¦{og"cuuc{"hqt"
n{uquqocn"IPU"cevkxkv{"kp"ewnvwtgf"Ýdtqdncuvu0"ORU"KKKF"ku"vjg"ngcuv"
eqooqp" qh" vjg" hqwt" uwdv{rgu" qh" UcpÝnkrrq" u{pftqog"ykvj" qpn{" 42"
patients have been described in the literature (1-7, 9, 11, 12). 
The causative GNS gene (MIM 607664) is located on chromosome 
34s36"gzvgpfkpi"68md"cpf"kpenwfkpi"36"gzqpu."yjkej"gpeqfg"c"rtq-
tein of 552 amino acids. To date, only seven mutations have been des-
etkdgf" kp" ugxgp"UcpÝnkrrq/F" hcoknkgu<" e0338;fgnC."T577Z."S499Z."
c.1168C>T, c.1138_1139insGTCCT, c.876-2A>G, and large intragenic 
deletion of exon 2 and exon 3. All individual mutations are predicted to 
cause a premature truncation of the protein (1, 2, 5, 9).
Vjg" rtgugpv" ecug" ku" vjg" Ýtuv" tgrqtvgf" Vwtmkuj" rcvkgpv" cpf" jcu" dggp"
found to be homozygous for a single base pair insertion, c.1226GinsG 
leading to a frame-shift and also premature truncation of the protein 
(p.R409Rfs21X). This novel mutation is the eighth mutation described 
in the GNS"igpg"cpf"vjg"rtgugpv"Ýpfkpi"rtqxkfgu"hwtvjgt"gxkfgpeg"vjcv"
loss-of-function is the underlying molecular mechanism.
Hkiwtg"4<"Owvcvkqpu"kfgpvkÝgf"kp"vjg"IPU"igpg0"*C+"Ugswgpeg"ejtqocvqitcou"ujqykpi"vjg"owvcvkqpu"kfgpvkÝgf"kp"vjg"
jqoq¦{iqwu"uvcvg"kp"vjg"rcvkgpv"cpf"jgvgtq¦{iqwu"uvcvg"kp"vjg"rctgpvu."eqorctgf"vq"yknf/v{rg"ugswgpeg0"*D+"Tguwnvu"
of the enzyme restriction method established for mutation detection. As seen, the mutation abolishes a Hpy1881 site 
leading to an uncut amplicon in the patient, while both parents show the pattern for a heterozygous carrier (bands 
indicated by arrows).
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UcpÝnkrrq"u{pftqog"v{rg"F"ku"mpqyp"cu"vjg"tctguv"hqto"qh"UcpÝnkrrq"
u{pftqog"ykvj"c"rqrwncvkqp"htgswgpe{"qh"3"kp"302220222"*:+0"Kpvgtgu-
tingly, 60% of the patients have been of Italian origin suggesting a 
common founder mutation; however, since 8 different mutations were 
found in 8 different families including the present one, this does not 
appear to be true.
Although few families have been analyzed at the molecular level to 
date, MPS-IIID syndrome seems as heterogeneous at the genetic level 
cu" qvjgt" UcpÝnkrrq" uwdv{rgu"ykvjqwv" cp{" rtgfkevcdng" igpqv{rg/rjg-
notype correlation. Thus in clinically and genetically heterogeneous 
uvqtcig"fkuqtfgtu"nkmg"vjg"ORU"itqwru."kv"ku"korqtvcpv"vq"eqpÝto"vjg"
diagnosis through both enzyme analysis and molecular studies in order 
to allow appropriate genetic counseling, family planning and prenatal 
diagnosis. 
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Abstract of the paper: 
Hearing loss (HL) is the most common sensory disorder in humans and affects one in 1000 
newborns. About 30% of hereditary hearing loss (HHL) is associated with co-inherited 
clinical abnormalities and therefore classified as syndromic HL. In the remaining 70% of 
cases, newborns have nonsyndromic HHL, which is characterized by hearing problems and 
mostly due to cochlear defects. Non-syndromic HHL is further classified by mode of 
inheritance. It is almost exclusively monogenic and inherited as an autosomal recessive trait 
(autosomal recessive non-syndromic hearing loss, ARNSHL) in about 70% of cases. HHL is a 
very heterogeneous trait and many gene localizations and causing genes have already been 
identified for non-syndromic hearing loss. One of these genes is Transmembrane channel-like 
gene 1 (TMC1) which has been identified as the disease-causing gene for autosomal dominant 
and autosomal recessive non-syndromic hearing loss at the DFNA36 and DFNB7/11 loci, 
respectively. 
In this study, we investigated one family with dominant and 10 families with recessive non-
syndromic sensorineural hearing loss (ARNSHL) plus additional 51 familial Turkish patients 
with autosomal recessive hearing loss. We amplified and sequenced all 24 intron/exon 
boundaries of the TMC1 gene located on chromosome 9. In seven families with ARNSHL, we 
identified the two known TMC1 c.100C>T and c.1165C>T mutations as well as the four 
novel c.2350C>T, c.77611G>A, c.767delT and c.1166G>A mutations. No proven disease 
causing mutation could be found in TMC1 or in 15 other genes in the remaining families and 
isolated cases. 
 
Own contributions: 
First of all, I designed primers for the TMC1 gene by using genome databases and established 
the test conditions for PCR amplification and sequencing. Then I screened 70 Turkish patients 
with autosomal recessive hearing loss (ARNSHL) for all 24 coding exons of TMC1. 
  40 
I identified the novel homozygous deletion c.767delT in exon 13 in a patient as well as 
another novel c.1166G>A missense mutation in exon 15 in another deafness patient (Table 2, 
p. 4).  
Furthermore, I evaluated the sequencing results by using database analysis and performed 
control studies of 100 control individuals either by an enzyme restriction method or by direct 
sequencing (data not shown). 
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Mutation analysis of TMC1 identifies
four new mutations and suggests an
additional deafness gene at loci DFNA36
and DFNB7/11
Hilgert N, Alasti F, Dieltjens N, Pawlik B, Wollnik B, Uyguner O,
Delmaghani S, Weil D, Petit C, Danis E, Yang T, Pandelia E, Petersen
MB, Goossens D, Favero JD, Sanati MH, Smith RJH, Van Camp G.
Mutation analysis of TMC1 identifies four new mutations and suggests
an additional deafness gene at loci DFNA36 and DFNB7/11.
Clin Genet 2008. # Blackwell Munksgaard, 2008
Hearing loss is the most frequent sensorineural disorder affecting 1 in
1000 newborns. In more than half of these babies, the hearing loss is
inherited. Hereditary hearing loss is a very heterogeneous trait with about
100 gene localizations and 44 gene identifications for non-syndromic
hearing loss. Transmembrane channel-like gene 1 (TMC1) has been
identified as the disease-causing gene for autosomal dominant and
autosomal recessive non-syndromic hearing loss at the DFNA36 and
DFNB7/11 loci, respectively. To date, 2 dominant and 18 recessive
TMC1 mutations have been reported as the cause of hearing loss in 34
families. In this report, we describe linkage to DFNA36 and DFNB7/11
in 1 family with dominant and 10 families with recessive non-syndromic
sensorineural hearing loss. In addition, mutation analysis of TMC1 was
performed in 51 familial Turkish patients with autosomal recessive
hearing loss. TMC1 mutations were identified in seven of the families
segregating recessive hearing loss. The pathogenic variants we found
included two known mutations, c.100C.T and c.1165C.T, and four
new mutations, c.2350C.T, c.77611G.A, c.767delT and c.1166G.A.
The absence of TMC1 mutations in the remaining six linked families
implies the presence of mutations outside the coding region of this gene
or alternatively at least one additional deafness-causing gene in this
region. The analysis of copy number variations in TMC1 as well as DNA
sequencing of 15 additional candidate genes did not reveal any proven
pathogenic changes, leaving both hypotheses open.
N Hilgerta, F Alastia,b,
N Dieltjensa, B Pawlikc,d,
B Wollnikc,d, O Uygunere,
S Delmaghanif, D Weilf, C Petitf,
E Danisa, T Yangg, E Pandeliah,
MB Petersenh, D Goossensi,
JD Faveroi, MH Sanatij,
RJH Smithg and G Van Campa
aDepartment of Medical Genetics,
University of Antwerp, Antwerp, Belgium,
bDepartment of Molecular Genetics,
National Institute for Genetic Engineering
and Biotechnology, Tehran, Iran, cCenter
for Molecular Medicine Cologne,
dInstitute of Human Genetics, University
of Cologne, Cologne, Germany, eMedical
Genetics Department, Istanbul Medical
Faculty, Istanbul University, Istanbul, Turkey,
fUnite´ de Ge´ne´tique et Physiologie
Auditive, INSERM U587, Institut Pasteur,
Paris, France, gDepartment of
Otolaryngology – Head and Neck
Surgery, University of Iowa, Iowa city, IA,
USA, hDepartment of Genetics, Institute
of Child Health, ‘Aghia Sophia’ Children’s
Hospital, Athens, Greece, iApplied
Molecular Genomics Group, Department
of Molecular Genetics, Flemish Institute
for Biotechnology, University of Antwerp,
Antwerp, Belgium, and jDepartment of
Medical Genetics, National Institute for
Genetic Engineering and Biotechnology,
Tehran, Iran
Key words: DFNA36 – DFNB7/11 –
sensorineural hearing loss – TMC1
Corresponding author: Professor Dr Guy
Van Camp, Department of Medical
Genetics, University of Antwerp,
Universiteitsplein 1, B-2610 Antwerp,
Belgium.
Tel.: 132-3-820-24-91;
fax: 132-3-820-25-66;
e-mail: guy.vancamp@ua.ac.be
Received 21 March 2008, revised and
accepted for publication 9 May 2008
1
Hearing loss is the most common sensory disorder
affecting 1 in 1000 newborns. In more than half of
these babies, the cause is hereditary (hereditary
hearing loss, HHL) (1). About 30% of HHL is
associated with co-inherited clinical abnormalities
and therefore classified as syndromic HL. In the
remaining 70% of cases, newborns have non-
syndromic HHL, which is solely characterized
by hearing problems and mostly due to cochlear
defects. Non-syndromic HHL is further classified
by mode of inheritance. It is almost exclusively
monogenic and inherited as an autosomal reces-
sive trait (autosomal recessive non-syndromic
hearing loss, ARNSHL) in about 70% of cases.
Post-lingual hearing loss, in contrast, is oftenmul-
tifactorial, the most prevalent example being age-
related hearing loss or presbycusis, which affects
about half of octogenarians. Families segregating
monogenic post-lingual autosomal dominant
non-syndromic hearing loss (ADNSHL) are well
described but rare compared with presbycusis.
The genetic heterogeneity of HHL is reflected by
the mapping of 43 dominant, 52 recessive and 4
X-linked non-syndromic loci and the identifica-
tion of 44 genes (Hereditary hearing Loss Home-
page, http://webh01.ua.ac.be/hhh/). One example
is transmembrane channel-like gene 1 (TMC1)
(GenBank ID NT_023935 position 4301249–
4615799), mutations of which are a cause of both
ADNSHL and ARNSHL at the DFNA36 and
DFNB7/11 loci, respectively. The gene has been
implicated as the cause of deafness in 34 families: 2
dominant families from North America and 32
recessive families from Pakistan, India, Turkey,
Sudan and Tunisia (2–8) (Table 1). In the mouse
ortholog Tmc1, mutations have been identified in
both the recessive mutant deafness (dn) and the
dominant mutant Beethoven (Bth) (2, 9).
The genomic structure of TMC1 consists of 24
exons that encode a full-length mRNA of
3201 bp. Its sequence is highly similar to TMC2
and to the corresponding mouse orthologs Tmc1
and Tmc2. These genes, together with six other
orthologs, belong to the new TMC gene family,
which has been created as none of the genes shows
nucleotide sequence similarity to other known
genes or domains. Two members of the gene fam-
ily, TMC6 and TMC8, are identical to the long
isoforms of EVER1 and EVER2, respectively.
Mutations in both genes have been found to be
associated with epidermodysplasia verruciformis
(MIM 226400). The exact function of the trans-
membrane proteins encoded by this gene family
remains to be determined. Based upon their struc-
ture, they may act as ion channels, ion pumps or
transporters (10, 11). Studies of the recessive
mutant dn and the dominant mutant Bth have
given some clues about the possible function of
Tmc1 (12). In mice, the protein is expressed before
the onset of hearing in the pericuticular necklace
and the endoplasmic reticulum of mature hair
cells as well as during early postnatal develop-
ment. Therefore, Tmc1 might play a role in nor-
mal maturation of the hair cells. It has been
suggested that the protein may be responsible
for the upregulation or downregulation of ion
channels ormolecules of the exocytoticmachinery
during development. Alternatively, it could be
involved in intracellular trafficking. The expres-
sion pattern of TMC1 is very specific: apart from
its expression in inner and outer hair cells of the
cochlea and in neurosensory epithelia of the ves-
tibular end organs, very low levels of transcript are
also found in human placenta and testis but in no
other tissues (2).
In this study, we report mutation analysis in 1
DFNA36 family, 10 DFNB7/11 families and 51
Turkish index patients of families with ARNSHL
(Table 2). In seven families with ARNSHL, we
identified two known and four novel mutations in
TMC1. In the remaining five DFNB7/11 families
and in the DFNA36 family, no proven disease-
causing mutation could be found in TMC1 or in
15 other genes in the overlap of all candidate re-
gions defined by the significantly linked families.
Materials and methods
Family data
In this study, different approaches were used to
collect families and perform mutation analysis.
Eleven families of different origin segregating
ADNSHL or ARNSHL were collected and ana-
lysed (Table 2) (Fig. S1, supplementary material
online). Family 101 has been reported before (13).
In addition, genetic analysis was performed in 51
Turkish index patients from families with
ARNSHL containing 2 or more affected patients.
All these patients were seen personally and com-
pleted a questionnaire to exclude syndromic hear-
ing loss. All participants signed an informed
consent form. For family PE, audiometry was per-
formed bymeasuring air conduction thresholds at
frequencies ranging from 125 to 8000 Hz. In fam-
ily GRE, auditory evoked potentials were mea-
sured in two affected individuals.
Linkage analysis
DNA was isolated from blood samples of partici-
pating subjects using a standard salting-out pro-
tocol. In a first part of the study, the information
Hilgert et al.
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Table 1. Overview of all TMC1 mutations identified to date
Family name Origin
Sequence variant
Exon
Type of
sequence
variant
Inheritance
pattern ReferencecDNA level Protein level
LMG128 North America c.1714 G.A p.D572N 19 Missense mutation ad (2)
LMG248 North America c.1714 G.C p.D572H 19 Missense mutation ad (7)
PKSR9, PKSN9, PKSN24, PKDF7, PKDF75,
PKDF69, PKDF178, PKDF243, PKDF319,
PKDF401, and three Tunisian cases
Pakistan and Tunisia c.100 C.T p.R34X 7 Nonsense mutation ar (2, 5, 6)
PKDF22 Pakistan c.IVS3_IVS5del27kb 5 Deletion ar (2)
IN-DKB6 India c.295_296delA 8 Deletion ar (2)
PKSR25 and 4090 Pakistan c.IVS10-8T.A Intron 10: 28 Splice site mutation ar (2, 4)
PKSR1a Pakistan c.IVS1311G.A Intron 13: 11 Splice site mutation ar (2)
TR56 Turkey c.776 A.G p.Y259C 13 Missense mutation ar (8)
TR47 Turkey c.821 C.T p.P274L 13 Missense mutation ar (8)
TR50 Turkey c.1083_1087delCAGAT p.R362PfsX6 15 Deletion ar (8)
TR63 Turkey c.1334 G.A p.R445H 16 Missense mutation ar (8)
PKSR20a Pakistan c.1534 C.T p.R512X 17 Nonsense mutation ar (2)
IN-M17 India c.1960 A.G p.M654V 20 Missense mutation ar (2)
4049 Pakistan c.830 A.G p.Y277C 13 Missense mutation ar (4)
DFNB7/11 Sudanese
family and Tunisian family
Sudan and Tunisia c.1165 C.T p.R389X 15 Nonsense mutation ar (3, 6)
DFNB7/11 Sudanese family Sudan c.IVS1915G.A Intron 19: 15 Splice site mutation ar (3)
PKDF431 Pakistan c.1541C.T p.P514L 17 Missense mutation ar (5)
PKDF329 and PKDF511 Pakistan c.1543T.C p.C515R 17 Missense mutation ar (5)
PKDF274 Pakistan c.IVS511G.T Intron 5: 11 Splice site mutation ar (5)
Tunisian family Tunisia c.1764G.A p.W588X 19 Nonsense mutation ar (6)
ad, autosomal dominant; ar, autosomal recessive.
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content for linkage of 11 hearing loss families was
estimated based on SLINK simulations using the
program EASYLINKAGE (version 4.01) (14).
Fixed linkage parameters were used for all LOD
score calculationswith an allele frequency of 0.001
and a phenocopy rate of 0%. For the dominant
family, the penetrance was 0% for the wild-type/
wild-type (wt/wt) genotype and 100% for the
wild-type/mutant (wt/mt) and mutant/mutant
(mt/mt) genotypes. For the recessive families, pen-
etrance was 0% for wt/wt and wt/mt and 100%
for mt/mt.
Different strategies were used for linkage analy-
sis. If the SLINK score had a value of 3.3 or
higher, the family was considered informative
enough for genome-wide linkage analysis (15).
For families in which the LOD score was below
3.3, linkage analysis was performed for known
deafness loci and LOD score calculations were
combined with haplotype analysis to confirm or
exclude linkage. For families 935, Nas and Fay,
DFNB1 was excluded by direct sequencing. Next,
a genome-wide scan was performed for these fam-
ilies as well as for families PE, TM and 101. Link-
age analysis on family 101 has been reported
before (13). In families GRE, G9 and M28, nine
of the more common recessive loci were checked
for linkage (DFNB1, DFNB2, DFNB3, DFNB4,
DFNB7/11, DFNB9, DFNB12, DFNB21 and
DFNB23). In familiesM13 andM36, onlyDFNB1
and DFNB7/11 were screened to find additional
TMC1 families. Linkage analysis was performed
by calculating two-point and multipoint LOD
scores using the EASYLINKAGE program.All gen-
otyping was performed by polymerase chain reac-
tion (PCR) amplification of fluorescently labelled
microsatellite markers and fragment analysis on
anABI 3130 automatedDNA sequencer (Applied
Biosystems, Foster City, CA) using standard
procedures.
DNA sequence analysis
To screen candidate genes, non-coding and coding
exons including the intron–exon boundaries were
PCR amplified. Subsequent DNA sequencing of
both strandswas carried out on anABI 3130 auto-
mated DNA sequencer (Applied Biosystems)
using the Big-Dye Terminator Cycle Sequencing
Kit, Version 3.1 (Applied Biosystems). DNA
sequencing of TMC1 was performed in 2 patients
of 11 hearing loss families and in 51 Turkish index
patients ofARNSHL families. In affected subjects
from larger families in which no TMC1 mutation
was identified, additional candidate genes were
sequenced. Most of these genes localize to theTa
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minimal shared candidate region defined by the
three significantly linked families negative for
TMC1 mutations and include TJP2, MIRN204,
TMEM2, LOC729027, C9ORF77, C9ORF85,
LOC653553, C9ORF57, LOC392350, GDA,
ZFAND5, ALDH1A1, ANXA1, LOC138971 and
LOC138972 (Fig. 2). In addition, DNA sequenc-
ing of TRPM3 was performed in families TM and
101. In all Turkish index patients, the coding exon
of GJB2 was sequenced.
We used the ConSeq Server to check the conser-
vation of amino acids affected by the identified
TMC1 mutations (16). A BLAST analysis of the
human TMC1 protein sequence showed 61 se-
quences with an e-value below 0.001 of which all
hits with a sequence identity below 20% were
excluded.With the remaining 27 sequences, amul-
tiple sequence alignment was made, which was
subsequently used as an input at the ConSeq
Server. The same strategy was used for calculating
the conservation scores for TJP2. ConSeq scores
that are obtained using this procedure vary from 1
(variable) to 9 (conserved).
The I-MUTANT2.0 program was used to predict
the effect of the TJP2 variant on the protein sta-
bility (17). A DDG value is calculated from the
unfolding Gibbs free energy value of the mutated
protein minus the unfolding Gibbs free energy
value of the wild-type protein (kcal/mol). The cal-
culation was performed at pH 7.0 and at temper-
atures of 25C (in vitro conditions) and 37C
(in vivo conditions). DDG values below zero indi-
cate a reduced stability of the mutant protein. A
reliability index (RI) is computed if a negative
DDG value is present, indicating how reliable the
prediction is.
Multiplex amplicon quantification
TMC1 was screened for copy number variations
(CNVs) using the multiplex amplicon quantifica-
tion (MAQ) technique (18, 19). This technique
consists of a multiplex PCR amplification of sev-
eral fluorescently labelled test and reference am-
plicons, followed by fragment analysis. Twelve
test amplicons located in TMC1 and eight refer-
ence amplicons located at randomly selected
genomic positions outside known CNVs were
simultaneously PCR amplified in samples from
two affected subjects and one control from each
of six families (PE, G9, M13, M28, TM and 101).
The primer sequences of the test and reference
amplicons are given in Table 3. Unlabelled and
FAM-labelled primers were ordered from Euro-
gentec (Seraing, Belgium). The multiplex PCR re-
actions were performed on 40 ng genomic DNA
in a 15 ml reaction containing 13 Titanium Taq
PCR buffer (Clontech, Palo Alto, CA) with a final
concentration of 2.5 mM for each dNTP (Invitro-
gen, Carlsbad, CA) and a total of 0.075 ml of
Titanium Taq DNA Polymerase (Clontech).
PCR cycle conditions were 2 min at 98C, fol-
lowed by 23 cycles of 45 s at 95C, 45 s at 60C
and 2 min at 68C. After a final extension step of
10 min at 72C, samples were cooled to 8C. Sub-
sequently, fragment analysis was performed on an
Table 3. Primer sequences of the test and reference amplicons used for MAQ analysis of TMC1
Amplicon name
Forward primer
sequence (3#–5#)
Reversed primer
sequence (3#–5#)
TMC1-Amp01 CTTCAATCAAGTCCCAGTTTCCT TCAAACACACAGTAGTGCCTTCTA
TMC1-Amp02 GATTCAGTTTCAATAAATGCTTCCT CTGTATCAGCCCAGCTTCCT
TMC1-Amp03 TATCTCTTCTTGGATTTCCTTTGCT CTCATACCATTCTCACATTCATTCC
TMC1-Amp04 GGGTAGTTTCCCTTTGTTTCCT CAACAATAGGGTTTGATGTCTCCT
TMC1-Amp05 TTGAGGGTAACTTATGTGTCAACAAC TAAACCCAGTGCTCAAAGTACACTAA
TMC1-Amp06 TGCCACATTCTCATTCTTCCT CTGTCTTGAAAGCCTTCTGATCTA
TMC1-Amp07 TCACTGGCCCACTCTTCC CAGTCAGGTCAACCACATTCC
TMC1-Amp08 TAAATCAAAGGGCATTTCACG CAAACCCTGAAATCCAACAAC
TMC1-Amp09 CGTCCACTTGATCAGATTCCT GATCTTGCTGTGCAAATTCCT
TMC1-Amp10 TTGGTCAGTCTCCTCTGATTCTCTA ATTCAATGTCCAGTCTCCATGTC
TMC1-Amp11 GCCAATAACTGTGTGTTCACG GAACCAAATCCTTTGCATCAAC
TMC1-Amp12 GTGAAAGGGTGAAAGTTCAATTC TTCAACCACCTCATCTTCTGC
TMC1-Contr01 TTCAATATGTATACCCAACCTTCG TAAACTTCAAGGCTACGCTTCTC
TMC1-Contr02 CAGTATCTAAGACCAGGGTGATTCT AAAGATTTCTTCTTCCCAGGCTA
TMC1-Contr04 CTTTGTATCCGAGCTCCATTCT TCATCCTGTCTGCTTTCACAAC
TMC1-Contr05 TGAAATTCTCCAAACACCTGTC TTTCCAAAGCCAGATTATTCCTAA
TMC1-Contr06 CATACCCTTAATGGCTCTTCTTTCT TTCTGGGTTCTCAGCTCTGC
TMC1-Contr08 TCAGGGTAAACAAGGGCAAC TGACTGCCACCATCTTTCG
TMC1-Contr09 CAAGCTCCTCCTCTCCTTCC TGCACACCCATGCATAATAAC
TMC1-Contr11 ACCGGATTCACACACTACCAC AACCACAGCGAGGGATTCT
MAQ, multiplex amplicon quantification.
Four novel TMC1 mutations
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Applied Biosystems 3730 DNA analyzer with the
GeneScan 500 LIZ Size Standard (Applied
Biosystems). The experiment was performed in
duplicate. Peak areas of the test amplicons were
normalized to those of the reference amplicons.
Chromatogram files were analysed with theMAQS
software (http://www.vibgeneticservicefacility.be/
soft/maqs.php). The dosage quotient (DQ) of every
amplicon is calculated as described by Suls et al.
(19). DQ values below 0.75 were considered indic-
ative of a deletion and values above 1.25 indicative
of a duplication.
Results
Clinical data
The Guatemalan family PE segregates ADNSHL
characterized by hearing impairment that starts in
the mid frequencies during the first decade of life
and progresses to involve all frequencies. The rate
of progression is faster in the higher frequencies,
leading to a downward-sloping audiogram after
several decades (Fig. 1). Five subjects in theGreek
family GRE were diagnosed as affected. For the
two youngest patients (3 and 7 years old), auditory
evoked potentials were available, which showed no
response at equipment limits, consistent with pro-
found pre-lingual ARNSHL. Affected subjects in
the other families as well as the Turkish index pa-
tients were reported to have congenital severe-to-
profound sensorineural hearing impairment. By
completing questionnaires, syndromic hearing loss
could be excluded in all cases.
Linkage analysis
Genome-wide linkage analysis in family PE re-
vealed linkage to DFNA36 with a maximal
LOD score of 4.44. About 80% of the total
genome was excluded with LOD scores below
22. Apart from the region on chromosome 9q,
no other linked regions were found. In the reces-
sive family GRE, linkage to locus DFNB7/11 was
identified by linkage analysis of known loci, show-
ing a LOD score of 3.96.We tried to identify addi-
tional families that link to this genomic region in
different ways. A series of Iranian families segre-
gating ARNSHL had been collected before and
although their SLINK scores were not above the
genome-wide significance level, we chose to per-
form linkage analysis for a set of known loci. This
screening revealed suggestive linkage atDFNB7/11
in four families, G9, M28, M13 and M36, all
having LOD scores between 1.66 and 2.91. Three
more families, 935, Nas and Fay, were identified
with probable linkage having LOD scores
between 1.79 and 2.46. All other genomic regions
were excluded. For one additional family, TM,
significant DFNB7/11 linkage was found with
a LOD score of 3.5, while no linkage to other
genomic regions was identified. Family 101 was
previously reported to show significant linkage
to DFNB7/11 and was also included in our anal-
ysis (13). For all families, candidate regions were
defined by polymorphic marker analysis and link-
agewas checked by both haplotype reconstruction
(Fig. S1, supplementary material online) and
LOD score calculation (Table 2). The linked re-
gions of the families included TMC1.
Candidate gene analysis
DNA sequencing of TMC1
Mutation screening of TMC1 was completed by
direct DNA sequencing in 2 patients of each fam-
ily with suggestive and significant linkage and in
51 Turkish index patients with ARNSHL. All
sequence variants segregating with the hearing
loss phenotype are listed in Table 2. In families
935 and Nas, the known mutation c.100C.T
was identified in homozygous condition in all
affected subjects. This change predicts the non-
sense mutation p.R34X. Similarly, in family
Fay, affected subjects were homozygous for the
known mutation c.1165C.T, which causes the
nonsense mutation p.R389X. In the Greek family
GRE, a new nonsense mutation was identified in
exon 20, which segregates with the hearing loss.
The identified nucleotide change c.2350C.T
causes a nonsense mutation p.R604X, leading to
Fig. 1. Air conduction thresholds of the better ear of four
patients of family PE at different ages. There is clear
progression of the hearing loss for individuals III:2 and V:4.
For all patients, mainly the mid and high frequencies are
affected.
Hilgert et al.
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a premature termination codon (PTC). In the Ira-
nian family M36, a new splice site mutation was
identified in all affected subjects. The mutation
c.77611G.A is located at the splice donor site
of exon 7 and changes the 5# splice site from GT
to AT. This change was not identified in 100 Ira-
nian control samples. In an index patient of family
DF139, a 1-bp deletion c.767delTwas identified in
exon 13 ofTMC1. The deletion changes the highly
conserved leucine at position 255 (ConSeq score 9)
and leads to a frameshift p.F255FfsX14. In
a patient of family DF135, a new missense muta-
tion c.1166G.A was identified, causing the
amino acid change p.R389Q. The mutation was
not found in 100 ethnically matched control sam-
ples, and the amino acid at position 389 has aCon-
Seq score of 8. In family G9, a nucleotide change
g.94615A.C was identified in exon 3 (non cod-
ing) ofTMC1 and was found to segregate with the
hearing loss. The variant was not found in 100
Iranian and 100 Belgian control samples.
MAQ of TMC1
In the six families in which no pathogenic TMC1
changes were found,MAQ analysis was completed
using 12 amplicons covering TMC1. Family G9
was also analysed as we could not prove that the
variantwe foundwas pathogenic.No differences in
peak areawere observed between normalized chro-
matograms of affected subjects and controls. This
result indicates that no deletion or duplication is
present at the regions of these amplicons.
Fig. 2. Candidate regions of three fam-
ilies significantly linked to DFNA36 or
DFNB7/11, without TMC1 mutation
identified. All analysed markers and
their corresponding positions from the
Decode genetic map are indicated. At
the left, all candidate genes located in
the common linked region are listed
containing eight genes and six gene
predictions. The common region is
1.49 cM large and includes the TMC1
gene.
Four novel TMC1 mutations
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DNA sequencing of other candidate genes
Other candidate genes were also selected for DNA
sequencing under the hypothesis thatmutations in
another gene in this region also cause HHL. To
narrow the interval, we assumed that the same gene
was mutated in the three families that were signif-
icantly linked to the TMC1 locus (PE, TM and
101), thereby defining a shared interval of
1.49 cM (2596 Mb) common to all families
(Fig. 2). This region contains eight genes and six
gene predictions, including TMC1. The coding
exons and intron–exon boundaries of all 13 candi-
date genes in this region were sequenced in the
three families with significant linkage as well as in
the remaining three families with suggestive link-
age, but no mutations could be identified.
LOC138971 and LOC138972 were also sequenced
because theywere located in the shared region in an
earlier phase of the project when fewer families had
been collected, but no possible pathogenic change
was found in these two genes. In addition to these
genes chosen on the basis of location,TJP2 (ZO-2)
was considered a good candidate due to its inter-
esting function as a tight junction protein and its
expression in the cochlea. In exon 19 of the gene,
a new sequence variant c.2971A.T was identified,
segregatingwith the hearing loss phenotype in fam-
ily PE and causing the amino acid change
p.D924V. This aspartic acid residue has a ConSeq
score of 7 andbelongs to a conserved acidic domain
of the protein. The Grantham score of the amino
acid changewas152,while scores above100 indicate
radical amino acid changes (20). The I-MUTANT2.0
program predicted a decreased stability of the
mutant protein (DDG ¼ 21.84 at 25C and
21.65 at 37C with RI ¼ 2). The change was not
found in any of the non-affected family members
or in 104 independent Belgian control samples and
103 ethnically matched controls. The gene was
sequenced in two affected subjects from 26 addi-
tional small families segregating deafness, but no
variants were identified (data not shown). The
DNA sequencing of GJB2 in all Turkish index
patients revealed the presence of 35delG in hetero-
zygous state in the index patient of family DF139.
Discussion
Twenty different mutations in TMC1 have been
reported as the cause of hearing loss in 2 families
segregating ADNSHL and 32 families segregating
ARNSHL. A literature search allowed making an
estimate of the most frequent causes of ARNSHL
based on the reported numbers of mutations.
GJB2 is without any doubt the most frequent
cause of ARNSHL carrying over 220 different
mutations. The othermore frequent genes, ranked
according to their reported frequency, are
SLC26A4,MYO15A,OTOF, CDH23 and TMC1.
The literature data together with the data from this
report indicate that TMC1 is one of the more fre-
quent causes of ARNSHL. In this study, we have
reported 1 additional dominant family linked to
the DFNA36 locus and 10 additional recessive
families linked to the DFNB7/11 locus. We were
able to identify disease-causing TMC1 mutations
in 5 of these 11 families. In two families, putative
mutations were identified, one inTMC1 and one in
TJP2, but for none of them, the pathogenicity
could be confirmed. In addition, we found two
new TMC1 mutations in an index patient of two
Turkish families segregating ARNSHL.
In families 935, Nas and Fay, known recessive
mutations c.100C.T and c.1165C.T were iden-
tified inTMC1. Both are nonsense mutations lead-
ing to aPTC.As themRNAcontains aPTC, itmay
be detected and degraded by nonsense-mediated
decay, a eukaryotic mRNA surveillance mecha-
nism (21). Including this study, c.100C.T has
been identified in 16 families segregating
ARNSHL, accounting for 47% of all recessive
TMC1 mutations.
In four families withARNSHL,we detected new
pathogenic changes in TMC1. In family GRE,
a nonsense mutation c.2350C.T was found to
cause a PTC at nucleotide position 47 of exon
20. In the Iranian family M36, a novel splice site
mutation c.77611G.A was found to change
the 5# splice donor site of exon 7 from GT to
AT. The effect of this splice site mutation depends
on the adjacent sequence. Use of a cryptic splice
site will lead to partial exon skipping or partial
intron retention. Alternatively, if no cryptic splice
site is used, then, either exon skipping or a greatly
reduced production of normal transcript will be
the predominant outcome (22). Experimental
study of this effect using patient mRNA is not
possible as TMC1 is not expressed in lympho-
cytes. In two Turkish families with ARNSHL,
new TMC1 mutations were identified in an index
patient. The first mutation c.767delT is a 1-bp
deletion causing a frameshift. As a result, 14 amino
acids are altered and followed by a stop codon. The
second mutation, c.1166G.A, causes the highly
conserved amino acid arginine to change into glu-
tamine at position 389of theprotein, causing a shift
from a positively charged into a neutral residue. In
addition, the variant was not found in 100 Turkish
control samples. Therefore, we believe that this
new variant may be pathogenic.
In family G9, a putative pathogenic change was
found in the third non-coding exon of TMC1 seg-
regating with the hearing loss and absent in 200
Hilgert et al.
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control samples. The variant may be located in the
promoter regionor in a regulatory regionof the gene,
but none of these regions has been identified so far.
Functional studies should be performed to further
investigate the effect of the variant on the protein.
In family PE, a putative mutation in TJP2 was
found to segregate with the hearing loss. Different
arguments support the hypothesis that the varia-
tion may be a true pathogenic change. The amino
acid is highly conserved and belongs to a con-
served acidic protein domain, it has a high Gran-
tham score, the mutant protein is predicted to
have a decreased stability and the variant was
absent in 207 control samples. However, no con-
clusive evidence could be given as it is a missense
mutation, and no TJP2mutations were identified
in other hearing loss families. Amutation in TJP2
has already been suggested to be associated with
familial hypercholanaemia (OMIM 607709) (23).
However, the inheritance may be oligogenic, only
causing the disease in combination with a muta-
tion in a second gene. It is possible that the TJP2
variant is a pathogenic variant involved in familial
hypercholanaemia or another autosomal recessive
disease and that the occurrence in the current
family is correlated to the hearing impairment.
In previous reports, patients of six families with
significant linkage to DFNB7/11 did not carry
TMC1mutations (4). In addition, we found three
significantly linked families and three families
with possible linkage that also lack pathogenic
changes in TMC1. To screen for possible disease-
causing mutations, we tested three hypotheses.
First, we hypothesized thatTMC1 is the disease-
causing gene in these families but that the patho-
genic change could not be detected by DNA
sequencing. Therefore, MAQ of TMC1 was per-
formed in six hearing loss families to determine
whether CNVs could be observed. While this
screen failed to identify any deletions or duplica-
tion of the amplicons we used, it should be noted
that smaller CNVs could have been missed as
TMC1 is large and only 12 amplicons were stud-
ied. Complete CNV analysis of TMC1 may allow
detecting smaller rearrangements. This could be
performed either by using a fine-tiling array com-
parative genomic hybridization with oligonucleo-
tides or by using a high-density single nucleotide
polymorphism microarray. Assaying for other
pathogenic changes in TMC1 at the transcription
level using mRNA from blood is not feasible
because TMC1 is not expressed in white blood
cells. It should be noted, however, that this type
of change is infrequent, making it somewhat
implausible that all families would carry this type
of pathogenic mutation. For family PE, we com-
pared the hearing loss phenotype with two other
families, LMG128 and LMG248, segregating
ADNSHL and carryingTMC1mutations (Fig. 1)
(2, 7). The hearing loss of patients from all three
families is comparable, starting in the first to sec-
ond decade and affecting mainly the mid-to-high
frequencies. Later on, the hearing loss becomes
profound across most frequencies, showing some
variation in the low-frequency thresholds. In fam-
ily LMG128, the rate of progression seems to be
faster compared with families LMG248 and PE.
This phenotypic similarity may be an additional
support to the hypothesis that TMC1 is the
disease-causing gene in family PE.
The second hypothesis we tested stated that
a second deafness gene lies near TMC1 and is
the cause of the hearing loss in the families lacking
aTMC1mutation. The common candidate region
shared by all families with significant linkage in-
cludes only 14 genes. No single pathogenic change
could be identified in any of these genes. However,
our screen does not definitively exclude these
genes as a possible new deafness gene. We may
have missed mutations not detectable by DNA
sequence analysis of exons. In addition, the LOC
and c9orf genes might have additional exons,
which have not been annotated yet.
In a third hypothesis, we considered that some
families carry an undetected TMC1 mutation,
while others carry mutations in one or more new
deafness genes. As a corollary to this hypothesis,
the candidate region that contains this new gene(s)
is much larger and many more candidate genes
must therefore be screened for mutations.
In conclusion, we have shown that TMC1 mu-
tations are one of the more frequent causes of
ARNSHL. Our data also show that a subset of
families linked to the DFNA36-DFNB7/11 loci
do not carry mutations in TMC1 exons, suggest-
ing either a remarkably high proportion of muta-
tions outside of the exons or an additional
deafness gene in this region.
Supplementary material
Fig. S1. Pedigrees of all families analysed, with the linked hap-
lotypes at loci DFNA36 and DFNB7/11. All individuals with
hearing loss are indicated with black symbols, the open symbols
are individuals with normal hearing and symbols with questions
marks indicate individuals with an uncertain phenotype. The
analysed markers are listed at the left, and the linked haplotype
is indicated with a box.
Supplementary materials are available as part of the online arti-
cle at http://www.blackwell-synergy.com
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7. Conclusions 
The identification and analysis of altered gene function in inherited forms of limb 
malformations can provide essential information, not only concerning the pathogenesis of the 
disease, but also for understanding physiological processes during limb development. The 
present Ph.D thesis aimed to identify novel key factors and new molecular mechanisms 
involved in physiological and pathophysiological mechanisms during limb development. In 
order to identify novel genes and types of mutations, we wanted to focus on different human 
inherited limb malformations, such as Cenani-Lenz syndrome (CLS), Werner mesomelic 
syndrome (WMS), or Temtamy preaxial brachydactyly syndrome (TPBS).  
During the Ph.D project, new genes and novel types of mutations were identified 
demonstrating that different components of evolutionary highly conserved pathways are 
important key factors during developing limb, each with specific function in limb patterning 
and outgrowth.  In this respect, we identified (i) LRP4 as an essential component of Wnt 
signalling during limb formation, (ii) specific alterations in the long-range limb-specific 
enhancer of the sonic hedgehog (SHH) gene, ZRS, to cause a defined limb malformation, and 
(iii) mutations in CHSY1 that alter chondroitin sulphate chain synthesis. Furthermore, we 
pointed out that the ciliary protein BBS12 is important in the pathogenesis of limb 
malformations seen in Bardet-Biedl syndrome, though the specific role in the context of limb 
bud initiation and patterning is yet unknown.  
Additional results from this Ph.D thesis showed new pathogenic mechanisms underlying 
impaired limb development. We showed that LRP4 mutations in CLS cause a loss of LRP4 
antagonistic function on Wnt signalling, which subsequently leads to an increased activation 
of LRP6-mediated Wnt signalling. Moreover, we elucidated the functional consequence of the 
described WNT10B mutation in SHFM and showed that the analyzed missense mutation 
causes a loss of WNT10B function and possibly a reduced LRP6-mediated Wnt signalling. In 
this context it is a highly interesting finding that we could provide first evidence for a putative 
direct cross-talk between the Wnt and Fgf signalling pathways by demonstrating the ability of 
Fgf8 to bind Wnt10b. As a consequence, Wnt10b looses its ability to activate Wnt signalling.  
In conclusion, this Ph.D thesis provides novel insights into the pathogenesis of limb 
malformations by the identification of new genes and mutations, the elucidation of underlying 
pathophysiological mechanisms, and the finding of a putative direct cross-talk between major 
signalling pathways involved in orchestrating physiological limb development.  
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